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ABSTRACT 
Bone morphogenetic protein (BMP) 4 signalling via BMPR1A is required for the 
maintenance of the epiblast in the early embryo, and for self-renewal of pluripotent 
mouse embryonic stem (ES) cells by inhibiting neural differentiation. In this study, the 
self-renewal and differentiation abilities of ES cells lacking BMPR1A were 
investigated. Bmpr1a-null ES cells did not respond to BMP4 but retained a degree of 
SMAD1/5/8 activation and Id1 expression. This activation was likely due to BMP7 
signalling via ACVR1. The observation that Bmpr1a-/- ES cells showed no self-
renewal or pluripotency defects suggested that signalling by BMPs of the 60a 
subgroup (such as BMP7) can also maintain pluripotency. When Bmpr1a-/- ES cells 
were differentiated, although they did form derivatives of the three germ layers, they 
displayed a higher propensity to undergo neurectodermal specification than control 
cells, likely due to their lower levels of BMP signalling. 
Cell Competition is the process by which viable cells are eliminated in the presence 
of metabolically more active or fitter cells. In Drosophila this process depends on 
dMyc levels and on limiting amounts of the survival factor Decapentaplegic 
(homologous to the mammalian BMPs). When Bmpr1a-/- ES cells were co-cultured 
with wild-type cells, they gradually disappeared from the culture and were therefore 
out-competed. This cell competition was enhanced by limiting the amounts of 
survival and growth factors and could be rescued by restoring BMP4 signalling in 
Bmpr1a-/- cells. In co-culture, Bmpr1a-/- ES cells showed no significant changes in 
apoptosis but had a decreased cell cycle rate and increased levels of differentiation.  
Concomitantly, higher c-MYC levels were observed in wild-type cells due to 
increased protein stability. The out-competition of Bmpr1a-/- cells was dependent on 
differentiation as it could be prevented by inhibiting this process. These results 
suggest that during development cell competition may be an important mechanism 
controlling cell fate and survival. 
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1.  INTRODUCTION 
1.1. Early Mammalian development  
1.1.1. Preimplantation embryo development  
During embryonic development, specific programmes of gene expression are 
progressively established leading to cell commitment into specific lineages and axis 
patterning (Arnold and Robertson, 2009). The expansion of early progenitor cells in 
the embryo, while gradually becoming more specialised and restricted in their 
developmental potential, is regulated by key signalling pathways and by 
developmentally regulated transcription factors. 
Mammalian embryonic development starts in the oviduct with fertilisation, when the 
haploid sperm and oocyte fuse generating a 1-cell embryo, the fertilized egg. During 
the first two days of development following fertilization, a series of mitotic cell 
divisions leads to the formation of an 8-cell embryo, a cluster of undifferentiated cells. 
These 8 cells (or blastomeres) subsequently undergo compactation and a further 
round of division, forming the 16-cell compacted morula (Johnson and McConnell, 
2004). The late compacted morula then experiences the first lineage segregation, as 
the polarized outer layer of cells differentiates into the trophectoderm, giving rise to 
the blastocyst at 3.5 days post coitum (dpc). The early mouse blastocyst comprises a 
cavity (the blastocoel) and two distinct cell populations (Figure 1.1A): the 
trophectoderm (TE), the precursor of all the trophoblast lineages that form the fetal 
part of the placenta, and the inner cell mass (ICM), which will give rise to all the 
embryonic tissues and to the lineages of the yolk sac. The ICM is positioned to one 
side of the TE, designated polar TE, whilst the mural TE surrounds the blastocoel. 
The asymmetric location of the ICM defines the Embryonic-Abembryonic (Em-Ab) 
axis. 
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Figure 1.1 Schematic representation of the early stages of mouse development, when 
the first cell fat decisions are made.  
A) Representation of the events from fertilisation to implantation. During the two days after 
fertilisation the mouse embryo undergoes cell divisions to form the 8-cell morula, which then 
suffers compactation, giving rise to the compacted morula. At 3.5 dpc the conceptus becomes 
a multilayered blastocyst. The outermost layer is the trophectoderm (TE; shown in yellow), 
which later gives rise to extraembryonic tissues such as the ectoplacental cone and 
eventually forms the placenta; The inner cell mass (ICM; shown in light blue) is a mass of 
pluripotent cells, which go on to form every tissue of the animal itself. By 4.0 dpc a 
subpopulation of cells within the ICM move to the inner surface and form the primitive 
endoderm (PE; shown in green). At 4.5 dpc the embryo implants into the uterine wall and 
undergoes morphogenetic changes to form the egg cylinder. The ICM has become the 
embryonic ectoderm, which is referred to as the epiblast (also shown in light blue).  B) Genes 
responsible for lineage segregation. Flow diagram showing the genes responsible for 
converting a totipotent precursor cell into the three lineages of the late blastocyst. Note the 
reciprocal inhibitory interactions that stabilize and reinforce lineage commitment. 
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This first cell fate decision is mediated by cell polarization and the mutually exclusive 
expression of Oct4 (Pou5f1) and Cdx2 (Jedrusik et al., 2008; Niwa et al., 2005; 
Ralston and Rossant, 2008; Strumpf et al., 2005). These transcription factors are 
initially co-expressed in all cells of the compacted morula. Subsequently, Cdx2 and 
Oct4 expression become restricted to the TE and ICM, respectively, by a mechanism 
that might depend on asymmetrical cell divisions of the morula (Jedrusik et al., 2008) 
and reciprocal repression of transcription (Niwa et al., 2005). OCT4 maintains 
pluripotency in the ICM (Nichols et al., 1998) whilst CDX2 expression is essential for 
the integrity and expansion of the TE lineage (Strumpf et al., 2005). Additionally, 
within the ICM of the early blastocyst, a mosaic and random “salt and pepper” 
expression of the transcriptions factors Nanog and GATA6 can be observed 
(Chazaud et al., 2006). Chazaud and coworkers have suggested that Nanog and 
Gata-6 expressing cells are already committed for the subsequent lineage 
segregation, which takes place just before implantation. Gata-6-positive cells are 
thus sorted to the distal surface of the ICM, where they form the hypoblast or 
primitive endoderm (PE), and Nanog-positive cells exclusively give rise to the 
pluripotent epiblast (Figure 1.1B). Lineage tracing and chimera studies in the mouse 
have shown that these lineages are restricted in fate by the time of implantation. The 
epiblast (or embryonic ectoderm) will give rise to all tissues of the embryo proper 
whereas derivatives of the TE and the PE give rise to the extraembryonic structures 
that support the intra-uterine development of the embryo and act as signalling 
sources to pattern the underlying embryonic tissues (reviewed in Rossant, 2004). 
 
As depicted here, with each cell division during embryonic development, cells 
increase their degree of differentiation and, inevitably, become more and more 
restricted in their developmental potential (reviewed in Arnold and Robertson, 2009). 
The fertilised egg and cells of the 2- and the 4-cell embryo are totipotent as they can 
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give rise to every cell type of the organism (including extra-embryonic lineages). By 
the blastocyst stage, the cells of the epiblast are still able to give rise to all somatic 
lineages but have lost the ability to generate cells of the extra-embryonic tissues 
(placenta and extra-embryonic membranes). These cells are thus called pluripotent 
and can differentiate into cells of the three somatic germ layers (ectoderm, 
mesoderm, endoderm) as well as primordial germ cells. The cells from the TE and 
PE are multipotent since they can differentiate exclusively into trophoblast, and 
visceral and parietal endoderm lineages, respectively (Bielinska et al., 1999; 
Rossant, 2001).  
This view has recently been questioned by Silva, Nichols and Smith (Nichols and 
Smith, 2009; Silva and Smith, 2008), who argue that the egg and blastomeres have a 
restricted developmental potential, being able to directly generate only two cell types, 
the trophoblast and the ICM. Subsequent development thus requires the acquisition 
of further potency by the ICM. Therefore, the authors suggest that the epiblast of the 
late blastocyst does not represent a restriction in potency from the egg; conversely, it 
constitutes a “ground state”, a completely unrestricted population with the potency 
and epigenetic flexibility to generate all the embryonic lineages during development. 
 
Epigenetic regulation, including regulation at the level of DNA, histones and nuclear 
organization, is also an essential part in the establishment and, more importantly, 
maintenance of a given cellular identity throughout development (reviewed in Kiefer, 
2007; and Ng and Gurdon, 2008). However, this level of regulation will not be 
explored here.  
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At 4.5 dpc the blastocyst hatches from the protective outer zona pellucida and 
implants into the uterine wall. At this stage the conceptus is referred to as the egg 
cylinder.  
 
1.1.2. Implantation and axis formation  
Implantation and formation of the egg-cylinder embryo 
During implantation, between 4.5 and 5.0 dpc, the embryo attaches to the 
endometrial surface and the trophectoderm invades the uterine epithelium, anchoring 
to the uterine connective tissue. 
For successful implantation to occur both the uterus and the blastocyst must be 
receptive, that is, have achieved implantation competency. There is a “window” of 
implantation, which depends on locally produced signalling molecules, including 
cytokines, growth factors, homeobox transcription factors, lipid mediators and 
morphogens (Wang and Dey, 2006). These signals, together with ovarian hormones, 
serve as autocrine, paracrine and juxtacrine factors to specify uterine receptivity.  
At the peri-implantation stage the mouse embryo undergoes a series of 
morphogenetic changes to form the “egg cylinder” (Figure 1.1A). The polar TE 
expands in response to fibroblast growth factor (FGF) 4 secreted by the epiblast 
(Tanaka et al., 1998), and forms the extraembryonic ectoderm (ExE) and the 
ectoplacental cone, the progenitors of the placenta. This pushes the epiblast towards 
the distal pole of the conceptus into the blastocoel cavity. At this stage the PE 
differentiates to become parietal endoderm, which migrates from the surface of the 
ICM and forms a protective membrane that envelops the entire egg cylinder, and 
visceral endoderm (VE). The VE constitutes a continuous cell monolayer that 
overlies both the ExE and the epiblast, and will eventually form part of the yolk sac 
(Arnold and Robertson, 2009). 
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A further morphogenetic process that takes place around the time of implantation is 
the formation of the pro-amniotic cavity, which forms in the centre of the epiblast 
converting it into a cup-shaped columnar epithelium. This process, named cavitation, 
is the result of a combination of apoptotic signals from the visceral endoderm 
(Coucouvanis and Martin, 1995) and selective cell survival mediated by adhesion to 
the basement membrane between the VE and epiblast (Murray and Edgar, 2000). 
Coucouvanis and Martin have also shown that Bone Morphogenetic Protein (BMP) 
signalling is capable of promoting, and is required for, differentiation of the VE and 
cavitation (Coucouvanis and Martin, 1999). The surviving epiblast cells that line the 
cavity become polarized, as the contact with the basement membrane defines an 
apical and basal surface, and form a pseudostratified columnar epithelium. 
Maintenance of pluripotency of the epiblast at the egg-cylinder stage also requires 
the TGF-β-related molecules Nodal and BMPs, as in their absence the epiblast 
prematurely differentiates into neurectoderm (Camus et al., 2006; Di-Gregorio et al., 
2007; Mesnard et al., 2006). 
 
Establishing the anterior–posterior (A-P) axis.  
Just after implantation, reciprocal signalling between the epiblast, ExE and VE, by 
secreted growth factors of the TGF-β (Nodal and BMPs), Wnt and FGF families, 
leads to regionalised gene-expression patterns in these tissues. This sets up the 
embryonic axis, marking the start of embryonic patterning, and is required for 
subsequent developmental steps such as cell lineage allocation and tissue 
differentiation.  
Around 5.25 dpc, Nodal signalling via SMAD2 leads to the specification of the distal 
visceral endoderm (DVE) at the distal tip of the embryo (Brennan et al., 2001). The 
DVE will act as a specialised signalling centre that orquestrates anterior-posterior (A-
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P) axis development. Inhibitory signals from the ExE prevent DVE induction in the 
proximal VE, restricting it to the distal tip of the conceptus (Richardson et al., 2006; 
Rodriguez et al., 2005). At 5.5 dpc the DVE moves towards the prospective anterior 
side of the embryo forming the anterior VE (AVE), and signalling by this tissue 
establishes embryonic A-P polarity (Beddington and Robertson, 1998; Thomas and 
Beddington, 1996).  
Nodal signalling also has an important role in driving DVE migration, as reduction in 
the level of Nodal transcription prevents it (Lowe et al., 2001). The exact mechanism 
that directs the coordinated movement of the DVE remains unknown but both 
differential proliferation and active migration have been suggested to play a role 
(reviewed in Srinivas, 2006). In particular, Dkk1 expression at the prospective 
anterior may act as an attractive signal for directing the active migration of DVE cells 
(Kimura-Yoshida et al., 2005). 
The AVE cells express extracellular Nodal and Wnt-signalling antagonists including 
cerberus-like-1 (Cer1), left–right determination factor 1 (Lefty1) and Dickkopf 
homologue 1 (Dkk1), attenuating Nodal and Wnt signalling and thus maintaining the 
anterior character of the adjacent epiblast (Srinivas, 2006). 
Positioning of the AVE and the consequent A-P molecular asymmetry precedes any 
morphological sign of embryonic pattern. 
 
1.1.3. Gastrulation and germ layer formation 
During gastrulation the three embryonic germ layers, ectoderm, mesoderm and 
definitive endoderm (DE), are generated and these will constitute the progenitor 
lineages of all the embryonic tissues. At later stages of development, ectoderm 
derivatives will form neural tissues, neural crest and skin. Mesoderm cells form many 
cell types of internal organs like muscle, bone, cartilage, connective tissues, 
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vasculature and blood. The outer layer of definitive endoderm gives rise to the gut 
tube and associated organs, such as the lungs, liver and pancreas.  
At around 6.0 dpc, epiblast cells begin to converge towards the proximal posterior 
pole of the embryo to form the primitive streak, which marks the onset of gastrulation 
(Beddington and Robertson, 1999; Tam and Behringer, 1997). At the primitive streak 
cells undergo an epithelial to mesenchymal transition (EMT), ingress in between the 
epiblast and the overlying VE, and subsequently emerge as mesoderm or 
incorporate the definitive endoderm (reviewed in Tam and Behringer, 1997). 
High levels of Nodal, BMP, and Wnt signalling at the proximal posterior epiblast are 
required for primitive streak (PS) induction. Auto-regulatory reciprocal interactions 
between the epiblast and the ExE maintain high levels of these morphogens at the 
appropriate location (reviewed in Tam and Loebel, 2007). Mutants in which the 
activation of these pathways has been compromised fail to form mesoderm and do 
not gastrulate (Conlon et al., 1994; Liu et al., 1999; Mishina et al., 1995; Tam and 
Loebel, 2007). Conversely, embryos that lack expression of Wnt and TGF-β 
antagonists exhibit the formation of multiple or enlarged primitive streaks (reviewed 
in Tam and Loebel, 2007).  
The PS, initially induced at the proximal posterior pole of the epiblast, progressively 
elongates and extends to the distal tip of the embryo. Molecular analyses and 
lineage mapping studies have shown that different regions of the primitive streak 
differ in gene expression patterns, signalling environments and developmental 
potential. The allocation of gastrulating cells to specific lineages is thus temporally 
and spatially controlled (Lawson, 1999; Lawson et al., 1991) by differences in 
signalling strength of BMP4, Nodal, Wnt3 or Wnt3a, and FGF8 (reviewed in Tam and 
Loebel, 2007).  
The first mobilized epiblast cells ingress trough the posterior part of the PS giving 
rise to the extraembryonic mesoderm. As gastrulation proceeds, cells migrate 
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through more anterior parts of the PS and generate cranial, cardiac and paraxial 
mesoderm, and subsequently axial mesendoderm. Definitive endoderm develops 
from epiblast cells that transit the most anterior region of the PS (reviewed in Tam 
and Loebel, 2007). In the anterior end of the primitive streak, another specialised 
structure can be distinguished, the node, which is an important signalling centre for 
A-P and left–right patterning. In contrast to mesoderm and definitive endoderm, the 
ectoderm lineage derives from the anterior region of the epiblast that does not enter 
the PS . 
At the molecular level, genes such as Brachyury (T), are expressed throughout the 
PS, whereas others are found preferentially in posterior (Cdx2, HoxB1), intermediate 
(Mixl1, Lhx1) or anterior regions (Foxa2 and Gsc) (reviewed in Arnold and 
Robertson, 2009; and Tam and Loebel, 2007). 
 
Segregation of primordial germ cells (PGCs) from the somatic lineages at 
gastrulation requires signals from the extraembryonic ectoderm and visceral 
endoderm (reviewed in Hayashi et al., 2007). Around 5.5 dpc, a group of cells at the 
proximal epiblast start expressing Fragilis in response to BMP4 signals from the ExE. 
Subsequently, some of these cells acquire Blimp1 expression, becoming restricted 
PGC precursors. After gastrulation, the PGC precursors locate to the posterior 
proximal region, where they undergo specification to form the population of Stella-
positive PGCs. PGCs undergo extensive epigenetic reprogramming to maintain 
pluripotency throughout the life cycle. 
 
1.2. Pluripotent stem cell lines 
Pluripotency, the capacity to generate all cell types, is a cellular property transiently 
found in vivo in the ICM of the mammalian blastocyst (reviewed in Rossant, 2007) 
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and conserved until 7.5 dpc only in some regions of the epiblast (Beddington, 1982; 
Beddington, 1983; Diwan and Stevens, 1976; Lawson et al., 1991) and later in PGCs 
(Donovan, 1998). Pluripotency can also be found ex vivo in stem cell lines, such as 
embryonic stem (ES) cells, derived and maintained under defined growth conditions 
that promote proliferation while preventing differentiation (Chambers and Smith, 
2004; Niwa, 2007; Silva and Smith, 2008) 
Embryonal carcinoma cells were the first pluripotent cells to be propagated in vitro 
(reviewed in Solter, 2006). Since then, pluripotent stem cell lines have been derived 
from different species, distinct tissues of the embryo, at different stages of 
development an even from reprogrammed adult somatic tissues (reviewed in 
Rossant, 2008).  
 
1.2.1. Embryonal carcinoma (EC) cells 
EC cells are derived from teratocarcinomas, malignant germ cell tumours that 
comprise both undifferentiated cells and differentiated derivatives of all three germ 
layers. When fragments of teratocarcinomas were put in culture, a variety of cell 
types was obtained, among them some that could be clonally expanded and that had 
the potential to form new teratomas once transplanted into host animals (reviewed in 
Solter, 2006). The use of a layer of feeder cells, usually fibroblasts, allowed the 
successful expansion of these pluripotent cells with little differentiation, and hence 
the establishment of EC cell lines. EC cells can be clonally derived from single cells, 
are capable of both self-renewal and multilineage differentiation, being even 
competent to contribute to various somatic cell types upon injection into mouse 
blastocysts (Papaioannou et al., 1978). Despite an abnormal karyotype, EC cells 
have similar developmental properties, and express markers in common with the 
pluripotent cells of the early embryo (Andrews et al., 2005). The isolation of EC lines 
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made possible the definition of conditions that allowed self-renewal and also some 
models of differentiation later used in ES cells.  
 
1.2.2. Embryonic stem (ES) cells 
ES cells were derived for the first time in 1981 (Evans and Kaufman, 1981; Martin, 
1981) from the ICM of mouse blastocysts, using the same culture conditions as the 
ones previously used for the isolation of embryonal carcinoma (EC) cells (reviewed in 
Solter, 2006). However, only more than 15 years later were the first human ES (hES) 
cell lines isolated (Thomson et al., 1998).  
Two essential properties characterise ES cells: self-renewal and pluripotency. Given 
their ability to self-renew, under appropriate conditions, ES cells can be maintained 
indefinitely in culture in an undifferentiated state without losing their pluripotency. 
Both mouse and human ES cells can differentiate in vitro into a variety of cell types, 
and after ectopic transplantation give rise to teratomas containing derivatives of the 
three germ layers (reviewed in Yu and Thomson, 2008). When mouse ES cells are 
reintroduced into developing blastocysts, they are readily incorporated into the ICM 
and re-enter embryonic development generating chimeric animals with contribution to 
all embryonic tissues, including germ cells (Bradley et al., 1984).  
The self-renewal and multi-lineage differentiation abilities make stem cells uniquely 
convenient for regenerative medicine, tissue repair and gene therapy applications 
(reviewed in Murry and Keller, 2008), reasons for which stem cells have become the 
focus of many current studies. Additionally, their potential for in vitro differentiation 
makes them a useful model for the study of embryonic development at the cellular 
and molecular level (reviewed in Nishikawa et al., 2007). Finally, ES cells can be 
genetically modified, providing a means of interfering with genetic functions and 
creating lines that bear specific markers. The ability for germline transmission allows 
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these modifications to be passed to the mouse progeny creating transgenic mouse 
lines (reviewed in Raymond and Soriano, 2006). 
 
Genetic control of Pluripotency  
Cell fate during development is decided by transcription factors that act as molecular 
switches to activate or repress specific gene expression programmes. The activity of 
transcription factors, however, is mainly controlled by stimuli from the extracellular 
environment. Lineage specification is thus determined by both extrinsic and intrinsic 
factors.  
Three main transcription factors have been suggested to form a core network that 
controls the maintenance of pluripotency in mouse ES cells (Figure 1.2) (reviewed in 
Boiani and Scholer, 2005; Boyer et al., 2006; and Chambers and Smith, 2004). 
These are the POU-family transcription factor Oct4 (Nichols et al., 1998; Niwa et al., 
2000), the homeodomain DNA-binding protein Nanog (Chambers et al., 2003; Mitsui 
et al., 2003) and the SOX-family transcription factor Sox2 (Avilion et al., 2003). 
These three transcription factors are all highly expressed in the inner cell mass and 
epiblast of the mouse embryo and in undifferentiated ES cells (reviewed in Niwa, 
2007).  
Null mutations of each of these genes results in early embryonic lethality due to the 
inability to maintain pluripotent cells (Avilion et al., 2003; Mitsui et al., 2003; Nichols 
et al., 1998). A key role of the Oct4, Sox2 and Nanog transcription factors seems to 
be to counteract differentiation by continuously suppressing functional expression 
and activity of lineage specification factors, thereby promoting self-renewal and 
maintaining pluripotency (Niwa, 2007; Silva and Smith, 2008; Smith, 2005). Co-
regulatory and auto-regulatory mechanisms appear to link the three factors in a self-
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reinforcing circuit (reviewed in Niwa, 2007). This network of transcriptional regulators 
is also conserved in human (h)ES cells.  
Oct4 expression in the mouse is restricted to early embryos and germ cells (Scholer 
et al. 1989). Homozygous deletion of this gene results in an embryo consisting 
exclusively of trophectoderm tissues due to a failure in the formation of the ICM 
(Nichols et al., 1998). In vitro, Oct4 expression is a hallmark of both mouse and 
human ES cells and is lost upon differentiation; overexpression of this protein causes 
differentiation into endoderm and mesoderm, whereas its repression leads to 
differentiation into trophoblast (Niwa et al., 2000). This clearly suggests that the 
precise regulation of the levels of Oct4, within a narrow range, is required to sustain 
self-renewal.  
Nanog expression, as for Oct4, decreases rapidly as ES cells differentiate 
(Chambers et al., 2003; Mitsui et al., 2003). Mouse ES cells lacking Nanog are still 
able to proliferate undifferentiated but show a greater tendency for spontaneous 
differentiation towards extra-embryonic endoderm and cannot give rise to mature 
germ cells (Chambers et al., 2003; Mitsui et al., 2003). Conversely, over-expression 
of Nanog sustains mouse ES cells in the absence of exogenous cytokines (LIF and 
BMPs) that would otherwise be required for self-renewal (Chambers et al., 2003; 
Ying et al., 2003a). 
Sox2, a member of the SOX (SRY-related high mobility group (HMG)-box) family of 
transcription factors, also plays a key role in the self-renewal and pluripotency of ES 
cells. Unlike Oct4 and Nanog, Sox2 expression is not restricted to pluripotent cells as 
it is also detected in early neural lineages (Ellis et al., 2004; Li et al., 1998) in addition 
to the ICM, epiblast, and germ cells (Avilion et al., 2003). Sox2-null embryos die 
around implantation due to a failure in epiblast development (Avilion et al., 2003). 
Also, similarly to what is observed for Oct4, Sox2 deletion in ES cells results in 
differentiation to trophectoderm (Masui et al., 2007). Indeed, Sox2 and Oct4 are 
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transcriptional partners that regulate the expression of several pluripotency-
associated genes, including Fgf4, Lefty1 and Nanog. This is achieved by the binding 
of both transcription factors to their respective motifs in Oct-Sox enhancers, which 
are highly active in undifferentiated ES cells but not in differentiated cells (Chew et 
al., 2005; Tomioka et al., 2002; Yuan et al., 1995). Oct4 and Sox2 are regulated by 
positive self-reinforcing loops, as the Oct-Sox enhancers are also important in 
promoting the expression of Oct3/4 and Sox2 themselves (Chew et al., 2005; 
Okumura-Nakanishi et al., 2005; Richardson et al., 2006; Tomioka et al., 2002). 
However, a recent report has argued that Sox2 is dispensable at the Oct-Sox 
enhancers and that, instead, it promotes pluripotency by regulating transcription 
factors that maintain the appropriate levels of Oct4 expression (Masui et al., 2007).  
The DNA-binding sites for Oct4, Sox2, and Nanog have been extensively studied 
using a genome-wide approach (Boyer et al., 2005; Loh et al., 2006). These studies 
have shown that, although the mouse and hES-cell models are different from each 
other and show very specific targets, the three transcription factors share many 
target genes in both of them, including a large number of developmentally important 
transcription factors. Additionally, these studies have confirmed that Oct4, Sox2, and 
Nanog positively influence their own transcription. 
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Figure 1.2 Intrinsic and extrinsic control of ES-cell self renewal.  
LIF and BMP act together to block differentiation. LIF activates STAT3 and blocks non-neural 
differentiation. BMP blocks neural differentiation by induction of Id’s. The intrinsic 
transcriptional regulators Nanog, Oct4 and Sox2 act to maintain an undifferentiated 
phenotype (adapted from Chambers and Smith, 2004).  
 
An extended transcriptional network 
Lately it has become evident that the network that controls pluripotency is more 
complex and involves other players (Kim et al., 2008). For example, EC cells express 
all three transcription factors at considerable levels, yet they do not have the same 
potential as pluripotent ES cells (Chambers and Smith, 2004). This strongly suggests 
that other transcription factors and regulators are required to either establish or retain 
pluripotency. Another piece of evidence is the reprogramming of somatic cells mouse 
embryonic fibroblasts to ES-like pluripotent stem cells by the induced expression of 
defined factors outside the traditional core such as Klf4 and c-Myc, in addition to 
Oct4 and Sox2 (Takahashi and Yamanaka, 2006). In fact, new regulators of 
pluripotency (such as Esrrb, Dax1, Sall4, Rex1, Stat3, among others) and their 
interaction networks, have recently been identified by shRNA knock-down screens 
(Ivanova et al., 2006), proteomics (Wang et al., 2006) and analysis of transcription 
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factor binding sites and gene expression data (Zhou et al., 2007). The analysis of 
target promoters of candidate transcription factors, including reprogramming factors, 
has shown that promoters bound by a high number of these regulators are generally 
active in the pluripotent state and become repressed upon differentiation (Kim et al., 
2008). The extent and complexity of the pluripotency transcriptional network will 
continue to expand as our understanding of ES cells improves and new tools for their 
study become available (Orkin et al., 2008). 
 
Extrinsic regulators of mouse ES cell self-renewal 
The culture conditions in which ES cells have been maintained over the years since 
their derivation have become progressively more defined. This has been both a 
cause and a consequence of a better understanding of the pathways that control ES 
cell self-renewal and differentiation.  
Mouse ES cells generally require extrinsic factors in the culture medium to maintain 
the undifferentiated state. The first mouse ES cell lines were derived using fibroblast 
feeder layers and serum (Evans and Kaufman, 1981; Martin, 1981). The feeder cells, 
besides providing a matrix for cell attachment, secrete factors that suppress 
spontaneous differentiation of ES cells in vitro. Medium conditioned by the culture of 
specific cell types was found to be able to sustain ES cells in the absence of feeders, 
and the factor in the conditioned medium responsible for this effect was identified as 
the cytokine leukemia inhibitory factor (LIF) (Smith et al., 1988; Williams et al., 1988). 
LIF and related cytokines act via LIFR/gp130 receptors, activating Janus-associated 
tyrosine kinases (JAK)/latent signal transducer activator of transcription factor 
(STAT)3 (Yoshida et al., 1994), and Shp2/ERK mitogen-activated protein kinase 
(MAPK) cascades (Takahashi-Tezuka et al., 1998). The self-renewal effect of LIF is 
mediated via STAT3 and its activation alone is sufficient for maintenance of mouse 
ES cells in the presence of serum (Matsuda et al., 1999; Niwa et al., 1998). ERK 
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activation, however, predisposes cells to differentiation (Kunath et al., 2007) and its 
suppression promotes ES cell self-renewal (Burdon et al., 1999). Thus the 
proliferative effect of LIF on mouse ES cells requires a finely tuned balance between 
positive and negative effectors. In addition to repressing differentiation, LIF also 
promotes growth and viability of ES cells (Duval et al., 2000). Myc activation has 
been reported to be a critical effector of LIF-induced self-renewal (Cartwright et al., 
2005). Myc is highly expressed in undifferentiated mouse ES cells and its levels 
promptly go down after LIF withdrawal. Cartwright and coworkers have shown that 
Myc is a STAT3 transcriptional target in ES cells, that it blocks differentiation, and 
that sustained MYC activity maintains ES-cell self renewal in the absence of LIF. 
Also, the downregulation of MYC protein levels during differentiation is dependent on 
threonine 58 phosphorylation and consequent GSK3-mediated degradation 
(Cartwright et al., 2005). 
In serum-free medium, LIF/STAT3 alone is insufficient to prevent mouse ES cell 
differentiation as some neural differentiation still occurs. However, in combination 
with BMPs, ES cell self-renewal is sustained (Figure 1.2) (Ying et al., 2003a). BMPs 
induce the expression of ID (inhibitor of differentiation) proteins through activation of 
the SMAD pathway, thereby repressing differentiation towards neural fates. Ying and 
coworkers have shown that the overexpression of Ids could indeed promote mouse 
ES cell proliferation in the presence of LIF alone without the need for either BMPs or 
serum. Qi and coworkers, however, replaced exogenous BMP4 in the culture 
medium by ERK and p38 inhibitors as a means to maintain ES self-renewal, arguing 
that BMPs act through inhibition of MAPK pathways independently of SMADs (Qi et 
al., 2004).  
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The ground state 
As described above, the activation of specific transcriptional regulators, in particular 
STAT3 and SMADs, via stimulation by extrinsic factors is generally considered 
necessary for ES cell maintenance. However, a recent report by Ying and coworkers 
has questioned this traditional view showing that extrinsic stimuli are dispensable for 
self-renewal as long as auto-inductive differentiation signals are repressed (Ying et 
al., 2008). FGF4 is produced in an autocrine fashion by undifferentiated ES cells. 
FGF4, among other extrinsic factors, activates the ERK signalling cascade, 
instructing ES cells to exit self-renewal and enter a primed state, where they become 
responsive to inductive cues for lineage specification (Kunath et al., 2007; Stavridis 
et al., 2007). Blockade of this pathway using chemical inhibitors enhances the growth 
of undifferentiated ES cells (Burdon et al., 1999; Sato et al., 2004), and in 
combination with suppression of glycogen synthase kinase-3 (GSK3) is sufficient to 
sustain ES cell self-renewal (Ying et al., 2008). The use of selective small-molecule 
inhibitors to suppress FGF receptor tyrosine kinases and ERK signalling (by SU5402 
and PD184352, respectively) in serum-free medium, significantly reduces 
spontaneous differentiation of ES cells, except for occasional neural differentiation, 
but it is insufficient to maintain ES-cell propagation due to impaired growth and 
survival. GSK3 inhibition, on the other hand, suppresses neural specification and 
enhances growth capacity, promoting non-neural differentiation. However, the 
combination of the three inhibitors (3i) results in a highly efficient expansion of 
undifferentiated colonies, even at a low cell density (Ying et al., 2008). The 3i 
combination of inhibitors allowed the derivation of ES cells from refractory strains and 
when these were injected into morulae resulted in high-contribution chimeras and 
germline transmission. A more potent MEK inhibitor, PD0325901, is sufficient to 
sustain ES cells in combination with the GSK3 inhibitor (2i), confirming the central 
role of ERK, downstream of FGF, in promoting ES-cell escape from self-renewal. 
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The authors have also shown that the contribution of GSK3 inhibition, beyond limiting 
differentiation, is mainly to maintain metabolic activity, biosynthetic capacity and 
overall viability, in this way possibly increasing the threshold for commitment (Ying et 
al., 2008). Additionally, the 2i condition, on feeders or with addition of LIF, was 
successfully used for the derivation of rat ES cells (Buehr et al., 2008; Li et al., 2008), 
a previously refractory species, and enhanced the isolation of induced pluripotent 
stem cell (iPSC) lines with full pluripotent capacity (Guo et al., 2009; Silva et al., 
2008). These observations led the authors to suggest that inhibition of autoinductive 
differentiation is sufficient to maintain ES cells in a fully unrestricted and intrinsically 
self-maintaining basal state, the “ground state” of pluripotency (Nichols and Smith, 
2009; Silva and Smith, 2008). 
 
Differentiation of mouse ES cells 
The ability of ES cells to differentiate into derivatives of the three primary germ layers 
establishes their potential, both for clinical applications and as models for the in vitro 
study of developmental processes. However, for their use in these areas it is 
essential to be able to control ES cell differentiation and to direct their development 
along specific pathways.  
Several protocols have been developed for the generation of a broad spectrum of 
cell types from ES cells (reviewed in Murry and Keller, 2008). These can be grouped 
into three basic approaches: 1) the formation of three-dimensional aggregates known 
as embryoid bodies (EBs), 2) the culture of ES cells as monolayers on extracellular 
matrix proteins, and 3) the culture of ES cells on supportive stromal layers. Efforts 
have been made towards the use of progressively more defined conditions, such as 
the use of serum-free media with specific inducers to direct differentiation. Also, ES-
cell differentiation has recently been approached from a developmental biology 
perspective, allowing the recapitulation of key events that regulate early lineage 
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commitment in the embryo. This results in the efficient and reproducible generation 
of highly enriched differentiated cell populations (Murry and Keller, 2008). 
When grown as aggregates in suspension, in the absence of LIF, ES cells form 
embryoid Bodies (EBs). In these structures, differentiation proceeds into the three 
germ layers, in a manner reminiscent of pre- and peri-implantation development. EB 
differentiation recapitulates embryonic events such as the formation of an external 
endoderm layer, differentiation of a columnar epithelium, formation of a central cavity 
and mesoderm specification (Coucouvanis and Martin, 1995; Martin et al., 1977). 
However, this is a poorly controlled system in which serum factors play undefined 
roles, and gives rise to very heterogeneous cell populations. 
Common to the different protocols, the first step in the differentiation pathway is 
generally the development of a population resembling the epiblast of the mouse 
embryo. When induced with Wnt, activin, BMP or serum, ES cells generate a 
Brachyury-positive, primitive streak-like population (reviewed in Murry and Keller, 
2008). Subsequent manipulation of the BMP, Wnt and Nodal pathways in ES-cell 
cultures modulates differentiation into representatives of specific germ layers and cell 
types (Figure 1.3) in a way that resembles the developmental programme of the 
embryo (reviewed in Murry and Keller, 2008). Therefore, the period of exposure and 
sequence of addition of particular factors can considerably alter the differentiation 
pathway induced. Also resembling what happens in the embryo, in the absence of 
PS-inducing signals, ES cells differentiate into the neurectoderm lineage (Tropepe et 
al., 2001; Ying et al., 2003b).  
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Figure 1.3 Schematic representation of ES-cell differentiation into primitive ectoderm 
and the primary germ layers and the main signalling pathways involved in these 
choices.  
A hypothetical primitive streak is shown consisting of both posterior and anterior populations 
from which the different cell types are established. BMP4 is shown to function to induce 
posterior mesoderm and skin. A gradient of activin/nodal signaling is indicated, with low 
concentrations inducing more posterior populations and high concentrations inducing 
endoderm, indicative of the anterior primitive streak. FGF is shown to play a role in neural 
induction, whereas Wnt, BMP, and activin are inhibitors of the early stages of this pathway.  
 
Human ES cells 
More than 15 years after the isolation of mouse ES cells, the first human ES (hES) 
cell lines were derived (Thomson et al., 1998). hES cells are different from mouse ES 
cells in several aspects (reviewed in Yu and Thomson, 2008). Self-renewal is 
maintained by the activation of different signalling pathways, some important 
transcription factors and specific markers are differentially expressed, and the 
developmental potential seems to partially differ. Nevertheless, ES cells of both 
species share the two properties that define them: pluripotency and self-renewal.  
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Similarly to the mouse, the core transcription factors OCT4, SOX2 and NANOG also 
maintain self-renewal in hES cells. OCT4 expression is lost when hES cells 
differentiate and its repression leads to commitment to the trophoblast lineage (Matin 
et al., 2004). NANOG overexpression enables feeder-independent growth of hES 
cells and improves cloning efficiency (Darr et al., 2006) and its repression also 
predisposes to differentiation to extraembryonic lineages (Hyslop et al., 2005) 
However, even though at the molecular level mouse and hES cells seem to be 
controlled by the same transcription factors, the signalling pathways that maintain 
them differ significantly (reviewed in Rao, 2004; Yu and Thomson, 2008). In contrast 
to the mouse, LIF/STAT3 activation is not able to maintain hES self-renewal 
(Daheron et al., 2004; Thomson et al., 1998). Instead, FGF and TGF-β/Activin/Nodal 
signalling are of central importance to the self-renewal of hES cells (Vallier et al., 
2005) and suppression of BMP activity improves hES cell maintenance (Xu et al., 
2005). The events downstream of these pathways responsible for sustaining self-
renewal are still not well understood. In the presence of BMP4, hES cells undergo 
differentiation to trophoblast cells (Xu et al., 2002). This fate is not generally obtained 
in mouse ES-cell cultures, unless in genetically modified cells, suggesting human 
and mouse ES cells also have different developmental potential.  
Whether the differences between mouse and hES cells are due to species variability, 
or whether they correspond to different stages of embryonic development, is still 
unclear. 
 
1.2.3. Epiblast Stem cells  
Recently, pluripotent stem cell lines have been established from epiblasts isolated 
from 5.5 to 6.5 dpc post-implantation mouse embryos (Brons et al., 2007; Tesar et 
al., 2007). These epiblast stem cells (EpiSCs) are capable of self-renewing in vitro 
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and are pluripotent. They express the core transcription factors known to regulate 
pluripotency (Oct4, Sox2 and Nanog), maintain their genomic integrity, and are 
capable of differentiating into various cell types of the three germ layers, both in vitro 
and in teratomas. However, these cells differ from mouse ES cells in many essential 
aspects and, interestingly, share key features with hES cells.  
The gene expression profile of EpiSCs is different from that of mouse ES cells and 
consistent with its post-implantation epiblast origin. This suggests that EpiSCs and 
mouse ES cells represent two distinct pluripotent states, comparable to the post-
implantation epiblast and the pre-implantation ICM, respectively. Also, EpiSCs do not 
incorporate into chimeric embryos after blastocyst injection or morula aggregation 
suggesting that they are incompatible with the pre-implantation embryo environment 
(Brons et al., 2007; Tesar et al., 2007).  
Similar to hES cells, the derivation and self-renewal of EpiSCs requires FGF and 
Activin/Nodal signalling, whereas in LIF and serum/BMP4 they promptly differentiate 
(Brons et al., 2007; Tesar et al., 2007). Additionally, EpiSCs and hES cells have 
common mechanisms of epigenetic regulation of transcription, which are distinct from 
mouse ES cells (Tesar et al., 2007).  
When mouse ES cells are transferred to EpiSCs culture conditions they continue to 
proliferate and, after passaging, give rise to relatively homogeneous and EpiSCs-like 
cultures (Guo et al., 2009). After this differentiation step, the cells obtained have 
stable alterations in gene expression (equivalent to the post-implantation epiblast), 
growth factor dependence and epigenetic status similar to EpiScs. Indeed, this 
represents a stable state that cannot be reversed unless by the induced expression 
of Klf4 in 2i+LIF culture conditions (Guo et al., 2009). 
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1.2.4. Embryonic germ (EG) cells  
Embryonic germ (EG) cells can be derived from PGCs between 8.5 and 11.5 dpc, 
using a combination of stem cell factor (SCF), LIF, and FGF in the presence of a 
feeder layer (Matsui et al., 1992; Resnick et al., 1992). EG cells are morphologically 
identical to mouse ES cells and express typical ES cell markers such as SSEA-1 and 
Oct4. Also, they differentiate in vitro into a variety of cell types, and upon blastocyst 
injection, can contribute extensively to chimeric mice including to germ cells 
(Labosky et al., 1994; Matsui et al., 1992). However, EG cells retain epigenetic 
features of the original PGCs which are distinct from those of ES cells (Labosky et 
al., 1994). 
 
1.2.5. Induced pluripotent stem (iPS) cells 
Nuclear reprogramming defines a switch in nuclear gene expression from a 
differentiated cell to an embryonic-like state or to another cell type (Gurdon and 
Melton, 2008). This can be achieved by somatic cell nuclear transfer, cell fusion, 
induction of pluripotency by ectopic gene expression, or direct reprogramming. 
Reprogramming has been an area of great interest due to its potential application for 
cell replacement without the hazard of immune rejection or the ethical problems of 
using human embryos.  
A great advance in this field was made with the discovery of a method for inducing 
direct reprogramming to pluripotent stem cells by simply introducing a small number 
of “reprogramming factors” into differentiated cells (Takahashi and Yamanaka, 2006). 
Takahashi and Yamanaka showed that the viral transfection of four transcription 
factors, Oct3/4, Sox2, c-Myc, and Klf4, into mouse fibroblasts under ES-cell culture 
conditions, is sufficient to direct the appearance of ES-like cells, designated induced 
pluripotent stem (or iPS) cells. These cells exhibited morphology and growth 
properties similar to ES cells, expressed ES cell marker genes, generated teratomas 
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containing tissues from all three germ layers, and following blastocyst injection, iPS 
cells contributed to mouse embryonic development (but did not give rise to adult 
chimeras) (Takahashi and Yamanaka, 2006). Additional selection for Nanog 
expression generates germline-competent iPS cells with increased ES-cell-like gene 
expression and DNA methylation patterns (Okita et al., 2007).  
These four factors were selected from a screen that started with 24 candidate genes 
(Takahashi and Yamanaka, 2006). Among these, the requirement for Oct4 and Sox2 
is not surprising given the well established key role of these transcription factors in 
self-renewal. Klf4 and c-Myc, however, were more unexpected. c-Myc has several 
downstream targets that enhance proliferation and transformation, thus probably 
having a central role in promoting cell growth. Additionally, c-Myc is regulated by 
STAT3 and has a important functions in self-renewal and maintenance of 
pluripotency in mouse ES cells (Cartwright et al., 2005). However, given the known 
oncogenic role of c-Myc, and the observation that mice obtained by injection of iPS 
reprogrammed with this factor frequently develop tumours (Okita et al., 2007), 
retroviral introduction of c-Myc should be avoided for clinical application. Klf4 is a 
Kruppel-like transcription factor that has been associated with both tumour 
suppression and oncogenesis (Evans and Liu, 2008). Also, Klf4 is highly expressed 
in undifferentiated mouse ES cells and has a positive effect in self-renewal. It 
represses p53 directly and in this way it might contribute to activation of Nanog and 
other ES cell-specific genes (Evans and Liu, 2008; Lewitzky and Yamanaka, 2007).  
Since the original derivation of iPS cells, many iPS lines have been established from 
various differentiated cell types, including adult human cells (Yamanaka, 2008). In 
these studies, several combinations of reprogramming factors were explored and 
different ways of delivering them were used. Some of the initial problems of iPS 
generation are thus now starting to be overcome: new methods are being developed 
in which c-Myc induced expression is not required (Nakagawa et al., 2008; Wernig et 
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al., 2008), the reprogramming factors can be introduced without the need for 
retroviral insertion (Kaji et al., 2009; Okita et al., 2008), and reprogramming efficiency 
is increased (reviewed in Amabile and Meissner, 2009). Therefore, the use of iPS 
cells may eventually provide a suitable source of different cell types for patient-
specific cell replacement therapy in humans and of disease-specific cell lines to test 
potential therapeutic agents (Yamanaka, 2008). 
 
1.3. BMP signalling 
 
Bone Morphogenetic proteins (BMPs) are secreted growth factors members of the 
transforming growth factor-β (TGF-β) superfamily. They have been implicated in a 
variety of functions, including many cell fate decisions during developmental 
processes (Chen et al., 2004b), and have a critical role in maintaining ES cell self-
renewal (Qi et al., 2004; Ying et al., 2003a).  
 
1.3.1. BMP/TGF-β signalling pathway 
BMPs are members of the TGF-β family of molecules and are subdivided into three 
main groups based on their structure and function (Miyazono et al., 2005): BMP2, 
BMP4 and the Drosophila Decapentaplegic (Dpp) gene product form the BMP2/4 
subgroup; BMP5, BMP6, BMP7, BMP8, and the Drosophila gbb-60A form the OP-1 
group; the growth differentiation factor-5 (GDF-5), GDF-6 and GDF-7 belong to the 
GDF-5 group. The biological functions of BMPs are diverse since they have distinct 
spatiotemporal expression profiles and bind to different receptors with different 
affinities (Miyazono et al., 2005; Shi and Massague, 2003). 
Members of the TGF-β superfamily bind to a receptor complex composed of two 
distinct receptor types known as type I and type II receptors (Heldin et al., 1997; Shi 
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and Massague, 2003) (Figure 1.4). Both receptor types are required for signal 
transduction and contain serine/threonine kinase domains in their intracellular 
portions. The type II receptor kinases are constitutively active; upon ligand binding, 
hetero-tetrameric complexes composed of two molecules of each receptor type are 
formed (Shi and Massague, 2003) and type II receptor kinases transphosphorylate 
the GS (Gly-Ser) domain of type I receptors. Active type I receptors phosphorylate 
receptor-regulated SMADs (R-SMADs), which in turn associate with common-partner 
SMADs (Co-SMAD) (Heldin et al., 1997) (Figure 1.4). The R-SMAD/Co-SMAD 
complexes then translocate into the nucleus and regulate the expression of target 
genes in cooperation with transcription factors, co-activators and co-repressors. Type 
1 BMP receptors are therefore critical for determining the specificity of downstream 
SMAD signalling.  
 
 
Figure 1.4 The Bone Morphogenetic Protein (BMP) signalling pathway. 
BMPs bind to receptor complexes composed of type I and II receptors, which upon activation 
lead to Smad phosphorylation and ultimately to modulation of the expression of target genes. 
Alternative transducers of BMPs include p38 and possibly other MAPK pathways. 
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BMPs interact with three distinct type II receptors: BMP type II receptor (BMPR-II), 
activin type II receptor (ACVR-II) and activin type IIB receptor (ACVR-IIB). 
Regarding type I receptors, three receptors have been shown to bind BMPs: ACVR1, 
BMPR1A and BMPR1B (also known as ALK2, ALK3 and ALK6) (Miyazono et al., 
2005; Shi and Massague, 2003). These receptors have different and dynamic 
expression patterns during early mouse development (Roelen et al., 1997). Acvr1 is 
expressed from the one-cell to the blastocyst stage, Bmpr1b transcripts are detected 
from the one-cell zygote to the uncompacted morula, and Bmpr1a is present in 
blastocysts (Roelen et al., 1997) and is the only type I BMP receptor expressed in 
the epiblast of post-implantation embryos (Mishina et al., 1995). This suggests that 
different receptor complexes can be formed at different developmental stages. 
Bmpr2, Bmpr1a and Bmpr1b mRNAs were also detected in undifferentiated and 
differentiated embryonal carcinoma and embryonic stem cells (Roelen et al., 1997). 
BMP type I receptors specifically phosphorylate the R-SMADs 1, 5 and 8, whereas 
SMADs 2 and 3 are activated by activin and TGF-β type-I receptors. SMAD 4 is the 
only Co-SMAD in mammals, and is shared by both BMP and TGF-β/activin signalling 
pathways (Heldin et al., 1997; Miyazono et al., 2000; ten Dijke et al., 2000). SMAD 6 
and 7 are inhibitory SMADs (I-SMADs), which act in opposition to signal transducing 
R- and Co-SMADs, forming stable associations with activated type I receptors and 
thus preventing the phosphorylation of R-SMADs (ten Dijke et al., 2000) (Figure 1.4). 
BMP2 and 4 preferentially bind to BMPR1A and 1B type I receptors, whereas 
proteins of the OP-1 group bind to ACVR1 and BMPR1B. Those of the GDF5 group 
bind to BMPR1B, but not efficiently to other receptors (Miyazono et al., 2005).  
ID (inhibitors of differentiation) proteins are one of the most crucial targets of BMPs in 
many cell types (Hollnagel et al., 1999; Lopez-Rovira et al., 2002; Ogata et al., 1993) 
and may be responsible for their biological activities (Kowanetz et al., 2004; 
Nakashima et al., 2001; Norton et al., 1998; Yokota and Mori, 2002). They constitute 
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a family of helix-loop-helix transcription factors that regulate a variety of cellular 
responses including cell growth, differentiation, tumorigenesis and neoplastic 
transformation (Norton, 2000), generally acting as positive regulators of cell 
proliferation and negative regulators of differentiation (Miyazono and Miyazawa, 
2002; Norton et al., 1998).  
BMP signaling is precisely regulated at various levels, and an important part of this 
regulation occurs extracellulary, mainly by BMP antagonists (Figure 1.4). Numerous 
extracellular BMP antagonists have been described; on the basis of protein 
sequence alignment these can be categorized into subgroups including noggin, the 
chordin family, twisted gastrulation, and the Dan family (Yanagita, 2009). BMP 
antagonists bind with high affinity to BMPs and have been shown to prevent the 
interaction of BMP proteins with their particular receptors. However, recently 
published studies have also described agonist activities of formerly recognised BMP 
antagonists, depending on the cellular context, developmental stage and 
concentration of the binding protein (Moreno-Miralles et al., 2009). 
 
Even though SMADs are the main transducers of BMP signalling, there is evidence 
that MAP kinases, particularly p38, act as an alternative pathway downstream of 
BMPs. The activation of the MAPK pathway by BMP2/4 is mediated by the activation 
of TGF-β-activated kinase (TAK1) and subsequent phosphorylation of p38 stress-
activated protein kinase (Iwasaki et al., 1999; Kimura et al., 2000; Nohe et al., 2004; 
Shibuya et al., 1998; Yamaguchi et al., 1995). BMP2 has been shown to induce 
apoptosis through the TAK1-p38 pathway and, interestingly, SMAD 6 and 7 have 
been shown to have an inhibitory effect on the same pathway (Kimura et al., 2000). 
Additionally, BMP signaling establishes extensive communication with other 
signalling pathways. Highly complex and context-dependent cross-talk has already 
been reported between TGF-β/BMP and a variety of other pathways, including 
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MAPK, phosphatidylinositol-3 kinase/Akt, Wnt, Hedgehog and Notch (Guo and 
Wang, 2009). 
 
1.3.2. BMP signalling in mouse development and ES cells 
The BMP family of proteins has pleiotropic roles during development and after birth 
in many different organisms. BMP ligands, receptors, and signal transducers are 
fairly conserved among species, with identified homologues in C. elegans, 
Drosophila, and vertebrates. 
Besides potent bone inducing properties, BMPs have diverse roles during vertebrate 
embryogenesis, as already described. Many of the functions of BMPs in mammalian 
development have been revealed by loss-of-function analysis of BMP ligands and 
their receptors in the mouse (Chen et al., 2004a; Zhao, 2003). Analysis of null 
mutations for BMP2 and BMP4 in mice have revealed important roles for these 
proteins in primordial germ cell (PGC) induction, localization and survival (Fujiwara et 
al., 2001; Lawson et al., 1999), mesoderm formation and patterning  (Winnier et al., 
1995), extra-embryonic mesoderm and cardiac development (Zhang and Bradley, 
1996), primitive streak formation and left-right patterning (Fujiwara et al., 2002). 
Mutations in either type I or type II BMP receptors display more severe phenotypes, 
suggesting functional redundancy between BMP proteins. Bmpr2 and Bmpr1a-null 
embryos show a defect in epiblast proliferation and the initiation of gastrulation, 
having no mesoderm formation and ectopic neural differentiation (Beppu et al., 2000; 
Di-Gregorio et al., 2007; Mishina et al., 1995), while in Acvr1a deficient embryos 
there is a later defect in gastrulation progression (Gu et al., 1999). SMAD4 deficient 
embryos also show a similar phenotype having growth retardation, failure to 
gastrulate and to express mesodermal markers and showing abnormal endodermal 
development (Sirard et al., 1998). 
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BMPs were first reported to be involved in the maintenance of stem cells in 
Drosophila where the BMP2/4 homologue Decapentaplegic (Dpp) is specifically 
required to maintain female germline stem cells and promote their proliferation (Xie 
and Spradling, 1998). 
In mouse ES cells, BMPs have been shown to antagonise neural differentiation and 
promote differentiation into non-neural fates (Johansson and Wiles, 1995; Tropepe et 
al., 2001; Ying et al., 2003a; Ying et al., 2003b). However, in combination with LIF, 
BMP proteins sustain self-renewal and pluripotency (see chapter 1.2.2). This role for 
BMPs is mediated by activation of the ID proteins via the SMAD pathway (Ying et al., 
2003a). The blockage of lineage-specific transcription factors by ID proteins enables 
the response to LIF/STAT3, an essential step for self-renewal maintenance (Niwa et 
al., 1998; Smith et al., 1988). However, overexpression of BMP, even in the 
presence of LIF, leads to differentiation into non-neural fates (Johansson and Wiles, 
1995; Ying et al., 2003a), indicating that a balance of SMAD and STAT signalling 
determines the choice between self-renewal and differentiation (Ying et al., 2003a). 
BMP4 has also been shown to be required for ES cell self-renewal by inhibiting the 
mitogen activated kinase (MAPK) pathways ERK and p38, as inhibitors of ERK and 
p38 MAPKs mimic the effect of BMP4 on ES cells (Qi et al., 2004). Importantly, by 
using a p38 inhibitor, Qi and coworkers could derive ES cells from Bmpr1a-/- 
blastocysts, something that had not been possible in the absence of the inhibitors (Qi 
et al., 2004; Zhao, 2003). 
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1.4. Cell Competition 
Cell competition is a type of cell-cell interaction in which the coexistence of two cell 
populations with different metabolic properties or growth rates, results in growth of 
the stronger population at the expense of the weaker one (Diaz and Moreno, 2005; 
Johnston, 2009; Tyler et al., 2007). This process of recognition and elimination of 
vulnerable, mispatterned or abnormal cells during tissue growth plays an important 
role in tissue homeostasis, organ size control, and stem cell maintenance.  
 
1.4.1. Cell Competition in the Drosophila wing 
Out-competition of Minute mutants 
Cell competition was first described in Minute mosaics in the epithelium of the 
Drosophila wing. Minute (M/+) mutants are deficient in a ribosomal protein (Rp)–
encoding gene (Lambertsson, 1998), making them slow-growing but viable. Morata 
and Ripoll induced clones of wild-type (+/+) cells in the epithelium of the developing 
wing of M/+ flies, and found that, surprisingly, the +/+ cells could overtake a big part 
of the wing (Morata and Ripoll, 1975). The finding that sibling cells compete for 
contribution to the adult tissues led the authors to define cell competition as a 
struggle between slow-growing M/+ cells (termed "losers") and faster-growing wild-
type cells ("winners"). Subsequent work by Morata and Simpson showed that cell 
competition is the result of local interactions between slow and faster-growing cells, 
with an intensity proportional to the differences in growth, and that the size and 
pattern of the adult wing is maintained during this process (Simpson, 1979; Simpson 
and Morata, 1981). It must be emphasized that the Minute cells are only non-viable 
when growing next to cells with higher metabolic activity, and, therefore, cell 
competition relies upon interactions between the two cell types. 
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Moreno and coworkers further investigated the mechanism for the elimination of M/+ 
cells in the wing mosaics, showing that the cells with reduced ribosomal activity are 
eliminated by apoptosis (Moreno et al., 2002). Elimination of the M/+ cells is 
accompanied by compensatory proliferation of wild-type cells, replacing apoptotic 
cells during cell competition, thereby maintaining the total number of cells in the 
developing tissue, and the normal size and shape of the resulting organ. 
These experiments demonstrated that the potential for proliferation and survival of a 
cell, and ultimaely its contribution to fully developed tissues, is determined by the 
interactions with its neighbours. 
 
Competition in response to Myc levels 
More recently, cells with different levels of the growth regulator Myc were also shown 
to experience cell competition (de la Cova et al., 2004; Moreno and Basler, 2004). 
Cells with reduced expression of dMyc (Moreno and Basler, 2004), when in contact 
with metabolically more active cells, are eliminated from the Drosophila wing, despite 
being viable when among cells of the same genotype. Conversely, dMyc over-
expression induces super-competition. Cells overexpressing dMyc over-proliferate 
and expand at the expense of WT surrounding cells, which are eliminated by 
apoptosis, maintaining total cell numbers (de la Cova et al., 2004; Moreno and 
Basler, 2004).  
 
Monitoring cell fitness 
Interestingly, promoting cellular growth by other mechanisms, such as the 
overexpression of the phosophoinositide 3-kinase Dp110 or of cyclin D/Cdk4, do not 
cause supercompetition (de la Cova et al., 2004). Further studies are needed to 
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clarify which growth pathways induce cell competition, and what distinguishes these 
from the ones that do not. 
In both models of cell competition (M/+ and Myc-dependent), ribosomal biogenesis is 
impaired, either directly by Minute mutations, or via the action of Myc-target genes. 
Ribosomal activity may thus be compared between cell types, by a yet unknown 
mechanism, as an indicator of the relative metabolic state or cell fitness (Johnston, 
2009). 
 
Involvement of Dpp/BMP signalling  
The cells eliminated by competition display a deficit in growth factor signalling 
(Moreno and Basler, 2004; Moreno et al., 2002), suggesting that competition for 
extracellular ligands present in limited concentrations might be the mechanism that 
supports cell competition. Metabolically less active cells, with a lower ability to 
translate limiting amounts of survival and growth proteins, would not obtain enough 
survival factors and consequently would die. Therefore, the capacity to translate 
limiting growth factors would determine the competitive behaviour of neighbouring 
cells (Diaz and Moreno, 2005).  
Decapentaplegic (Dpp), a BMP homologue, is a key growth and survival factor during 
development of the Drosophila wing (Burke and Basler, 1996; Martin-Castellanos 
and Edgar, 2002). Cells with a disadvantage in competing for, or in transducing, Dpp 
show increased expression of the transcription repressor brinker and activation of the 
c-Jun amino-terminal kinase (JNK) pathway, which in turn triggers apoptosis in these 
cells (Moreno et al., 2002). Constitutive activation of the Dpp pathway enhances the 
survival of M/+ clones (Moreno et al., 2002) and of lower dMyc-expressing cells 
(Moreno and Basler, 2004), thus reducing cell competition. Furthermore, in a genetic 
screen for mutations that induce survival of M/+ cells during cell competition, most of 
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the genes identified enhance Dpp signalling activity (Tyler et al., 2007). However, 
mutations in which important Dpp transducers are absent were also able to rescue 
M/+ clones and no known JNK pathway mutations were identified in this screen 
(Tyler et al., 2007). Additionally, in other studies no differences in Dpp signalling 
were observed in competing cells (de la Cova et al., 2004; Li and Baker, 2007) and in 
the absence of JNK signalling, cell competition still occurred (de la Cova et al., 
2004). Therefore, Dpp signalling does seem to play an important role during cell 
competition, but other mechanisms and signalling pathways are also likely to be 
involved.  
 
Mechanism of cell competition  
Triggering of apoptosis is a consistent mechanism for the elimination of out-
competed cells in the epithelium of Drosophila wing in both models described (de la 
Cova et al., 2004; Diaz and Moreno, 2005; Moreno et al., 2002). Recently, it was 
shown that cell death is indeed essential for cell competition to occur, that it takes 
place at the boundary between the two cell populations, and that apoptotic cells are 
engulfed by the neighbouring “winner” cells (Li and Baker, 2007). Surprisingly, more 
than a passive response to the presence of dying cells, engulfment is required for 
cell competition to occur. Several engulfment genes are required specifically in wild-
type cells for the killing and elimination of M/+ cells, and in the absence of these 
genes, competition is prevented. Conversely, ectopic activation of engulfment 
effectors could promote death and engulfment of cells that do not differ in growth rate 
(Li and Baker, 2007). Thus engulfment genes seem to act downstream of growth 
differences to eliminate cells with reduced metabolic activity. However, not all out-
competed cells are engulfed by winners, since it has been described that many 
delaminate and are extruded from the epithelium, possibly for phagocytosis by 
hemocytes (Moreno and Basler, 2004).  
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A more detailed study of the mechanisms involved in cell competition has been 
facilitated by the development of an in vitro model of cell competition with Drosophila 
cell lines expressing different levels of dMyc (Senoo-Matsuda and Johnston, 2007). 
In this model, co-culture of cells with different levels of dMyc expression induces 
apoptosis specifically in lower-expressing dMyc cells and over-proliferation of cells 
with higher dMyc expression. These effects do not require physical contact but 
instead are mediated by soluble factors, as they can be induced by medium 
conditioned by competing cells. This suggests that cells recognize their competitive 
status using a mutual sensing mechanism involving production of diffusible factors. 
For the production of these factors the medium has to be conditioned by both cell 
types, an observation that once again emphasizes the fact that cell competition is 
instigated by the relative, not absolute, “fitness” of each cell population. The 
presence of both cell types therefore allows the comparison of metabolic levels and 
recognition of the winner or loser status. 
 
In summary, cell competition in Drosophila appears to proceed through a series of 
discrete steps: local sensing and recognition of cellular differences, production of 
diffusible factors, signalling that activates stress pathways and apoptotic suicide of 
loser cells, activation of an engulfment program, and growth stimulation of winner 
cells (reviewed in Johnston, 2009). 
 
1.4.2. Niche Occupancy: Stem Cell competition 
A different type of competition at the cellular level takes place in the Drosophila 
gonad, where both somatic stem cells and germline stem cells (GSCs) compete for 
occupancy of the particular niche or microenvironment (Jin et al., 2008; Nystul and 
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Spradling, 2007). During niche competition, stem cell fitness is also compared and 
“winners” and “losers” are recognized. However, unlike cell competition in somatic 
epithelia, the “weaker” cells are not killed but instead displaced from the stem cell 
niche (reviewed in Johnston, 2009). 
The GSC niche in the Drosophila developing ovary contains many different cell types 
in relatively close proximity, including stem cells, their accompanying support cells 
(the cap cells), and the differentiating stem cell-progeny. GSCs associate directly with 
cap cells via adherent junctions and are anchored firmly by E-cadherin–dependent 
interactions (reviewed in Kirilly and Xie, 2007). The tight GSC–cap cell association 
ensures that the GSC receives proximity-dependent signals, such as Dpp, from the 
niche. High Dpp activity is required to repress expression of the differentiation-
promoting genes bam and bgcn in the GSC. GSCs divide asymmetrically, allowing 
one daughter to remain in the niche while the other moves away from the niche and 
differentiates. Niche residency is essential for a functional GSC and for continued 
production of new daughter cells. Cells lacking the Dpp-repressed differentiation 
genes (bam and bgcn) cannot differentiate and out-compete wild-type GSCs for 
niche residency, probably due to increased E-cadherin expression (Jin et al., 2008).   
Myc expression has also been shown to induce cell competition in the GSC niche: 
cells with relatively higher expression of dMyc out-compete wild-type stem cells 
without affecting total stem cell numbers (Rhiner et al., 2009). Also, a naturally 
occurring cell competition border formed by high dMyc-expressing stem cells and low 
dMyc-expressing progeny has been described. This may facilitate the concentration 
of the niche self-renewal factor Dpp in metabolically active, high dMyc-expressing 
stem cells (Rhiner et al., 2009). 
Niche space for somatic follicle stem cells (FSCs), the progenitors of the follicular 
epithelium that surrounds the germline cysts, is also subject to competition (Nystul 
and Spradling, 2007).
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Niche stem cell competition and epithelial cell competition are thus fundamentally 
different. In both types of cell competition there is a struggle for supremacy. 
However, competition for niche occupancy is adhesion-based and leads to 
differentiation of out-competed cells, whereas competition between disc epithelial 
cells involves a direct cell-cell comparison of metabolic status determining the death 
of weaker cells. Nevertheless, in both cases, cell competition is a subtle but 
important mechanism that ensures optimal organ function and promotes 
homeostasis. 
 
1.4.3. Cell competition in homeostasis and disease 
Competition in mammalian cells 
Some evidence suggests that cell competition may also occur in the mouse. Belly 
spot and tail (Bst) heterozygous mice (defective for the ribosomal protein L24) 
behave in a similar way to the Minute mutants, and Bst+/- cells show a competitive 
disadvantage in chimera colonisation (Oliver et al., 2004). Also, competitive-like 
interactions have been described between highly proliferative transplanted wild-type 
cells and diseased host hepatocytes during liver regeneration in rats (Oertel et al., 
2006) 
 
Cell competition in development and disease 
Competition between cells is an efficient mechanism of quality selection. It regulates 
the balance between proliferation, differentiation and apoptosis in expanding or 
dynamic tissues, hence controlling cell number and optimizing tissue fitness and 
organ function. Cell competition may therefore be involved in the homeostatic 
processes that regulate organ size and quality control during development (Adachi-
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Yamada and O'Connor, 2002), as well as in tissue repair and regeneration (Oertel et 
al., 2006). 
However, cell competition may not only be involved in maintaining homeostasis. The 
expansion of one cell population at the expense of another is a hallmark of cancer. 
Indeed, both stem cell competition and cell competition are emerging models for 
tumorigenesis (reviewed in Baker and Li, 2008; and Rhiner and Moreno, 2009). The 
acquisition of mutations that confer a growth advantage in a subset of cells in a 
tissue or organ, along with the killing of their neighbours, is a recognized part of 
tumour progression. Likewise, mutations that increase adhesiveness or "stemness" 
of winner stem cells could out-compete wild-type cells and lead to tumour formation. 
During Drosophila embryonic development, naturally occurring discontinuities in the 
reception of morphogens also lead to apoptosis of cells at the discontinuity boundary 
by activating the JNK pathway (Adachi-Yamada and O'Connor, 2002; Manjon et al., 
2007).  This is most likely related to the process of cell competition, and may 
represent an evolutionarily important mechanism that helps preventing abnormal 
tissue specification and growth during development.  
 
 
1.5. Aims of this study 
BMP4 signalling via BMPR1A has been shown to be required for the maintenance of 
the epiblast population in the early embryo, and for self-renewal of pluripotent mouse 
embryonic stem (ES) cells, by inhibiting differentiation into neural fates.  
The first aim of this study was to further explore the role of BMP signalling via 
BMPR1A in mouse ES cell self-renewal and differentiation. For this purpose, 
Bmpr1a-null ES cells were initially derived and characterised in terms of signalling 
activation and gene expression patterns. Next, the self-renewal ability of these cells 
was analysed, as well as their potential to differentiate into different lineages in 
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embryoid bodies and by monolayer differentiation. A possible compensation 
mechanism that may be sustaining ES cells in the absence of BMPR1A was also 
investigated. 
A second aim of this study was to analyse the role of BMP signalling in a related but 
distinct context: cell competition in ES cells. BMP/Dpp signalling has an important 
role in cell competition in Drosophila, both in the somatic epithelium and in the GSC 
stem cell niche, contributing to the selection of “fitter” cells during development.  
Making use of the Bmpr1a-null ES cells, in which BMP activation is lower than in 
wild-type cells, a co-culture system was developed for the study of cell competition. 
In order to determine the mechanism by which Bmpr1a-null cells were being out-
competed, the proliferation, apoptosis and differentiation of the two cell types were 
analysed in co-cultures. The involvement of c-MYC in these competitive interactions, 
as well as the role of extracellular BMP concentrations and of secreted soluble 
factors, were also investigated. 
 
This study will therefore help to clarify the function of BMP4 in ES cells and extend its 
scope beyond the traditional view, investigating new roles for this pathway during 
mammalian development. 
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2. MATERIALS AND METHODS 
2.1. Tissue Culture Methods 
All tissue culture reagents were from Gibco (Invitrogen) unless stated otherwise.  
 
E14Tg2a.IV ES cells were a gift from Austin Smith; Bmpr1a mutant FR88 and FR124 
cell lines (Qi et al., 2004) were kindly provided by Yuji Mishina. 
 
2.1.1. ES cell maintenance  
ES cells were maintained in an undifferentiated state on 0.1% gelatine-coated flasks 
(Nunc, Thermo Fisher) in Dulbelcco’s Modified Eagle Medium (DMEM) 
supplemented with 15% (v/v) foetal calf serum (FCS; Sigma), 1X Dulbelcco’s non-
essential amino acids (DNAA), 2 mM L-glutamine, 0.1 mM β-mercaptoethanol and 
1500 U/ml ESGRO® leukemia inhibitory factor (LIF; Chemicon-Millipore). ES cells 
were routinely dissociated with trypsin-EDTA and frozen for future use in media 
containing 10% tissue-culture grade dimethyl sulfoxide (DMSO, Sigma), 90% FCS. 
All cells were cultured at 37ºC in an atmosphere with 5% CO2. 
 
2.1.2. Blastocyst outgrowths and ES cell derivation 
Bmpr1a+/- (Mishina et al., 1995) mice were maintained on a 129SvCC genetic 
background. For the derivation of ES cells, 3.5 dpc blastocysts were harvested from 
Bmpr1a+/- intercrosses and cultured on gelatine-coated 4-well plates (Corning Life 
Sciences) in ES cell medium containing 15% FCS and LIF. After 6-7 days in culture, 
the ICM of the explants was picked, dissected out from the trophoblast cells, 
trypsinized and mechanically dissociated, and replated into gelatinised 4-well plates. 
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Three to four days later, ES-like colonies were picked, trypsinised and each 
transferred to a new 4-well plate. Subsequently grown ES colonies were expanded 
and treated as established ES cell lines. ES cell lines were subsequently genotyped 
and karyotyped. 
 
For blastocyst outgrowth assays, blastocysts obtained from Bmpr1a+/- intercrosses 
were cultured on gelatine-coated 48 well plates in serum-free medium with BMP4 
and LIF (ESGRO Clonal Grade, Chemicon) or supplemented with 200ng/µl BMP7 
(R&D Systems) for 10 days and then stained for alkaline phosphatase activity. 
Outgrowth assays were carried out by Aida di Gregorio. 
 
2.1.3. Electroporation and establishment of transgenic ES cell 
lines 
Prior to electroporation, ES cells were plated into a gelatine-coated 75 cm2 tissue 
culture flask (Nunc, Thermo Fisher) and grown until confluent. Cells were trypsinised 
and counted using a haemocytometer. Approximately 3 x 107 cells were used for 
electroporation in 1 ml DMEM without any additives. 30 µg of linear DNA was added 
to the cell suspension in a 0.4cm electroporation cuvette (BioRad) and cells were 
electroprated using a BioRad Genepulser electroporation unit.  Cells were exposed 
to two pulses; the first was at 240 volts, and the second at 230 volts, with 
capacitance set to 500 µF. After second pulse the cuvette was tapped on the bench 
and placed on ice for 10 minutes.  The cells were then plated on gelatinised 10 cm 
culture plates (Nunc, Thermo Fisher) in normal ES-cell growth medium (DMEM with 
15% FCS and LIF). One to two days after the electroporation, media containing 
puromycin (Sigma) at a final concentration of 1.5 µg/ml was added to the plates to 
select for colonies positive for transgene expression.  
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After 8 to 10 days of puromycin selection, 20 to 50 colonies were picked into 
gelatinised, flat bottom 96 well plates. These clones were subsequently expanded in 
normal ES cell culture conditions (DMEM with 15% FCS and LIF), screened for 
expression of the transgene, karyotyped and frozen. 
 
2.1.4. Karyotyping ES cells 
ES cells were plated into a gelatine-coated 25 cm2 tissue culture flask (Nunc, Thermo 
Fisher) and grown until 50-75% confluent. When cells were ready for karyotyping, the 
medium was changed and 2 hrs later Demecolcine (Sigma) was added directly to the 
medium to a final concentration of 20 ng/ml. After 1 hr, cells were trypsinized and 
washed once in PBS. The pellet was resuspended in 5 ml hypotonic solution (0.56% 
w/v KCl) until a single cell suspension was obtained. Cells were kept in hypotonic 
solution at RT for exactly 6 mins, then spun and the supernatant removed, leaving a 
drop to resuspend the pellet in. 5 ml of ice-cold fixative (Methanol: Acetic acid, 3:1 
made up fresh) was added dropwise, whilst flicking the tube. After 5 mins at RT, cells 
were spun down, and the fixing procedure was repeated a further 3 times. After the 
last fixation step, cells were resuspended in a final volume of 1 ml fixative.  
Metaphase spreads were obtained by dropping a drop of cell suspension from a 
height of around 40 cm onto acid-washed slides (treated overnight with 5% acetic 
acid in ethanol). After drying thoroughly, the slides were stained in 10% Giemsa’s 
(BDH Lab Supplies) in PBS for 20 mins. Slides were then washed gently in tap water 
twice, with a final wash in dH2O. Slides were left to dry overnight and coverslips 
were mounted using DPX medium (BDH Lab Supplies). Slides were observed on a 
normal dissection microscope. Murine nuclei possess a full complement of 40 
chromosomes. The chromosomes of 10 to 20 nuclei were counted and a 10% 
tolerance for variability in chromosome number was accepted.  
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2.1.5. Alkaline Phosphatase staining 
Staining was performed using the Alkaline Phosphatase kit from Sigma. Cells were 
fixed in Citrate-acetone-formaldehyde fixative solution for 30 seconds and 
subsequently rinsed in deionised water for 45 seconds. Cells were then incubated 
with alkaline-dye mixture at room temperature for 15 minutes, protected from the 
light, rinsed for 2 minutes in deionised water, left to dry, and finally visualised and 
images acquired using a Leica MZ FLIII dissection microscope with a Leica Image 
Manager 50 software package. 
 
2.1.6. β-Galactosidase staining 
Cells were fixed for 10 minutes at 4°C in fixing solution (0.2% Gluteraldehyde, 2% 
Formaldehyde in PBT), and after that washed in rinse solution, pH 7.3 (0.1M 
Phosphate Buffer, 0.1% Sodium Deoxycholate, 0.2% Igepal, 5 mM EGTA, 2 mM 
MgCl2). Cells were then incubated in stain solution (5 mM Potassium Ferrocyanide, 5 
mM Potassium Ferricyanide and 1 mg/ml X-gal in rinse solution) overnight at 37°C in 
a humid chamber. The day after cells were washed in PBS and visualised and 
images acquired using a Leica MZ FLIII dissection microscope with a Leica Image 
Manager 50 software package. 
 
2.1.7. Crystal violet staining 
For analysis of cell growth, ES cells were plated in triplicate in 24-well plates at a 
density of 1x104 cells per well. A plate was fixed with glutaraldehyde (Sigma-Aldrich; 
0.5% in PBS) 6 hours after plating the cells and then every day for 4 days, and 
stained with a solution of 0.2% crystal violet (in dH2O) for 30 minutes at room 
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temperature (RT). The plates were then gently but thoroughly washed in dH2O and 
left to dry. Relative cell number was determined by dissolving the crystal violet stain 
in 1M acetic acid and measuring its absorbance at 595 nm. 
 
2.1.8. ES cell differentiation 
For ES cell differentiation by embryoid body (EB) formation, 2x106 cells were plated 
per in a 10cm non-gelatinised bacterial petri dish in complete DMEM medium (with 
FCS and all additives) in the absence of LIF. Medium was changed every two days 
during the course of differentiation. 
 
For adherent monolayer differentiation in Basal medium, cells were plated on 
gelatine-coated dishes (Nunc, Thermo Fisher) at low (1x106 cells per well of a 6-well 
plate) or medium (4x106 cells per 6-well) confluency in complete DMEM medium 
(with FCS and all additives) in the absence of LIF. 6 hours after plating, the cells 
were washed and serum-free ESGRO Complete™ Basal Medium (Millipore) was 
added to the wells. Medium was changed every day during the desired period of 
differentiation.    
Monolayer differentiation in the presence of BMPs was performed as previously 
described with the exception that 10 ng/ml BMP4 (R&D Systems) ou 25 ng/ml BMP7 
(R&D Systems) were added to the Basal culture medium. 
 
For monolayer neural differentiation (Ying et al., 2003b), cells were plated at 
relatively high confluency the day before starting differentiation so that they were 
around 70-80% confluent and in exponential growth phase at the time of starting the 
differentiation protocol. ES cells were then trypsinised, washed twice in serum-free 
medium and counted using a haemocytometer. 1x105 cells were plated per well of 
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gelatine-coated 6-well plates (Nunc, Thermo Fisher) in N2B27 medium (Stem Cell 
Sciences). After this, medium was changed every 2 days for the desired period of 
differentiation. 
 
2.2. Plasmid construction and bacterial transformation 
Enzymes and buffers were all from New England Biolabs. For plasmid constriction, 2 
µg of insert and 2 µg of vector were digested with appropriate restriction enzymes 
following manufacturer’s instruction. Digestion products were run on 1% agarose 
gels with the 100 bp or 1 Kb ladders and bands of correct size were purified using 
QIAquick Gel Extraction Kit (Qiagen) according to manufacturer’s instructions. When 
for blunt-blunt end ligations, the purified DNA was treated for 30 min with 1 µl Antartic 
Phosphatase at 37°C and then the phosphatase inactivated by 15 min at 65°C. 100 
ng of vector and a three-molar excess of insert were ligated with 1 µl (400 U) of T4 
DNA ligase overnight at 16°C in a total volume of 10 µl. 2 µl of the ligation mixture 
were then transformed into XL10-Gold ultracompetent cells (Stratagene) according to 
the manufacture’s protocol. Briefly, 90 µl of XL10 cells were mixed with 4 µl β-
mercaptoethanol and 2 µl of the ligation mixture and incubated on ice for 30 min. For 
heat-shock transformation the cells were incubated at 42°C for 30 seconds and then 
on ice for 2 min. Pre-heated SOB broth was then added to the cells and these were 
incubated at 37°C for 1 hour with shaking at 250rpm. The transformation mixture was 
then plated into Lysogeny Broth (LB) agar supplemented with 50 µg/µl of ampicillin 
or other appropriate antibiotic and incubated overnight at 37°C. The day after, 
individual colonies were picked into LB broth containg 50 µg/µl of ampicillin or other 
appropriate antibiotic and incubated overnight at 37°C with agitation. DNA was 
extracted from exponentially growing cultures with the Miniprep or Maxipreps kits 
(Qiagen) according to manufacturer’s instructions and final DNA diluted in double 
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distilled water. The plasmids obtained after each cloning step were subjected to 
restriction digests to confirm the insertion and sequenced at the MRC Clinical 
Sciences Centre sequencing facility. 
 
pPyCAGIP-EGFP construct 
 
Figure 2.1 Map of the pPyCAGIP-EGFP expression vector. 
 
To generate the PyCAGIP-GFP vector, the EGFP coding sequence was excised 
from the EGFP-N2 plasmid (Clontech) and inserted into the pPyGAGIP (a gift from 
Ian Chambers) (Chambers et al., 2003) downstream of the CAG promoter using the 
XhoI and NotI sites. The PyCAGIP-GFP vector was then grown, linearised by PvuI 
digestion, purified by phenol-chloroform extraction (Sigma) and electroporated into 
ES cells. 
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pPyCAGIP-Bmpr1a-2A-EGFP construct 
 
Figure 2.2 Map of the pPyCAGIP-Bmpr1a-2A-EGFP expression vector.  
 
The Bmpr1a coding sequence (excluding the stop codon) was amplified from the 
Bmpr1a cDNA using the PCR primers Fw 5’-CTCGAGCAGCAGGACV 
AGTCATTCAA-3’ and Rv 5’-GTCGACAATCTTTACATCCTGGGATTC-3’ which 
introduced flanking restriction sites for XhoI and SalI (underlined). The PCR mix was 
as follows: 100 ng of cDNA, 0.2 mM of each primer (Sigma-Genosys), 0.2 mM of 
dNTPs (Roche Diagnostics), 1 µl Formamide (Fluka), 1.25 µl Dimethyl Sulphoxide 
(DMSO, Sigma), 10 units Pfu Ultra and 5µl 10x Pfu PCR buffer (Promega) in a total 
volume of 50 µl.  PCR conditions included an initial denaturation step at 92 ºC for 3 
minutes, followed by 15 amplification cycles of 15 seconds at 92 ºC, 35 seconds at 
58ºC and 2 min at 68 ºC.  This was followed by a further 15 cycles of 15 seconds at 
92 ºC, 35 seconds at 58 ºC and 2 min 25 sec at 68 ºC.  Finally there was a final 
elongation step of 15 minutes at 68 ºC.  The resulting PCR products were size-
fractionated by electrophoresis in a 1% agarose gel containing ethidium bromide, 
visualised under ultraviolet light and the DNA band removed from the gel and purified 
using Qiaquick gel purification kit (Qiagen). The PCR product was then blunt cloned 
into pCR-Blunt II-TOPO using the Zero Blunt TOPO PCR Cloning Kit (Invitrogen).   
The following synthetic oligos with the sequence for the viral 2A, XhoI and NcoI 
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protruding ends (underlined) and 3’ phosphorylated ends were ordered from Sigma-
Aldrich: s 5’-TCGAGGGCAGTGGAGAGGGCAGAGGAAGTCTGCTAACATGCGG 
TGACGTCGAGGAGAATCCTGGCCCATC-P-3’;  as 5’-CATGGATGGGCCAGGATT 
CTCCTCGACGTCACCGCATGTTAGCAGACTTCCTCTGCCCTCTCCACTGCCCTC
GAG-P-3’. These synthetic oligos were resuspended in TE buffer (10 mM Tris pH7.6, 
1 mM EDTA), and 5 µg of each oligo diluted in annealing buffer  (100 mM Tris pH7.4, 
150 mM NaCl, 10mM EDTA) to a final volume of 100 µl, incubated at 95°C for 10 min 
and allowed to cool slowly to room temperature for annealing. The annealed oligos 
were then ligated to XhoI/NcoI pUC21 plasmids where the EGFP had already been 
subcloned at the XhoI and NotI sites. The resulting plasmids were sequenced (MRC 
Clinical Sciences Centre sequencing facility) and plasmids with the correct sequence 
selected for subsequent cloning steps. 
The 2A-EGFP fragment was excised and cloned into the pPyGAGIP plasmid (a gift 
from Ian Chambers) using XhoI and NotI. Finally, the Bmpr1a coding sequence was 
inserted into the pPyGAGIP-2A-EGFP at the XhoI site using XhoI and SalI sites. The 
automatic destruction of the SalI/XhoI site allowed determining the direction of the 
insertion. The PyCAGIP-Bmpr1a-2A-EGFP vector was then grown, linearised by 
PvuI digestion, purified by phenol-chloroform extraction (Sigma) and electroporated 
into ES cells. 
 
2.3. Genomic PCR analysis 
2.3.1. Cell lysis for genotyping  
Pellets of approximately 1x105 cells were digested in 30 to 50 µl of lysis buffer (50 
mM Tris-HCl, pH 8.5, 1 mM EDTA, 0.5% Tween-20) overnight at 55°C in the 
presence of 6 µg/ml Proteinase K. Proteinase K was inactivated by incubation of 
 63 
lysates at 95 °C for 10 mins. Samples were vortexed, spun down and stored at 4°C. 
2 µl of lysate were used per 50 µl PCR reaction. 
 
2.3.2. Genotyping and sexing ES-cell lines by PCR 
Bmpr1a-/- (Mishina et al., 1995) ES cells were genotyped by PCR using the following 
primers: F0 (5’-AGACTGCCTTGGGAAAAGCGC-3’), and F5 (5’-GGACTATGGA 
CACACA ATGGC-3’) to amplify the wild-type allele (280 bp) and F3 (5’-
CTCTGAATTTCTA GTCCACATCTGC-3’) and F5 to amplify the mutant allele (190 
bp), by standard PCR. 
 
ES cells were sexed by PCR using the primers Ube1xa (5’-TGGTCTGGACCC 
AAACGCTGTCCACA-3’) and Ube1xb (5’-GGCAGCAGCCATCACATAATCCAG 
ATG-3’) that give bands of distinct sizes for the UBE1X and UBE1Y genes on the X 
and Y chromosome, respectively (Chuma and Nakatsuji, 2001). 
  
The standard PCR reaction mix was made up in a 50 µl total volume as follows: 2 µl 
DNA lysate, 1 unit of Amplitaq, 10 µmol of each primer (Sigma), 5 µl 10x buffer and 
0.2 mM of each dNTP (all Roche Diagnostics). PCR was performed on a Peltier 
thermal cycler (PTC-100) using the following program: initial denaturation step at 
95°C for 5 mins, then 40 amplification cycles of 30 secs at 94 °C, 30 secs annealing 
(at 60°C for the Bmpr1a-/- genotyping PCR and 66 °C for the Ube1 sexing PCR), 45 
secs at 72 °C, followed by a final elongation step of 5 mins at 72 °C. The resulting 
PCR products were size-fractionated by electrophoresis in 1% agarose gels 
containing ethidium bromide (Sigma) and visualised under UV light.  
 
 64 
2.4. RNA and gene expression analysis 
2.4.1. RNA extraction and cDNA synthesis  
RNA extraction was performed using TRIzol reagent (Invitrogen) and residual 
genomic DNA was eliminated using the in column DNase digestion set (Qiagen) 
followed by the RNeasy (Qiagen) RNA Cleanup protocol.  
1.5µg of total RNA was then reverse transcribed using SuperScript III Reverse 
Transcriptase system (Invitrogen, Life Technologies). 1 µl of nonamer primers 
(Sigma),  1.5 µg of total RNA and RNase free water were mixed to a final volume of 
10 µl. After a 5 minute incubation at 65°C the samples were put on ice and a mix 
containing 2 µl of 10 mM dNTP mix (Roche), 2 µl of 0.1 M DTT, 4 µl of 5X first strand 
buffer, 1 µl of Rnase inhibitor (Roche) and 1 µl of 200 U/µl Superscript III was added. 
A reaction mixture without the enzyme was also set up as a negative control 
(designated “-RT”). The mixture was incubated at 25°C for 5 min, 42°C for 1 h 30 min 
and at 70°C for 15 min. The cDNAs were diluted 1:10 in dH2O and kept at -20°C until 
PCR analysis. 
 
2.4.2. Quantitative RT-PCR analysis 
Quantitative PCR (qRT-PCR) analysis was carried out using an OpticonII™ DNA 
engine (MJ Research Inc.) and Opticon Monitor software (MJ Research Inc.). PCR 
reactions included Sybr-Green PCR Mastermix (Qiagen), 300nM primers and 2µl of 
diluted cDNA template in a 30µl reaction volume. PCR conditions were as follow: 
95°C for 15 min, then 40 cycles of 94°C for 15 sec, 60°C for 30 sec, 72°C for 30 sec, 
followed by plate-read. Each measurement was performed in triplicate and data 
normalised according to the expression of selected housekeeping genes (Ohl et al., 
2005). RNAs from mouse embryo head, spleen, liver and trophoblast stem (TS) cells 
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were used as positive controls. Negative controls included reactions without reverse 
transcriptase (-RT). Sequences of the specific primers used for qRT-PCR 
amplification are indicated in Table A1 (in Appendixes section). 
 
2.4.3. Microarray analysis 
RNA samples were obtained as previously described (section 2.4.1). Sample 
labelling, hybridization to the mouse Gene 1.0 ST Array system (Affymetrix), and 
data acquisition were performed by UCL Genomics at the Institute of Child Health. 
Normalisation and statistical analysis of the resulting array data was performed by 
Marion Leleu using GeneSpring software. 
 
2.5. Methods for protein analysis 
2.5.1. Western Blot 
5x105 cells were plated on gelatin-coated 6-well plates in ES medium, allowed to 
grow for 24 hours, and then changed to serum-free medium (ESGRO Basal medium, 
Chemicon) for overnight starvation prior to stimulation with 10, 50, or 500 ng/µl 
BMP4; 27 ng/ml or 250 ng/ml BMP7; 25 ng/ml FGF4; 25 ng/ml Activin; 50 or 250 
ng/µl Noggin; 50 or 250 ng/µl BMPR1A-FC (all from R&D Systems), or 3000units/ml 
LIF (Chemicon). 
Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris pH8, 0.5% sodium 
deoxycholate, 0.1% SDS, 1% NP-40) containing Complete Mini Protease Inhibitors 
(Roche). Protein extracts were then quantified usind the Bradford Method (reagent 
from BioRad). After denaturation (10 min at 95°C), 5 µg of protein were loaded and 
separated in a 10% acrylamide/Tris-HCl gel in glycine/Tris-HCl buffer. Proteins were 
then transferred onto a polyscreen PVDF membrane (Amersham) using vertical wet 
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transfer. Membranes were blocked in 0.1uM sodium orthovanadate / 5% milk in TBS 
/ 0.1% Tween (TBST) for 1 hour before incubation with primary antibody in 5% 
BSA/TBST (or 5% milk/TBST for c-MYC), overnight at 4ºC. The following antibodies 
and concentrations were used: rabbit anti phospho-SMAD1/5/8 (1:1000), rabbit anti 
phospho-SMAD2 (1:1000), rabbit anti phospho-p38 (1:1000), rabbit anti phospho-
ERK1/2 (1:2000), rabbit anti phospho-STAT3 (1:1000), rabbit anti α-tubulin (1:1500) 
(all from Cell Signalling), rabbit anti-cMYC (N-262 clone, 1:200), mouse anti-PCNA 
(1:5000, Santa Cruz).  
On the following day, membranes were washed in TBST and subsequently incubated 
in peroxidase-conjugated secondary antibody (anti-rabbit, 1:2000, from Santa Cruz 
or anti-mouse 1:5000, from Sigma) in 5% milk/TBST for 1 hour at room temperature. 
Finally, membranes were washed in TBST, and chemiluminescence assayed using 
ECL-Plus Western blotting detection system (Amersham Biosciences) and visualised 
on a Hyperfilm ECL X-ray film (Amersham Biosciences). 
 
2.5.2. Immunofluorescence  
For immunofluorescence analysis cells were grown on gelatine-coated glass 
coverslips. For BrdU incorporation cells in exponential growth phase were exposed 
to 20 µM BrdU for appropriate periods of time (5, 45 or 120) minutes before fixation. 
 
Coverslips were removed from culture plates, washed in PBS and fixed in 2% 
paraformaldehyde (PFA) in PBS for 20 min. Fixed samples were washed in PBS 
and, for intracellular staining, permeabilised with 0.4% Triton X-100 for 5 min. 
Samples were then incubated in blocking solution [2.5% bovine serum albumin 
(BSA), 0.05% Tween20, 10% Normal Goat Serum (Vector) in PBS] for 30 min 
followed by incubation in primary antibody: rabbit anti-cleaved caspase3 antibody 
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(1:100, Cell Signalling) was diluted in blocking solution; rat anti-BrdU antibody anti-
BrdU (Abcam, Cat no. ab6326) was incubated in DNase and DNase buffer (Ambion) 
diluted in blocking solution. Cells were incubated in primary antibodies for 2 h at 
room temperature in a humid chamber. Coverslips were subsequently washed in 
washing buffer (0.2% BSA, 0.05% Tween20 in PBS; 3x5 min) and incubated with 
secondary antibodies coupled with appropriated fluorophores (Molecular Probes) 
diluted in blocking solution for 45 min. Finally, cells were washed twice in wash buffer 
(5 min), once in PBS (3 min) and mounted in Vectashield (Vector) with DAPI (0.1 
µg/ml). Samples were visualised using a SP1 Leica laser-scanning confocal 
microscope. Images were processed using Leica Confocal software and Adobe 
Photoshop CS2. 
 
2.6. Flow Cytometry (FC) analysis  
All flow cytometry (FC) analyses were performed in a FACScalibur (BD Biosciences) 
with CellQuest software.  
 
2.6.1. GFP and PI analysis of live cells  
For the analysis of GFP expression in single and mixed cell cultures, cells were 
trypsinised, washed and resuspended in FACS buffer (3% FCS in PBS). For 
propidium iodide (PI) exclusion, 5 µl of 1mg/ml PI solution (Sigma) were added per 
ml of cell suspension. EGFP expression was assessed using the FL1 detection 
channel and propidium iodide staining was detected in the FL2 detection channel. 
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2.6.2. Methods for cell cycle analysis by FC 
 
PI cell cycle profiles 
For the analysis of cell cycle profiles by Flow Cytometry, cells were trypsinised and 
washed twice in cold PBS without Ca2+ and Mg2+. Approximately 1x106 cells were 
pelleted and fixed in 10 ml of ice-cold 70% ethanol (VWR) added dropwise. Cells 
were washed twice and the resuspended in 1 ml of PI staining buffer (50 µg/ml PI, 
0.05% NP-40, 1 mg/ml RNaseA in PBS without Ca2+ and Mg2+). Cells were then 
incubated in PI staining buffer for 30 min in the dark and immediately analysed. PI 
fluorescence was assessed using the FL2 detection channel. 
 
SNARF-1 analysis 
For loading of the carboxyl seminaphthorhodafluor (SNARF-1) dye, SNARF-1 
solution (Molecular Probes) was added to the cell suspension at a final concentration 
of 12.5 µM and incubated for 20 minutes at room temperature in the dark. Cells were 
then washed twice in 5%FCS/PBS, resuspended in ES cell medium (containing FCS 
and LIF), and plated in gelatine-coated dishes. SNARF1 is cell permeable in the 
acetomethyl ester form and diffuses passively into the cells where after deacetylation 
it is captured by cellular esterases. Once bound intracellularly this dye is 
symmetrically diluted in the daughter cells after each cell division. Cells were 
collected at regular time intervals (0. 12, 24, and 48 hours after loading) and 
resuspended in FACS buffer for analysis. SNARF-1 fluorescence was detected in the 
FL3 channel and was combined with GFP detection in the FL1 channel. 
 
Analysis of BrdU incorporation  
For analysis of BrdU incorporation, cells in exponential growth phase were exposed 
to 20 µM BrdU during 5, 45 or 120 minutes before fixation. 
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After incubation with BrdU, cells were trypsinised, washed and fixed in 4% 
paraformaldehyde (PFA) for 20 min at room temperature. Next, cells were washed in 
PBS and permeabilised in 0.5% Triton X-100, 5%BSA in PBS for 30 min at room 
temperature. Samples were then treated with DNase at a final concentration of 300 
µg/ml in DNase buffer and PBS for 1 hour at 37°C and subsequently washed and 
incubated with APC-conjugated anti-BrdU antibody (BD Pharmingen) diluted 1:50 in 
1% BSA, 0.05% Tween20 in PBS for 30 min at room temperature in the dark. After 
this period the cells were washed and resuspended in PBS with 3%FCS for flow 
cytometry analysis. BrdU staining was detected in the FL4 channel and was 
combined with GFP detection in the FL1 channel. 
 
2.6.3. Methods for apoptosis analysis by FC 
Annexin V staining 
Annexin V staining was used to assess the exposure of phosphatidylserine caused 
by loss of phospholipid asymmetry in the plasma membrane during the initial stages 
of apoptosis. Cells were harvested and approximately 2x105 cells were pelleted. 
These were ressuspended in 100 µl of annexin-binding buffer (0.1% BSA in 10mM 
HEPES, 140mM NaCl, 2.5mM CaCl2, pH7.4) with 5 µl of APC-conjugated annexinV 
(Molecular Probes) and incubated at RT in the dark for 15 min. After this period, 10 µl 
of 1 mg/ml PI was added and cells were incubated in the dark for further 5 min. After 
the incubation period, 400 µl of annexin-binding buffer were added to each sample 
and these were immediately analysed. AnnexinV-APC fluorescence was detected in 
the FL4 channel, PI fluorescence was detected in FL2, and GFP detected in the FL1 
channel. 
 
 
 70 
Analysis of mitochondrial membrane potential using DiIC1(5) 
The use of the the cationic lipophilic dye DiIC1(5) allowed assessing changes in 
mitochondrial membrane potential, a feature that is lost during apoptosis. When 
loaded to the cells, this dye accumulates primarily in mitochondria with active 
membrane potential and is released when this is lost during apoptosis, leading to a 
decrease in the fluorescence intensity of the dye (Galluzzi et al., 2007b). For the 
loading of DiIC1(5) (Molecular Probes) into the cells, ES cells were trypsinised and 
1x106 cells were ressuspended in 1 ml of pre-warmed medium. DiIC1(5) was added 
to each sample to a final concentration of 50nM and these were incubated at 37ºC in 
5%CO2 atmosphere for 20 minutes. The cells were then washed in pre-warmed 
PBS, ressuspended in 100 µl of FACS buffer (3%FCS, PBS) to which 5 µl of 1mg/ml 
PI were added and incubated for further 10 min at 37ºC (the temperature is important 
to maintain membrane potential). After the incubation period, 400 µl of FACS buffer 
were added and the samples were immediately analysed. DiIC1(5) fluorescence was 
detected in the FL4 channel, PI fluorescence was detected in FL2, and GFP detected 
in the FL1 channel. 
To control for the efficiency of the method, one sample was treated with carbonyl 
cyanide m-chlorophenylhydrazone (CCCP), a compound that disrupts mitochondrial 
membrane potential. For this sample the procedure was the same as previously 
described except for CCCP being added to a final concentration of 50µM 
simultaneously with DiIC1(5). 
 
2.6.4. SSEA-1 staining 
Analysis of the SSEA1 surface antigen was performed as follows:  cells were 
trypsinised,washed twice in FACS buffer (PBS, 3% FCS), and 1x106 cells were 
resuspended in APC-conjugated-SSEA1 antibody (R&D Systems; diluted 1:10 in 
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FACS buffer) and incubated 30 min at room temperature. The cells were then 
washed twice and resuspended in 500 µl of FACS buffer for analysis. APC 
fluorescence was detected in the FL4 channel and was combined with GFP detection 
in the FL1 channel. 
 
2.6.5. Fluorescence-activated cell sorting (FACS) 
For the separation of cells in mixed cultures of cells, based on GFP expression, the 
cells were trypsinised, washed and resuspended in FACS buffer (3%FCS in PBS). PI 
was added to the cell suspension just before sorting to allow for dead cell exclusion 
at a final concentration of 5 µg/ml. The cells were then FACS sorted (GFP-positive 
and GFP-negative populations isolated) using a FACSAria cell sorter (BD 
Biosciences) at the MRC Clinical Sciences Centre Flow Cytometry facility. The 
samples were kept on ice or refrigerated during the whole procedure. After sorting, 
the cells were pelleted and used for RNA or protein analysis. 
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3. DERIVATION AND CHARACTERIZATION OF Bmpr1a-/- 
ES CELLS 
3.1. Introduction 
BMP signalling plays important roles during mammalian development, namely 
determining embryonic patterning and cell fate specification (Kishigami and Mishina, 
2005; Kitisin et al., 2007). In mouse ES cells, BMPs block neural differentiation, 
thereby maintaining self-renewal and pluripotency in combination with LIF (Ying et 
al., 2003a). 
Activation of SMAD1/5/8 is the main pathway downstream of BMP stimulation (Shi 
and Massague, 2003). However, MAPK signalling, in particular p38 and ERK, can 
also be activated in response to BMPs (Nohe et al., 2004). Both SMAD activation, 
and the consequent expression of ID proteins (Ying et al., 2003a), and MAPK 
inhibition (Qi et al., 2004) have been suggested to be important in the self-renewal 
activity of BMPs.  
 
BMPR1A is a type I BMP receptor that is specifically bound by BMP4 and BMP2, and 
with lower affinity by BMP6 and BMP7. Upon ligand binding, BMPR1A forms a 
heteromeric complex with BMPR2, whose constitutively active kinase phosphorylates 
and activates BMPR1A, thus initiating intracellular signalling by SMAD1/5/8 or MAPK 
(Nohe et al., 2004). Both BMPR1A and the other type I BMP receptors, BMPR1B and 
ACVR1, seem to activate the same downstream signalling pathways, even though 
different functions during embryonic development have been described (Kishigami 
and Mishina, 2005; Nohe et al., 2004). 
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Bmpr1a is expressed in the mouse embryo from the blastocyst stage (Roelen et al., 
1997), and is ubiquitously expressed in the epiblast and extraembryonic region at 
gastrulation (Mishina et al., 1995), whereas the two other type I BMP receptors are 
only expressed at different stages and in a more restricted manner (Dewulf et al., 
1995; Roelen et al., 1994). Even though Bmpr1a is the main type I BMP receptor 
expressed in the blastocyst (Roelen et al., 1997), Bmpr1a-null embryos do not show 
any pre-implantation defects, suggesting that it is not required at this stage, or that 
other mechanisms can compensate for its absence. In the pre-gastrulation egg-
cylinder embryo, BMP signalling via BMPR1A is required to maintain epiblast 
pluripotency by inhibiting premature neural differentiation (Di-Gregorio et al., 2007). 
Bmpr1a-null embryos also show a defect in epiblast proliferation and in the initiation 
of gastrulation, having no mesoderm formation (Beppu et al., 2000; Mishina et al., 
1995). This phenotype is more severe than that of Bmp2 or Bmp4 knockouts, 
indicating that functional redundancy exits between BMP proteins (Mishina, 2003). 
In mouse ES cells, BMPR1A is highly expressed and apparently required for their 
derivation, given the difficulty in isolating ES cells devoid of this receptor (Qi et al., 
2004). However, inhibition of p38 MAPK by SB203580 allowed the derivation of 
Bmpr1a-null ES cells, on feeder cells and using medium supplemented with LIF and 
serum (Qi et al., 2004), suggesting that the p38 pathway acts downstream of BMPs 
in maintaining self-renewal. 
 
In order to better understand the role of BMP signalling via BMPR1A in mouse ES 
cells, ES cells were derived from Bmpr1a-null blastocysts and their signalling 
activation, self-renewal ability, and gene expression profile were analysed. A 
possible mechanism that may be compensating for the lack of BMPR1A in these 
cells was also investigated. 
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3.2. Results 
3.2.1. ES cells can be isolated from Bmpr1a-/- embryos 
To investigate the importance of BMP signalling via BMPR1A in maintaining self-
renewal and pluripotency, the ability to isolate ES cells from Bmpr1a-/- embryos was 
tested. Blastocysts obtained from crosses of Bmpr1a heterozygous (+/-) mice 
(Mishina et al., 1995) were cultured on gelatine-coated dishes in ES cell medium 
(containing LIF and FCS) to generate outgrowths. Control and Bmpr1a-/- outgrowths 
had a similar morphology and were positive for alkaline phosphatase (AP) activity (a 
marker of undifferentiated cells) (Figure 3.1A). The outgrowths were then dissociated 
and replated to establish ES cell lines. Two ES cell lines were obtained and 
genotyped using primers specific for the Bmpr1a-null mutation (Mishina et al., 1995) 
showing that the 3.5 cells are wild-type (WT) and the C1 are null for Bmpr1a (Figure 
3.1C).  C1-Bmpr1a-/- cells could be passaged at least 30 times whilst still retaining 
the ability to form AP-positive colonies (Figure 3.1A) with characteristic ES-cell 
morphology (Figure 3.1B), and maintained a normal karyotype (Figure 3.1D). PCR 
analysis of the Ube1 gene, which gives different sized products for the X and Y linked 
copies (primers provided by TB Nesterova), revealed that both cell lines derived are 
XX (Figure 3.1E). 
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Figure 3.1 ES cell derivation from Bmpr1a-/- mouse embryos.  
(A) Blastocysts obtained from Bmpr1a+/- intercrosses were cultured on gelatine-coated dishes 
in ES cell medium containing FCS and LIF. The outgrowths were subsequently disaggregated 
and replated in order to establish ES cell lines. Staining for alkaline phosphatase activity 
shows that Bmpr1a-/-outgrowths after 5 (d5) and 10 (d10) days in culture, and the established 
C1-Bmpr1a-/- ES cell line have levels of pluripotency similar to wild-type (WT) controls. (B) 
Bright field images of 3.5 WT and C1-Bmpr1a-/- ES cells. (C) DNA extracted from the newly 
derived 3.5 and C1 ES cell lines was analysed by PCR using primers specific for the Bmpr1a 
WT (WT PCR, 280bp PCR product) and mutant (-/-PCR, 190bp product) alleles (Mishina et 
al., 1995). DNA samples obtained from the previously established E14 and Fr88 (Qi et al., 
2004) cell lines were used as positive controls for the WT and mutant alleles, respectively. 
PCR genotyping showed that 3.5 cells are WT and C1 cells are Bmpr1a-null (-/-). (D) 
Metaphase spreads were performed to confirm that the derived cell lines had normal 
chromosomal numbers. (E) PCR analysis of the Ube1 gene using primers that generate 
different sized products for the X (217bp) and Y (198bp) linked copies. The XY E14 cell line 
was used as positive control. Both the newly derived 3.5 and C1 cell lines were XX. 
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3.2.2. BMP4 cannot signal in Bmpr1a-/- ES cells  
BMP signalling cooperates with LIF/STAT3 in the maintenance of ES cell 
pluripotency and self-renewal (Ying et al., 2003a). Activation of SMAD1/5/8 is the 
main pathway downstream of BMPs (Shi and Massague, 2003), but p38 and ERK 
signalling have also been reported to be activated in response to BMP stimulation 
(Nohe et al., 2004; Ying et al., 2003a).  
The activation of intracellular signalling pathways in wild-type (WT) and Bmpr1a-/- 
cells in response to BMP4 and LIF was analysed. Cells were serum starved 
overnight and then stimulated for 1 hour with 50 or 500 ng/ml of BMP4, LIF (3000 
Units/ml), LIF and BMP4 (50 ng/ml), or ES cell medium containing LIF and FCS. The 
activation of SMAD1/5/8, p38 and ERK was then investigated by immunoblotting. 
As shown in Figure 3.2, BMP4 stimulates SMAD1/5/8 phosphorylation in WT ES 
cells, but not in C1-Bmpr1a mutant cells. Even at increased BMP4 concentration 
(500 ng/ml), which could lead to binding to lower affinity receptors, no 
phosphorylation of SMAD1/5/8 was observed in Bmpr1a-null cells. At this 
concentration, activation of SMAD1/5/8 in WT ES cells was not increased compared 
to stimulation with 50 ng/ml BMP4, suggesting saturation of the receptors. No 
difference in SMAD activation was seen when cells were stimulated with BMP4 in 
combination with LIF, indicating that the effect of BMP4 in SMAD signalling is 
independent of that cytokine. 
The ability of BMP4 to stimulate p38 and ERK signalling, as shown by Ying et al. 
(2003), or to antagonise these MAPK pathways in ES cells as suggested by Qi and 
coworkers (Qi et al., 2004), was next investigated. Neither increased phosphorylation 
of p38 and ERK1/2 in Bmpr1a-/- cells, nor diminished signalling in WT cells were 
observed upon BMP4 stimulation (Figure 3.2). These observations suggest that 
BMP4 signalling is not required to block the activity of these pathways as proposed 
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by Qi et al. (2004). On the contrary, BMP4 stimulation led to a slight increase in p38 
phosphorylation in WT but not in Bmpr1a-/- cells indicating that activated BMPR1A 
can also signal via p38 in ES cells. These results show that self-renewal in Bmpr1a-/- 
ES cells cannot be maintained by BMP4, as BMP4 does not stimulate any of the 
known BMP signal transducers in these cells.  
 
 
Figure 3.2 Bmpr1a-/- cells do not respond to BMP4 via the Smad1/5/8, p38 or ERK 
pathways.  
C1-Bmpr1a-/- and control 3.5 WT cells were starved overnight and subsequently treated for 1 
hour with 50 ng/ml BMP4, 500 ng/ml BMP4, LIF (1500U/ml), BMP4 (50 ng/ml) plus LIF, 15% 
FCS plus LIF or left untreated. Protein lysates were obtained, separated by electrophoresis 
and analysed by western blotting using antibodies against phosphorylated (p-)SMAD1/5/8, p-
p38 and p-p44/42 (ERK1/2). PCNA and α-tubulin were used as loading controls. BMP4 
stimulated phosphorylation of SMAD1/5/8 in 3.5-WT but not in C1-Bmpr1a-/- ES cells. No 
significant activation of p38 or ERK MAP kinases by BMP4 was observed in either cell line. 
 
 
The signalling ability of Bmpr1a-/- ES cells was further investigated by looking at the 
activation of SMAD1/5/8, SMAD2, p38, and STAT3 in response to FCS+LIF, BMP4, 
LIF, FGF4 and Activin after 1 and 24 hours (Figure 3.3A). As expected, in FCS plus 
LIF all the pathways analysed were activated, even though this activation was 
stronger for the shorter pulse. For both stimulus durations, SMAD1/5/8 and p38 
activation were lower in C1-Bmpr1a-/- compared to 3.5-WT cells in FCS+LIF. As 
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before, BMP4 induced strong phosphorylation of SMAD1/5/8 in WT cells, but not in 
Bmpr1a-/-cells, and had no significant effects on the other pathways. Apart from 
SMAD1/5/8 activation in response to BMP4 and to FCS+LIF, no major signalling 
differences were observed between the two cell types.  
 
Figure 3.3 Bmpr1a-/- cells do not respond to BMP4 nor show altered response to other 
stimulus but have SMAD1/5/8 activation after long-term culture in ES-cell maintenance 
conditions. 
(A) Western blot analysis of protein lysates obtained from 3.5-WT (WT) and C1-Bmpr1a-/- (-/-) 
cells after overnight starvation followed by 1 or 24 hour treatments with FCS plus LIF 
(1500U/ml), 10 ng/ml BMP4, 1500U/ml LIF, 25 ng/ml FGF4, 25 ng/ml Activin, or no stimulus 
(untreated). Specific antibodies were used to detect activation of the SMAD1/5/8, p38, 
SMAD2, and STAT3 pathways; PCNA and α-tubulin were used as loading controls. C1-
Bmpr1a-/- ES cells showed similar responses to the different stimuli compared to the control 
WT cells, except for the BMP4 treatment to which the mutant cells did not respond. (B) 
Analysis of SMAD1/5/8 activation by western blotting after 4 days culture in medium 
containing FCS plus LIF or BMP4 plus LIF. C1-Bmpr1a-/- ES cells show lower levels but still 
clear SMAD1/5/8 phosphorylation in both these conditions.  
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SMAD1/5/8 phosphorylation was also analysed in ES cells maintained for 4 days 
either in medium with FCS and LIF, or in serum-free medium with BMP4 and LIF. In 
both these conditions Bmpr1a-/- cells showed a lower, but evident, level of 
SMAD1/5/8 activation (Figure 3.3B). This observation was particularly surprising for 
the serum-free condition given that BMP4 cannot stimulate SMAD1/5/8 in the 
absence of BMPR1A. This indicates that either long-term stimulation with BMP4 can 
activate low affinity receptors in these cells, or that in BMP4+LIF medium SMAD1/5/8 
phosphorylation is indirectly induced, possibly via autocrine stimulation. The residual 
SMAD1/5/8 activation is probably required and sufficient to maintain the self-renewal 
of Bmpr1a-/- ES cells. 
 
3.2.3. Bmpr1a-/- ES cells do not have self-renewal defects. 
In order to investigate the self-renewal of C1-Bmpr1a-/- ES cells, these and control 
3.5-WT cells were plated at a low density on gelatinised plates, grown for 6 days in 
different culture conditions and finally stained for alkaline phosphatase activity 
(Figure 3.4A). To overcome the low plating efficiencies of some conditions, the cells 
were all plated in medium containing FCS and 6 hours later washed in PBS and the 
media replaced. As shown in Figure 3.4B, quantification of AP staining revealed that 
the self-renewal ability of C1 Bmpr1a-/- ES cells is not significantly different from that 
of WT ES cells in any of the conditions tested. The similar levels of AP staining in 
ES-cell medium (containing FCS and LIF) had initially led us to hypothesise that 
compensatory factors in the serum could be maintaining self-renewal in Bmpr1a-/- 
cells. Given that C1-Bmpr1a-/- cells do not respond to BMP4 (Figures 3.2 and 3.3), 
these cells should not be able to self-renew in serum-free medium with BMP4 (10 
ng/ml) and LIF, conditions that are generally sufficient to maintain ES cells (Ying et 
al., 2003a). However, even in these serum-free conditions (BMP4+LIF), Bmpr1a-/- 
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cells formed an only slightly lower number of colonies, with equivalent levels of 
alkaline phosphatase activity compared to WT cells (41% high and 53% medium 
stained in WT cells compared to 35% high and 60% medium stained colonies in null 
cells). The highest degree of differentiation for both WT and Bmpr1a-/- cells was 
observed in serum-free Basal medium. Conversely, the use of 2i conditions (with 
MEK and GSK3 inhibitors) maintained highly pluripotent colonies, as shown by the 
levels of AP staining, which are in fact considerably stronger than those obtained for 
the usual ES culture conditions (FCS+LIF). 
 
Figure 3.4 Bmpr1a-/- ES cells do not show defects when grown at clonal density. 
(A) 3.5-WT and C1-Bmpr1a-/- cells were plated at low density (1000 cells per 9.6 cm2 well of a 
6-well plate) in serum-containing medium, and 6 hours later replaced by Basal medium alone 
or with LIF (1500U/ml), FCS plus LIF, BMP4 (10 ng/ml) plus LIF, or 2i (PD0325901 + 
CHIR99021). Alkaline phosphatase activity was assessed 6 days after culture in these 
conditions. (B) ES-cell colonies were classified as having high, medium or low alkaline 
phosphatase activity according to the amount of staining as well as the staining intensity 
(representative images are shown on the right). For the quantification of alkaline phosphatase 
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activity 100 arbitrary colonies were assessed. No major differences were observed between 
the two cell types. 
 
The proliferation and viability of wild-type and Bmpr1a-/- ES cells were examined by 
looking at cell cycle profiles and crystal violet growth curves. As shown in Figure 
3.5A, the propidium iodide cell cycle profiles of C1-Bmpr1a-/- cells growing in normal 
ES-cell maintenance conditions (FCS+LIF) were very similar to those of control ES 
cells. Quantification of the percentages of cells in S and G2/M phases showed that 
these were comparable for both cell types (3.5-WT: 39.4%±1.9 cell in S phase, 
32.2%±2.1 cells in G2/M; C1-Bmpr1a-/-: 39.1%±2.6 cells in S, 31.2%±1.6 cells in 
G2/M phase; Figure 3.5A). The growth of the two cell types in different culture 
conditions was next analysed by staining the cells with crystal violet, a dye that binds 
to DNA, allowing visualisation of cell numbers (Figure 3.5B). Quantification of crystal 
violet staining of WT and C1-Bmpr1a-/- ES cells during the first four days after plating 
at relatively low cell densities showed that the two cell types have similar growth 
curves both in serum-containing and in serum-free conditions (Figure 3.5C). 
However, both cell types experienced a moderate decrease in proliferation rate in 
serum–free medium compared to cells grown in FCS-containing medium (Figure 
3.5C). 
In summary, even though C1-Bmpr1a-/- cells did not respond to BMP4 (Figures 3.2 
and 3.3), they could be maintained both in FCS plus LIF and in BMP4 plus LIF 
conditions, without major differences in morphology (Figure 3.1), alkaline 
phosphatase activity (Figure 3.4) or proliferation rate (Figure 3.5C), compared to WT 
cells. Therefore, these results show that C1-Bmpr1a-/- ES cells do not have 
proliferation and self-renewal defects, neither in serum-containing nor in serum-free 
conditions. 
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Figure 3.5. Bmpr1a-/- and WT ES cells have similar growth patterns. 
(A) The cell cycle profiles of 3.5-WT and C1-Bmpr1a-/- cells were assessed by flow cytometry 
after propidium iodide staining. The pie charts represent the percentage of cells in each cell 
cycle phase (average of 3 independent assays +/- standard deviation) in each cell type. (B) 
3.5-WT and C1-Bmpr1a-/- ES cells were grown in basal medium only or with LIF, BMP4+LIF 
or FCS+LIF for 4 days. During this period a plate was fixed every day and stained for crystal 
violet to assess cell numbers. Representative plates of the staining observed at days 2 and 4 
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are shown. (C) Spectrophotometric quantification of the crystal violet staining shows that 3.5-
WT and C1-Bmpr1a-/- ES cells have a similar growth rates in all the conditions tested. Data 
was normalised to the initial number of cells plated (absorbance at 595nm obtained at the 
beginning of the experiment, d0); data shown as mean +/- standard deviation (s.d.) of 3 
independent experiments (n=3). 
 
3.2.4. Bmpr1a-/- and control ES cells show similar gene expression 
patterns 
To characterise the pluripotency of C1-Bmpr1a-/- cells in ES-cell maintenance 
conditions, the expression of the pluripotency markers Oct4 and Nanog, as well as 
that of lineage specific markers such as Flk1 and Nkx2.5 for mesoderm, Msx1 and 
Sox1 for neuroectoderm, Gata 4 and 6 for endoderm and Eomes and Cdx2 for 
trophoblast, was analysed by quantitative RT-PCR. As shown in Figure 3.6A, no 
significant differences were observed between WT and mutant cells in the levels of 
expression of any of the genes analysed. These results indicate that Bmpr1a-/- ES 
cells do not have pluripotency defects. 
The gene expression pattern of Bmpr1a-/- ES cells was further characterized by 
looking at global gene expression profiles by Microarrays, and comparing them to 
those of WT cells. In this experiment, the independently derived ES cell lines Fr88 
and Fr124 Bmpr1a-/- cells (Qi et al., 2004), and E14 WT cells were also included. 
Clustering analysis showed that the gene expression profiles of mutant cells do not 
greatly differ from those of WT cells (Figure 3.6B). Also, the different WT and null ES 
cells do not cluster together, indicating that there is no specific change in the gene 
expression profiles between mutant and control cells.  
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Figure 3.6 Gene expression analysis in Bmpr1a-/- and WT ES cells 
(A) Quantitative RT-PCR analysis of the expression of markers of pluripotency (Oct4, Nanog), 
neuroectoderm (Sox1, Msx1), mesoderm (Flk1, Nkx2.5), endoderm (Gata4, Gata6) and 
trophectoderm (Eomes, Cdx2) in 3.5-WT and C1-Bmpr1a-/- ES cells grown in FCS+LIF or 
BMP4+LIF for 3 days. No significant differences in gene expression were observed between 
the two cell types. Expression values were normalised to Hmbs and βActin expression; data 
shown as mean +/- s.d. (n=3). (B) The genome-wide gene expression pattern of 2 
independent WT ES cell lines (E14 and 3.5) and 3 Bmpr1a-/- ES cell lines (C1, Fr88 and 
Fr124) maintened in LIF and FCS was analysed using the Affimetrix Gene 1.0 Arrays. 
Hierarchical clustering analysis and heat map representation of the gene expression patterns 
show that WT and Bmpr1a-/- ES cell lines do not cluster together. 
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3.2.5. Bmpr1a-/- ES cells respond to BMP7 stimulation 
The previous results have suggested that a low activation of the SMAD1/5/8 pathway 
is sufficient to sustain ES-cell self-renewal. Bmpr1a-/- ES cells were able to maintain 
this low activation even in serum-free conditions (only with BMP4 and LIF), indicating 
that this can be achieved via an indirect, BMPR1A-independent, mechanism. 
Therefore, one possibility is that ES cells secrete other BMPs that stimulate 
SMAD1/5/8 phosphorylation in an autocrine manner. Alternatively, the low levels of 
SMAD1/5/8 phosphorylation observed could be insufficient to induce the expression 
of Id genes and so other pathways have to compensate for this.  
To address this issue, the expression levels of the BMP target genes Id1, 2 and 3 
were analysed by quantitative RT-PCR. Consistent with the lower activation of the 
SMAD1/5/8 pathway in C1-Bmpr1a-/- cells, expression of Id genes was also reduced 
in comparison to control cells (Figure 3.7A). However, Id expression was still 
detectable both in serum containing and in serum-free medium with LIF and BMP4. 
In particular, Id1 expression in BMP4 plus LIF, even though it was considerably 
upregulated in WT cells, in Bmpr1a-/- cells showed levels comparable to those of both 
cell types in FCS and LIF. This confirms that there is still activation of the BMP 
pathway in the absence of BMPR1A and that it is sufficient to counteract ES-cell 
differentiation by inducing the expression of Id genes.  
The activation of SMAD1/5/8 and expression of Id1 in Bmpr1a-/- ES cells could be 
explained by autocrine stimulation by BMPs other than BMP4, something that has 
previously been reported to occur in ES cells (Monteiro et al., 2004). To investigate 
the mechanism by which Bmpr1a-/- cells maintain this activation in the absence of 
BMP4 signalling, expression of the different type I BMP receptors and of the type II 
receptor Bmpr2 were analysed. As seen in Figure 3.7A, no increase was observed in 
the expression of either receptor in Bmpr1a-/- cells, both in FCS plus LIF and in 
serum-free conditions with LIF and BMP4. Importantly, even though Bmpr1b 
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expression is hardly detectable in both cell types, Acvr1 is expressed at considerable 
levels. The expression of BMP ligands was also examined and, in addition to Bmp4, 
Bmp7 was also found to be significantly expressed in ES cells.  This expression of 
Bmp7 was almost 3-fold higher in C1-Bmpr1a-/- cells than in 3.5-WT cells in serum-
free conditions containing LIF and BMP4 (Figure 3.7A). 
BMP7 is a member of the OP-1 subgroup, which binds to, and preferentially 
activates, the type I BMP receptor ACVR1 (Podos and Ferguson, 1999; ten Dijke et 
al., 1994). Given that both Bmp7 and its high affinity receptor are expressed in 
Bmpr1a-/- ES cells (Figure 3.7A), autocrine signalling could be one mechanism by 
which SMAD1/5/8 activation is stimulated in these cells. The observation that, in 
contrast to BMP4, BMP7 was capable of activating the phosphorylation of 
SMAD1/5/8 in Bmpr1a-/- ES cells (Figure 3.7B) strengthened this hypothesis.  
To further test the hypothesis that BMP7 was capable of maintaining self-renewal in 
the absence of BMP4 signalling, blastocyst outgrowth assays were carried out by 
Aida di Gregorio, in our lab. Initially, Bmpr1a-/- blastocysts were cultured in the 
presence of BMP4 and LIF. In these conditions Bmpr1a-/- blastocysts showed 
severely impaired proliferation and variable levels of alkaline phosphatase activity 
compared to WT blatocysts (Figure 3.7C). This indicates that BMP4 is unable to 
sustain self-renewal of the inner cell mass in these embryos. The capacity of BMP7 
to rescue the defects of Bmpr1a-/- blastocyst outgrowths was subsequently analysed. 
When Bmpr1a-/- blastocysts were cultured in the presence of BMP7 and LIF they 
formed outgrowths that were equivalent both in size and alkaline phosphatase 
activity to control outgrowths (Figure 3.7C).  
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Figure 3.7 Bmpr1a-/- cells upregulate Bmp7 expression, can respond to BMP7 
signalling and in this way maintain their self-renewal. 
(A) Quantitative RT-PCR analysis of gene expression of BMP targets (Id1, Id2, Id3), BMP 
receptors (Bmpr1b, Acvr1, Acvrl1, Bmpr2) and BMP ligands (Bmp4, Bmp2, Bmp7) in 3.5-WT 
and C1-Bmpr1a-/- ES cells in medium containing LIF and FCS or LIF and BMP4. Mutant cells 
express BMP target genes and in serum-free medium have increased expression of Bmp7. 
Data was normalised to Hmbs and PGK1 expression. (B) Western blot analysis showing that 
BMP7 stimulation induces SMAD1/5/8 phosphorylation both in 3.5-WT and C1-Bmpr1a-/- ES 
cells. PCNA was used as loading control. (C) Bmpr1a-/- embryos showed self-renewal defects 
when cultured in serum-free conditions with BMP4, as shown by decreased proliferation and 
alkaline phosphatase staining. The self-renewal defects were rescued when BMP7 was 
added to the culture conditions (published in Di-Gregorio et al., 2007). 
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These results indicate that signalling by BMPs of the OP-1 subgroup via ACVR1 may 
be maintaining self-renewal in the absence of BMP4/BMPR1a signalling, both in ES 
cells and the early embryo. 
 
3.3. Discussion  
BMPs are necessary, in combination with LIF, to sustain self-renewal of pluripotent 
ES cells (Qi et al., 2004; Ying et al., 2003a; Ying et al., 2003b). Bmpr1a is the type I 
BMP receptor most highly expressed in undifferentiated ES cells (Qi et al., 2004; 
Ying et al., 2003a), in the pluripotent ICM and in the early epiblast of the mouse 
embryo (Mishina et al., 1995; Roelen et al., 1997). Recently, our group has shown 
that signalling via BMPR1A is required during mouse development to maintain the 
pluripotency of the epiblast and prevent precocious neural differentiation of this 
tissue (Di-Gregorio et al., 2007)  
Whether the ability to maintain ES cell self-renewal is restricted to specific BMP 
ligands and receptors, or is a general property of this family of proteins is still an 
unanswered question. Furthermore, the mechanisms by which BMPs exert their 
effects on ES cells and the downstream signalling pathways involved, is also 
controversial. Bmpr1a-/- ES cells had previously only been successfully isolated using 
a p38 inhibitor (Qi et al., 2004). However, in this study, Bmpr1a-/- ES cells were 
derived in the absence of inhibitors, in feeder-free conditions. This can be explained 
by the fact that all the previous efforts to isolate ES cells from Bmpr1a-/- blastocysts 
had been carried out on a fibroblast feeder layer (of which the main function is the 
production of LIF), with the addition of LIF to the medium (Qi et al., 2004), thus using 
a double source this cytokine. This may have inhibited the generation of Bmpr1a-/- 
ES cells since there has to be a finely tuned balance between the levels of 
BMP/SMAD and LIF/Stat3 signalling to maintain self-renewal and pluripotency in ES 
 89 
cells (Ying et al., 2003a). A more detailed study of the interactions between these 
two pathways would be needed to understand how this balance determines the 
maintenance of undifferentiated ES cells. Alternatively a difference in the 
composition of the serum (mainly in concentration of BMPs) could account for these 
differences. 
Three main mechanisms have been proposed to explain how BMPs sustain self-
renewal in combination with LIF. Ying and coworkers have shown that this can be 
achieved through an increase in Id expression due to SMAD activation (Ying et al., 
2003a). Another report suggested that self-renewal is dependent on BMP-mediated 
inhibition of the p38 and ERK differentiation promoting pathways (Qi et al., 2004). 
Finally, more recently, a negative feedback mechanism has been reported in which 
the combined action of BMPs and LIF lead to the up-regulation of Nanog, thus 
preventing BMP-induced mesoderm specification and ES-cell differentiation in 
general (Suzuki et al., 2006).  
In the present study, BMP4 stimulation of ES cells led to an increase of SMAD1/5/8 
phosphorylation and a slight activation of p38, but no significant changes in the 
activation of the ERK pathway were observed. Furthermore, C1-Bmpr1a-/- cells did 
not respond to BMP4 stimulation by any of the known BMP transducers in ES cells. 
However, these cells could self-renew and retained pluripotency, as indicated by 
alkaline phosphatase activity, cell cycle profiles and gene expression patterns. This 
suggests that BMP4 signalling via BMPR1A is not essential for ES cell maintenance, 
and that its absence is compensated by other mechanisms. To further confirm that 
Bmpr1a-/- ES cells do not show any pluripotency defects, the ability of these cells to 
give rise to all the different cell lineages should be analysed using in vitro 
differentiation assays (see next chapter) and, ultimately by generation of chimeras. 
Although the levels of BMP signalling are decreased in Bmpr1a-/- cells, these cells 
still retain SMAD1/5/8 phosphorylation and expression of the target gene Id1, both in 
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the presence of FCS and, more surprisingly, in serum-free conditions. This low 
activation of the SMAD1/5/8 pathway is probably sufficient for these cells to 
propagate in serum-free media.  
Overexpression of the inhibitory Smad6 or Smad7 has shown that inhibition of 
SMAD1/5/8 activation makes BMP4 and serum ineffective in suppressing ES-cell 
neural differentiation (Gambaro et al., 2006; Ying et al., 2003a). Also, inhibition of 
p38 using a specific chemical inhibitor had no effect on the ability of BMP4 to support 
self-renewal in combination with LIF, nor did it inhibit ES-cell differentiation in LIF 
only (Ying et al., 2003a). These reports, together with the results of the present 
study, confirm that SMAD1/5/8 activation is the main pathway involved in the 
maintenance of self-renewal downstream of BMPs. 
The lack of self-renewal defects observed in Bmpr1a-/- cells and in blastocyst 
outgrowths cultured in serum suggests that secreted factors are compensating for 
the deficiency in transducing BMP2/4 by these cells. The activation of SMAD1/5/8 
observed in Bmpr1a-/- ES cells cultured in serum free condition, indicates that these 
factors could be other BMPs produced in an autocrine fashion.  It is shown here that 
Bmp7, a BMP of the OP-1 subgroup, is up-regulated in Bmpr1a-/- cells, and that it 
can activate its specific type I receptor Acvr1 inducing SMAD1/5/8 phosphorylation in 
these cells. Furthermore, addition of BMP7 rescues the self-renewal defects of 
Bmpr1a-/- blastocysts grown in serum-free medium. Expression of BMP7 by mouse 
ES cells, as well as their ability to respond to autocrine loops, have also been 
previously reported (Monteiro et al., 2004). Therefore, autocrine BMP7 signalling via 
ACVR1 is the likely mechanism by which SMAD1/5/8 activation is stimulated in 
Bmpr1a-/- cells, allowing their maintenance independently of an exogenous source of 
BMPs. This indicates that, in the absence of BMP4/BMPR1A signalling, members of 
the OP-1 subgroup, like BMP7, can maintain self-renewal and pluripotency in ES 
cells. 
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In the mouse embryo it has been shown that BMP2/4 signalling via BMPR1a is the 
main source of BMP signalling that inhibits neural fate prior to gastrulation (Di-
Gregorio et al., 2007). However, as gastrulation commences, the sources of BMP2/4 
in the AVE and extra-embryonic ectoderm start to be displaced from being in contact 
with the embryo, and BMPs of the 60A subgroup, such as BMP7, start to be 
expressed (Solloway and Robertson, 1999). Therefore, signalling via ACVR1 at this 
stage is likely to cooperate with BMP2/4 to reinforce the inhibition of neural induction.  
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4. DEVELOPMENTAL POTENTIAL OF Bmpr1a-/- ES 
CELLS 
4.1. Introduction 
During gastrulation, the pluripotent epiblast gives rise to the three primary germ 
layers, ectoderm, mesoderm and definitive endoderm (Beddington and Robertson, 
1999; Tam and Behringer, 1997), the progenitor lineages of all the embryonic 
tissues. According to the spatio-temporal position of primitive streak (PS) ingression, 
epiblast cells are exposed to different levels of BMP, Nodal, FGF and Wnt signalling 
that will determine the patterning of the emerging mesoderm and endoderm cells 
(reviewed in Tam and Loebel, 2007). Neural and surface ectoderm cells are formed 
in the anterior region of the epiblast, which does not enter the PS, in response to the 
low levels of BMPs signalling present in this region.  
Pluripotent stem cell lines can differentiate in vitro and give rise to derivatives of the 
three germ layers. Two types of pluripotent stem cells have been derived from the 
epiblast of early embryos: ES cells, isolated from the epiblast of the blastocyst-stage 
embryo (Evans and Kaufman, 1981; Martin, 1981), and epiblast stem cells (EpiSCs), 
obtained from the post-implantation epithelial epiblast (Brons et al., 2007; Tesar et 
al., 2007). Whereas ES cell self-renewal is sustained by LIF and BMP4 (or serum), 
EpiSCs require FGF and Activin/Nodal signalling for their maintenance. Although 
EpiSCs express the core pluripotency transcription factors Oct4, Sox2 and Nanog, 
their global gene expression pattern is different from that of mouse ES cells, and 
related to their post-implantation epiblast origin (Brons et al., 2007; Tesar et al., 
2007). Gene expression and epigenetic regulation analysis have revealed that ES 
and EpiSCs represent two distinct pluripotent states, comparable to the pre-
implantation ICM and the post-implantation epiblast, respectively. ES cells can stably 
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differentiate into an EpiSC-like state when put in appropriate culture conditions (Guo 
et al., 2009). 
Both ES cells and EpiSCs, in accordance with the developmental potential of their in 
vivo counterparts, are capable of differentiating into various cell types of the three 
germ layers. This can be accomplished in vitro, either via the formation of three-
dimensional aggregates known as embryoid bodies (EBs), or by culturing ES cells on 
extracellular matrix proteins or on supportive stromal layers (reviewed in Murry and 
Keller, 2008). 
The first step in the ES-cell differentiation pathway is generally the formation of a cell 
population resembling the epiblast of the mouse embryo. When stimulated with Wnt, 
activin, BMP or serum, ES cells generate a Brachyury-positive, primitive streak-like 
population (reviewed in Murry and Keller, 2008). Subsequent manipulation of the 
BMP, Wnt and Nodal pathways in ES-cell cultures modulates differentiation into 
specific germ layers and cell types in a way that resembles what happens in the 
embryo (reviewed in Murry and Keller, 2008).  
In vivo, when the PS-inducing pathways (Wnt, Nodal and BMP) are not activated, 
epiblast cells differentiate into the neuroectoderm lineage. ES cells in comparable 
conditions follow an identical fate. Several neural differentiation protocols have been 
developed, some involving an initial step of EB formation or co-culture with different 
cell types, leading to the production of neural precursors with varying efficiencies 
(Kawasaki et al., 2000; Keller, 2005; Li et al., 1998; Ying et al., 2003b). Importantly, 
when ES cells are cultured at low density in serum-free medium in an adherent 
monoculture, the appearance of a high number of Nestin (Tropepe et al., 2001) or 
Sox1-positive cells (Ying et al., 2003b) can be observed, indicating neuroectodermal 
specification. LIF reduces the efficiency of neural differentiation (Ying et al., 2003b), 
which is in accordance with its role in maintaining undifferentiated ES cells 
(Chambers and Smith, 2004; Ying et al., 2003a; Ying et al., 2003b), even though it 
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mainly inhibits the development of non-neural cell types (Tropepe et al., 2001; Ying 
et al., 2003a) and also maintains cell survival in minimal conditions (Duval et al., 
2000; Tropepe et al., 2001; Ying et al., 2008). Furthermore, monolayer neural 
differentiation is dependent on autocrine FGF signalling and inhibited by BMPs, 
which induce alternative fates (Tropepe et al., 2001; Ying et al., 2003b). Wnt and 
activin/Nodal activation also suppress neural differentiation by inducing alternative 
fates (reviewed in Murry and Keller, 2008). This is consistent with the observation 
that these pathways are not active in the region of ectoderm induction in the early 
embryo. Notch signalling is also a key player in establishment of neural progenitor 
cells (Lowell et al., 2006), mainly promoting cell survival and expansion of the 
progenitors by blocking their differentiation (Androutsellis-Theotokis et al., 2006). ES-
cell derived neural precursors can afterwards be directed to particular neuronal 
subtypes using factor combinations known to regulate these steps during 
development (Murry and Keller, 2008).  
In addition to the neural lineages, ectodermal precursors also give rise to epidermal 
cells. The mammalian epidermis is derived from surface ectoderm through a process 
of cell fate selection and lineage progression that results in the stratified squamous 
epithelium (Turksen and Troy, 1998). Epidermal epithelial cells can be identified by 
the expression of keratin intermediate filaments, the composition of which is specific 
for particular types of epithelial differentiation and development. Keratin 8 (Krt8) and 
Krt18 are expressed earliest during embryonic development and characterize simple 
epithelium, the epidermal progenitor marker Krt19 is expressed in embryonic, simple, 
and stratified epithelia, and Krt5 and Krt14 are expressed in mature keratinocytes. In 
the epidermis, keratinocytes that undergo terminal differentiation to epidermal cells of 
the cornified layer start expressing Krt1, Krt10 and proteins of the cornified envelope, 
such as involucrin (Turksen and Troy, 1998). 
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ES cells can differentiate to epidermis in embryoid bodies (EBs). Simple epithelial 
markers (Krt 8, 18, and 19) can be detected by 12-15 days of EB culture, and 
expression of Krt10, Krt14 and involucrin from 21 days, indicating that keratinocyte 
differentiation has taken place (Bagutti et al., 1996). Coraux et al. (2003) developed a 
protocol in which ES cells were cultured on secreted matrix proteins in the absence 
of LIF, resulting in the formation of mouse skin in vitro, with both epidermal and 
dermal layers. Addition of BMP4 from the fourth day of culture totally prevented 
neural commitment while promoting commitment to Krt8/18-positive epidermal 
progenitors, which, in the presence of serum, further differentiated to Krt5/14-positive 
keratinocytes (Coraux et al., 2003).  Subsequent studies showed that, besides 
inducing epidermal differentiation, BMP4 further determines the choice between 
ectodermal fates by inducing the SMAD-dependent apoptosis of Sox1-positive neural 
precursors (Gambaro et al., 2006). 
BMP4 has thus been suggested to be the main factor regulating the commitment of 
ESC-derived ectodermal precursors to the alternative ectodermal fates, inducing 
epidermal differentiation while inhibiting neural specification (Aberdam et al., 2007a; 
Kawasaki et al., 2000; Munoz-Sanjuan and Brivanlou, 2002).  
In this chapter, the pluripotency of Bmpr1a-/- ES cells was tested in vitro. With this 
aim, their ability to differentiate into cells of the three germ layers was analysed using 
both embryoid bodies and monolayer differentiation protocols. 
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4.2. Results 
4.2.1. Embryoid Bodies of Bmpr1a-/- cells express markers of the 
three primary germ layers. 
To test the general ability of C1-Bmpr1a-/- ES cells to differentiate into derivatives of 
the three primary germ layers, the expression of lineage-specific genes was 
analysed during embryoid body formation. Embryoid bodies are structures that form 
when ES cells are grown in suspension as aggregates, in the absence of LIF, in 
which differentiation proceeds into the three germ layers in a manner reminiscent of 
peri-implantation development (Keller, 1995). EB differentiation recapitulates 
embryonic events such as the formation of an external endoderm layer, 
differentiation of a columnar epithelium, formation of a central cavity and mesoderm 
specification (Coucouvanis and Martin, 1995; Martin et al., 1977). The signals that 
direct differentiation during EB formation are largely unknown given the undefined 
composition of the serum in the culture medium, in addition to the factors produced 
by the cells themselves, which have an increased importance due to their close 
proximity. 
C1-Bmpr1a-/- and control 3.5-WT ES cells were thus grown in suspension in the 
absence of LIF for 12 days, RNA was extracted at days 0 (ES), 4, 8 and 12 of 
differentiation, and the expression of genes specific of pluripotent ES cells (Oct4 and 
Nanog), neuroectoderm (Sox1 and Pax6), mesoderm (Flk1 and T), endoderm (Gata4 
and Gata6) and trophectoderm (Cdx2 and Eomes) was analysed at these time-points 
(Figure 4.1). 
In ES-cell conditions (FCS+LIF) the expression level of the pluripotency genes Oct4 
and Nanog was somewhat higher in C1-Bmpr1a-/- compared to control ES cells, even 
though no increased expression in any of the differentiation markers was observed.  
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Figure 4.1 Bmpr1a-/- ES cells can differentiate into derivatives of the three germ layers 
but have propensity for neural commitment during embryoid body formation. 
C1-Bmpr1a-/- and control 3.5-WT ES cells were grown in suspension in the absence of LIF for 
12 days and gene expression was analysed by qRT-PCR at days 0 (ES), 4, 8 and 12 of 
embryoid body (EB) formation. The expression of genes specific of pluripotent ES cells (Oct4 
and Nanog), neuroectoderm (Sox1 and Pax6), mesoderm (Flk1 and T), endoderm (Gata4 
and Gata6) and trophectoderm (Cdx2 and Eomes) was analysed by qRT-PCR. During 
differentiation there is an increase in expression of markers of all the different lineages in both 
cell types but in Bmpr1a-/- ES cells the upregulation of neural genes is significantly higher that 
in WT cells (*, p<0.05, student’s t-test). All expression values were normalised to Hmbs and 
βActin expression; data shown as mean +/- s.d. of 3 independent experiments. 
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As seen in Figure 4.1, during the first four days of EB formation there was no 
significant increase in expression of lineage specific genes, even though a tendency 
for increased T and Eomes expression was observed in both cell types. This 
suggests that by this stage a PS-like population of cells was starting to appear.  
By day 8 of differentiation a considerable downregulation of the pluripotency 
transcription factors Oct4 and Nanog was observed both in 3.5-WT and C1-Bmpr1a-/- 
cells. Simultaneously, increased expression of the neuroectoderm marker Sox1, the 
mesodermal Flk1, and the endoderm transcription factors Gata 4 and Gata 6 were 
detected.  
From day 8, but most significantly at day 12 of EB formation, a significantly higher 
expression of Sox1 (3-fold, p<0.05) and Pax6 (10-fold, p<0.05), was detected in C1- 
Bmpr1a-/- cells compared to 3.5-WT controls. This suggests a higher commitment of 
Bmpr1a-null cells to the neuroectodermal lineage. At this stage of differentiation, 
lower expression of Gata 4 and Gata 6 were also observed in C1-Bmpr1a-/- cells, 
suggesting a concomitant lower propensity for the endodermal fate. This 
differentiation can be either to definitive endoderm or to visceral endoderm, as BMP 
signalling has also been involved in commitment to this lineage (Coucouvanis and 
Martin, 1999). No significant differences were observed in mesodermal commitment 
between the two cell types. 
Since ES cells do not generally give rise to extraembryonic lineages, the increase in 
expression of Cdx2 and Eomes shown in Figure 4.1 probably does not indicate 
specification to the trophectoderm lineage. Alternatively, as Cdx2 is also involved in 
gut endoderm development (Gao et al., 2009), and Eomes is important for 
mesoderm formation  and specification of the definitive endoderm lineage (Arnold et 
al., 2008), expression of these genes is most likely related to specification to 
mesoderm and definitive endoderm. 
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4.2.2. Bmpr1a-/- cells show a tendency for ectodermal 
specification in basal medium 
In another approach to test the developmental potential of Bmpr1a-/- ES cells, these 
and control E14-WT cells were grown in adherent culture, at medium confluency, in 
serum-free Basal (ESGRO) medium. In this study, besides the C1-Bmpr1a-/- cells, 
the two independently derived ES cell lines Fr88 and Fr124-Bmpr1a-/- cells (Qi et al., 
2004) were also included.  
Unlike what happened in the previous system, in this differentiation model no 
unknown exogenous factors from the serum were present. However, the relatively 
high confluency at which the cells were cultured allowed their response to 
endogenous secreted factors. The gene expression patterns of the E14-WT and the 
C1, Fr88 and Fr124-Bmpr1a-/- cells grown for 3 days in these conditions were 
analysed by microarrays.  
The differentiation pathway chosen by the different cell lines using this system was 
investigated by looking at a set of candidate genes representative of pluripotent ES 
cells, EpiSCs, neuroectoderm, epiderm, mesoderm and endoderm cells (Figure 4.2).  
During the 3 days of differentiation, the expression of pluripotency genes was 
significantly downregulated, at approximately the same extent both in WT and 
Bmpr1a-/- cells. This shows that in the absence of LIF or any other exogenous 
factors, Bmpr1a-/- ES cells, similarly to WT cells, do not have the ability to self-renew 
and therefore start differentiating. 
To determine whether ES cells in these conditions differentiate into an EpiSC-like 
state, the expression of genes characteristic of these stem cells was examined. The 
epiblast genes Fgf5 and Otx2 were indeed expressed at low levels in the ES cell 
condition and considerably upregulated after 3 days in basal medium, both in Bmpr1-
null and control cells. However, other markers of EpiSCs such as Nodal, Lefty 1 and 
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Lefty 2 decreased in expression upon differentiation. It is known that mouse ES cells 
express high levels of several TGFβ signalling factors, including Nodal, and exhibit 
strong autocrine SMAD2/3 signalling (Mavrakis et al., 2007). This activation of the 
Nodal pathway has been suggested to be required for the propagation of mouse ES 
cells (Ogawa et al., 2007). EpiSCs, which represent a developmentally more 
differentiated stage, require exogenous Nodal/Activin signals (Brons et al., 2007; 
Tesar et al., 2007), which were not present in the culture conditions in this assay. In 
the embryo, high Nodal signalling is also found in the early epiblast and becomes 
restricted to only a few cells is the posterior epiblast before gastrulation (Conlon et 
al., 1994). The decreased expression of Nodal, Lefty 1 and Lefty 2, with similar levels 
in Bmpr1a-/- and control cells, therefore suggests that both cell types have 
differentiated into a more anterior-like epiblast population.  
Differentiation into the neuroectodermal fate was next investigated. Even though the 
culture conditions used do not particularly induce neural differentiation, increased 
expression of specific neural genes such as Six3 and Hesx1 was observed in some 
cell lines. Interestingly, Nestin expression was considerably increased in basal 
medium in all the mutant cell lines, but not in WT cells, suggesting an increased 
tendency of mutant cells to undergo neural specification. 
The expression of cytokeratins gives an indication of the degree of specification to 
the epidermal fate. After 3 days of LIF and FCS withdrawal, an upregulation of the 
early epidermal markers keratins 8, 18 and 19 was evident in Bmpr1a-null cells but 
not in E14-WT cells. No differences were observed in expression of the keratinocyte 
marker Krt14 (which is present only later in epidermal development). 
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Figure 4.2 Bmpr1a-/- ES cells show increased ectodermal commitment. 
Microarray gene expression heat map representing the relative expression of lineage specific 
markers in Fr88, Fr124 and C1 Bmpr1a-/- cells and control E14-WT ES cells, in ES 
maintenance conditions (with FCS+LIF), and after 3 days differentiation in basal medium. For 
each gene (rows) the heat map colours the average gene expression of 3 independent 
experiments for each sample (columns) in units of standard deviation from the mean across 
all samples. Increased expression is coloured in shades of red and decreased expression in 
shades of green according to the scale shown at the bottom of the map.  
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Together, these results show that culture of ES cells at medium confluency in serum-
free basal medium is permissive of ectodermal specification and that Bmpr1a-null 
cells have a higher tendency to differentiate into this fate compared to WT cells. 
Expression of genes related to specification to mesodermal and endodermal fates 
was also analysed but no significant changes were observed in these culture 
conditions. 
 
4.2.3. Increased neural specification of Bmpr1a-/- cells during 
monolayer differentiation  
Given the apparent propensity for neural differentiation of Bmpr1a-null ES cells 
observed in EB formation and serum free conditions, this issue was further studied 
using the monolayer neural differentiation protocol (Ying et al., 2003b). The adherent 
monoculture of ES cells at low density in serum-free medium minimizes the presence 
of inductive signals and favours neural specification (Tropepe et al., 2001; Ying et al., 
2003b).  
As seen in Figure 4.3A, after four days of monolayer differentiation both C1-Bmpr1a-/- 
and control 3.5-WT ES cells exhibited the appearance of colonies with a rosette 
conformation typical of neuroepithelial cells (Ying et al., 2003b). 
Expression analysis revealed a rapid decrease in Nanog expression from the first 
day of LIF and serum withdrawal, whereas Oct4 expression was maintained for 
longer (Figure 4.3A). The decrease in expression levels of these pluripotency factors 
was similar for C1-Bmpr1a-/- and 3.5-WT cells. 
The expression of the neural progenitor markers Sox1 and Pax6 gradually increased 
during the course of differentiation and by the fourth day they were significantly 
overexpressed in Bmpr1a-null compared to WT cells. Once again, C1-Bmpr1a-/- cells 
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underwent neural commitment more efficiently in differentiation conditions that favour 
this fate.  
 
Figure 4.3 Bmpr1a-/- ES cells have increased propensity for neural differentiation. 
 (A) Bright field images of 3.5-WT and C1-Bmpr1a-/- ES cells after 4 days of monolayer neural 
differentiation in N2B27 (Ying et al., 2003b). (B) qRT-PCR expression analysis of the 
pluripotency markers Oct4 and Nanog, neural markers Sox1 and Pax6, and the BMP target 
genes Id1 and Id3, during the first four days of monolayer neural differentiation. At the fourth 
day of differentiation C1-Bmpr1a-/- cells show upregulation of neural markers compared to 
control 3.5-WT cells. Expression values were normalised to Hmbs and Hprt1 expression; data 
shown as mean +/- s.d. (n=3); *, p<0.05, student’s t-test. 
 
BMPs inhibit differentiation, particularly neural commitment, by inducing the 
expression of Id proteins which then act as inhibitors of basic helix-loop-helix (bHLH) 
neurogenic transcription factors (Norton et al., 1998; Ruzinova and Benezra, 2003; 
Ying et al., 2003a). As shown in Figure 4.3B, Id1 and Id3 expression was relatively 
higher in 3.5-WT than in C1-Bmpr1a-/- ES cells maintained in LIF+FCS, although the 
expression levels in the mutant cells seem to be sufficient to maintain them in an 
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undifferentiated state. After LIF and serum withdrawal the levels of expression of Id1 
and Id3 declined and similarly low expression levels were maintained through the 
course of differentiation for 3.5-WT and C1-Bmpr1a-/- cells. Therefore, the increased 
neural specification observed in Bmpr1a-/- cells by day 4 of differentiation cannot be 
explained by a lower expression of Id genes at this stage. 
Activation of SMAD1/5/8, the main signalling pathway downstream of BMPs and the 
one that leads to Id induction (Ying et al., 2003a), was also investigated during neural 
differentiation. In ES-cell maintenance conditions (with serum and LIF), SMAD1/5/8 
phosphorylation was higher in WT than in Bmpr1a-/- cells. Figure 4.4 shows that after 
1 day in serum-free differentiation conditions the levels of SMAD1/5/8 activation have 
dropped for both cell types but remain relatively higher in WT cells. However, from 
day 2 of differentiation SMAD1/5/8 phosphorylation was practically undetected both 
in 3.5-WT and C1-Bmpr1a-/- cells. This observation suggests that, in agreement with 
what was seen with the expression of Id genes, it is the initially lower activation of 
BMP signalling in mutant cells that facilitates their increased neural specification.  
Low activity of SMAD2/3, the other branch of TGFβ signalling, is also thought to play 
a role in neural induction. Nodal mutant embryos show premature neuronal 
differentiation of the epiblast (Camus et al., 2006) and in human ES cells inhibition of 
Nodal signalling promotes neuronal specification, indicating a role for this pathway in 
controlling early neural development of pluripotent cells (Smith et al., 2008).  
For these reasons the levels of pSMAD2/3 were analysed during neural 
differentiation. Activation of the SMAD2/3 pathway is high in ES cells (Figure 4.4) 
and as differentiation was initiated the levels of activation dropped significantly. 
However, from the second day of differentiation, pSMAD2/3 levels increased again 
and remained relatively high during the next 2 days of the monolayer neural 
differentiation. Interestingly, SMAD2/3 phosphorylation was lower in C1-Bmpr1a-/- 
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compared to WT controls throughout the differentiation protocol, which might also 
explain the increased neural differentiation observed in these cells. 
 
 
Figure 4.4 Analysis of SMAD1/5/8 and SMAD2 activation during neural differentiation. 
Western blot analysis of SMAD1/5/8 and SMAD2 phosphorylation in 3.5-WT and C1-Bmpr1a-
/- cells in medium containing FCS plus LIF and during the first four days of the monolayer 
neural differentiation protocol. SMAD1/5/8 activation is higher in 3.5-WT than in C1-Bmpr1a-/- 
cells at the onset of differentiation, but signalling in both cell types decreases to similar levels 
during the first couple of days after LIF and serum withdrawal. SMAD2 has a more complex 
activation pattern during neural differentiation. PCNA was used as loading control. 
 
 
4.2.4. Epidermal differentiation in response to BMPs 
Finally, differentiation in response to BMPs was studied, again using a monolayer 
serum-free differentiation system. C1-Bmpr1a-/- and control 3.5-WT ES cells were 
cultured at relatively low confluency in basal medium to which 10 µg/ml BMP4, 25 
µg/ml BMP7 or BMP4+LIF were added for 4 days.  
In BMP+LIF most cells were maintained in an undifferentiated state as can be seen 
by the compact colony morphology in Figure 4.5 and the high levels of expression of 
the pluripotency factors in Figure 4.6. However, both the cell morphology and the 
expression of some lineage-specific genes (namely Sox1 and Nestin) indicated a 
somewhat higher amount of differentiation in C1-Bmpr1a-/- cells.   
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In basal medium some rosettes typical of neural progenitor cells were observed both 
in WT and in Bmpr1a-/- cells (Figure 4.5). Gene expression analysis revealed that in 
this condition the expression levels of pluripotency factors, primarily Nanog, were 
considerably reduced, and the neural precursor markers Sox1 and Nestin were 
moderately upregulated (Figure 4.6). This suggested that even though this condition 
does not particularly favour the neural fate, some degree of neural specification was 
occurring in the cultures, at a similar extent in both cell types.  
 
Figure 4.5 Differentiation in the presence of BMP4 and BMP7. 
Bright field images of 3.5-WT and C1-Bmpr1a-/- ES cells after 4 days of adherent culture in 
serum-free basal medium only, or with 10 ng/ml BMP4, 25 ng/ml BMP7 or BMP4 and LIF. 
BMPs induce the appearance of flattened differentiated cells in both cell types. This type of 
differentiation is more evident in 3.5-WT cells in the presence of BMP4. 
 
When BMP4 was added at 10 µg/ml to basal media, WT ES cells adopted an 
epidermal-like morphology and formed big epithelial sheets as shown in Figure 4.5. 
Compared to the basal condition, WT cells showed decreased expression of Nestin, 
faintly higher levels of expression of Gata4 and Flk1, and a considerable 
overexpression of the epidermal progenitor markers Krt18 and Krt14 (Figure 4.6). 
This indicates that BMP4 counteracted specification to the neural fate while 
promoting alternative fates, particularly epidermal commitment. C1-Bmpr1a-/- cells, 
however, did not show the same kind of response. In these cells, both Sox1 and 
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Nestin were still highly expressed in the presence of BMP4 and the expression of 
keratins was lower than in WT cells. Surprisingly though, the C1-Bmpr1a-/- cells did 
show a degree of response to BMP4 stimulation since morphological differences 
could be seen in these cells compared to culture in the absence of BMP4 and some 
expression of Krt14 and Krt18 was detected. This may indicate that the prolonged 
exposure to BMP4 may facilitate binding to other low-affinity type I BMP receptors, 
eliciting a much weaker response.  
Similar to the effect of BMP4, exposure of WT ES cells to BMP7 induced the 
generation of cells with an epithelial morphology (Figure 4.5) and an upregulation in 
endodermal, mesodermal and epidermal genes (Figure 4.6). Unlike what happened 
with BMP4 treatment, Bmpr1a-/- cells were able to respond to BMP7 and adopted a 
similar fate to the WT controls. 
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Figure 4.6 Gene expression analysis during ES-cell differentiation induced by BMP4 
and BMP7. 
qRT-PCR expression analysis of the pluripotency markers Oct4 and Nanog, neural markers 
Sox1 and Nestin, endoderm markers Gata4 and Gata6, mesodermal markers Flk1 and T and 
the epidermal markers Krt14 and Krt18 at the fourth day of differentiation in adherent culture 
in serum-free basal medium only or with BMP4+LIF, BMP4 or BMP7. The expression analysis 
shows that addition of BMP4 to the medium represses neural differentiation and promotes 
non-neural differentiation. C1-Bmpr1a-/- cells upregulate epidermal markers in the same way 
as control 3.5-WT cells in the presence of BMP7 but not in the presence of BMP4. Expression 
values were normalised to Hmbs and βActin expression; data shown as mean +/- s.d. (n=2). 
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4.3. Discussion 
BMPs have an important role in regulating the fate of different cell types, both during 
mouse embryonic development (Di-Gregorio et al., 2007; Kishigami and Mishina, 
2005; Kitisin et al., 2007; ten Dijke et al., 2003) and in in vitro ES cell differentiation 
(reviewed in Gadue et al., 2005; Murry and Keller, 2008). 
In the epiblast of the early embryo, signalling via BMPR1A is required to maintain 
pluripotency and prevent premature neural differentiation (Di-Gregorio et al., 2007). 
At a slightly later stage, Bmpr1a-null embryos show a defect in the initiation of 
gastrulation, not being able to form mesoderm or endoderm (Beppu et al., 2000; 
Mishina et al., 1995). BMP4 has also been suggested to be the main factor 
regulating the cell fate choice of ectodermal precursors, preventing neural 
specification while inducing epidermal differentiation (Aberdam et al., 2007a; 
Kawasaki et al., 2000; Munoz-Sanjuan and Brivanlou, 2002) 
Bmpr1a-/- ES cells do not respond to BMP4 but are able of self-renewing and can 
therefore be maintained in culture in a pluripotent state (see Chapter 3). In this 
chapter, the developmental potential of Bmpr1a-/- ES cells was analysed by studying 
their ability to differentiate into different lineages in vitro.  
C1-Bmpr1a-/- cells were able to give rise to derivatives of the three germ layers in 
embryoid bodies. However, higher levels of expression of the neural progenitor 
markers Sox1 and Pax6 suggested a greater propensity for the Bmpr1a-null cells to 
commit to the neuroectodermal lineage. When cultured in serum free basal medium, 
ectodermal specification was favoured in Bmpr1a-null cells, as indicated by the 
increased expression of Nestin and of the early epidermal markers keratins 8, 18 and 
19. Bmpr1a-/- cells have a lower activation of the BMP signalling pathway, therefore 
the observed tendency of these cells to undergo neural specification agrees with the 
requirement for low BMP signalling during neural induction in the embryo (Arnold and 
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Robertson, 2009; Hemmati-Brivanlou and Melton, 1997; Kishigami and Mishina, 
2005). On the other hand, it was shown here that C1-Bmpr1a-/- cells also express 
higher levels of Bmp7 and can respond to BMP7 stimulation (see previous chapter). 
In case BMP7 has an epidermal-inducing activity similar to the one described for 
BMP4 (Aberdam et al., 2007b; Coraux et al., 2003), response to this auto-stimulatory 
signal could be responsible for the observed epidermal specification. The 
upregulation of both neural and epidermal markers in basal medium may therefore 
indicate that both these ectodermal fates were being favoured in these culture 
conditions, probably depending on specific local microenvironments. Alternatively, 
Bmpr1a-/- cells could be differentiating into bipotent Sox1-positive ectodermal 
precursors, capable of generating both neural and epidermal cells depending on 
external signals, an intermediate stage previously speculated to exist by Aberdam 
and coworkers (Aberdam et al., 2007a). It would be interesting to further explore this 
issue by analysing protein expression of markers of both lineages and, in case of co-
expression, to investigate the developmental potential of these cells. 
The monolayer neural differentiation protocol allowed a more detailed study of the 
ability of C1-Bmpr1a-/- cells to undergo neural commitment. In agreement with what 
was observed in embryoid bodies and in basal conditions, C1-Bmpr1a-/- cells in 
monolayer differentiation showed a higher propensity to undergo neural commitment, 
as indicated by the higher expression of the neural progenitor markers Sox1 and 
Pax6 at the fourth day of the differentiation protocol. Although the expression of Id 
genes at this stage of differentiation was equally low in both cell types, in 
undifferentiated WT cells Id1 and Id3 expression was higher. Id proteins are induced 
in response to BMP signalling and act as repressors of basic helix-loop-helix (bHLH) 
neurogenic transcription factors (Norton et al., 1998; Ruzinova and Benezra, 2003; 
Ying et al., 2003a). Decreased levels of Id proteins in Bmpr1a-null cells at the initial 
stages of neural commitment could thus lead to a faster or more efficient initiation of 
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the differentiation programme. Activation of SMAD1/5/8, which leads to induction of 
Id proteins, was also higher in WT cells at the beginning of differentiation but not 
after the first couple of days of the differentiation protocol. This observation once 
again suggests that the initial stages of neural differentiation could determine the 
efficiency of the process. 
From this study it is not clear whether this different susceptibility of C1-Bmpr1a-/- cells 
to neural differentiation is a direct consequence of the differences in phosphorylated 
SMAD1/5/8 and in Id expression at the onset of differentiation. Clarification of this 
matter would require a more detailed study of the RNA and protein levels of Ids 
during the initial period of differentiation and an analysis of how these relate to the 
expression of bHLH neurogenic transcription factors. However, the observation that 
the most significant differences in expression of neural markers are only detected 4 
days after the onset of differentiation suggests that an Id-independent mechanism is 
responsible for these differences. One hypothesis is that the lower levels of BMP 
signalling in Bmpr1a-/- cells in undifferentiated conditions determine a more 
permissive epigenetic state of the promoters of genes involved in neural 
specification. To verify this hypothesis, an investigation of the epigenetic status of 
these promoters should be performed, as well as an analysis of the expression of 
epigenetic regulators suggested to be involved in lineage specification, such as the 
transcriptional repressor REST and the Polycomb Group proteins (Ballas and 
Mandel, 2005; Rajasekhar and Begemann, 2007). 
Another question that remains is whether C1-Bmpr1a-/- cells undergo faster or more 
efficient neural differentiation in relation to WT cells. The observation that the levels 
of pluripotency markers do not decrease faster in mutant cells during the first days of 
differentiation suggests a higher efficiency of the process but does not definitively 
answer the question. To resolve this issue, a careful study of the timing of onset of 
early markers of differentiation would have to be made, as well as a quantification of 
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the amount of neural progenitors and neurons obtained at different stages of 
differentiation (including later stages than the ones analysed here).  
The epidermal-inducing activity of BMP4 during mouse ES cell-differentiation is well 
documented (Aberdam et al., 2007b; Coraux et al., 2003). A similar role for BMP7 in 
the mouse has not yet been reported but, in this study, the increased expression of 
the early epidermal markers Krt8, Krt18 and Krt19 in C1-Bmpr1a-/- cells in basal 
medium had already suggested that auto-stimulation of these cells by other BMPs 
could also be driving epidermal differentiation. This aspect was thus further 
investigated by culturing ES cells at low density in serum-free medium in the 
presence of BMP4 or BMP7. In these conditions, ES cells undergo commitment 
preferentially to the epidermal lineage, as observed by the upregulation of the 
epidermal progenitor markers Krt18 and Krt14 in WT cells, both in response to BMP4 
and to BMP7. Bmpr1a-/- cells are not responsive to BMP4 but do respond to BMP7 
(see previous chapter). In agreement with this, C1-Bmpr1a-/- cells showed deficient 
epidermal differentiation in response to BMP4 but followed a similar fate to WT cells 
when treated with BMP7, indicating that they have an equivalent potential for 
epidermal commitment when in adequate conditions.  
Confirmation of full pluripotency of Bmpr1a-/- ES cells can only be provided in vivo by 
analysing their contribution to embryonic development following blastocyst injection. 
Even though the cells derived in this study have not been submitted to this final test, 
Fr124-Bmpr1a-/- ES cells, derived in the presence of p38 inhibitor, could give rise to 
derivatives of the three germ layers in chimeras (Di-Gregorio et al., 2007). 
In summary, these results show that although Bmpr1a-/- cells cannot respond to 
BMP4, they are pluripotent and have the ability to differentiate into derivatives of the 
three primary germ layers. However, the lower level of BMP activation in these cells 
predisposes them for ectodermal commitment.  
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5. CELL COMPETITION IN ES CELLS 
 
5.1. Introduction 
 
Cell competition is the process by which cells are eliminated by the presence of 
metabolically more active or faster proliferating cells (Diaz and Moreno, 2005; 
Johnston, 2009; Tyler et al., 2007).  
This type of cell interaction is responsible for the elimination of Minute (M/+) mutant 
and lower dMyc expressing cells from the epithelium of the Drosophila wing in 
mosaic organisms (de la Cova et al., 2004; Johnston et al., 1999; Morata and Ripoll, 
1975; Moreno and Basler, 2004; Simpson, 1979).  
Transduction of the BMP homologue Dpp has been suggested to be one of the main 
factors determining the competitive potential of cells in the Drosophila wing 
epithelium (Moreno and Basler, 2004; Moreno et al., 2002). Besides acting as a 
morphogen important for patterning and cell fate specification in wing imaginal discs, 
Dpp is a key growth and survival factor during development of the Drosophila wing 
(Burke and Basler, 1996; Martin-Castellanos and Edgar, 2002). Clones in which loss 
of function mutations are induced in proteins required for transduction of Dpp/BMP 
signalling show impaired cell growth and proliferation and thus are eliminated from 
the wing epithelium during development (Burke and Basler, 1996). Conversely 
ectopic expression of Dpp results in over-proliferation of surrounding cells, indicating 
that it has a direct role in promoting cell proliferation in the wing imaginal discs. Cells 
in which protein synthesis and biometabolic function are compromised, such as the 
M/+ and low-expressing Myc mutant cells, are likely to have a reduced capacity to 
internalize and transduce survival and growth factors such as Dpp. This 
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disadvantage in competing for limiting amounts of extracellular survival factors may 
therefore cause lower levels of Dpp/BMP signaling which lead to increased 
expression of the transcription repressor brinker and activation of the c-Jun amino-
terminal kinase (JNK) pathway, triggering apoptosis and out-competition (Moreno et 
al., 2002). Further evidence for the importance of Dpp/BMP signalling in cell 
competition comes from two observations. In the first place, constitutive activation of 
the Dpp pathway enhances the survival of M/+ clones (Moreno et al., 2002) and of 
lower dMyc-expressing cells (Moreno and Basler, 2004), thus reducing cell 
competition. Second, most genes identified in a genetic screen for mutations that 
induce survival of M/+ cells during cell competition enhance Dpp activity (Tyler et al., 
2007). However, competition for the Dpp survival signal probably does not represent 
a universal mechanism by which weaker cells are eliminated. In some studies no 
differences in Dpp/BMP signalling were observed in competing cells (de la Cova et 
al., 2004; Li and Baker, 2007) and in the absence of JNK signalling, cell competition 
still occurred (de la Cova et al., 2004). 
In the ovarian stem cell niche Dpp/BMP signalling sustains self-renewal of germline 
stem cells (GSCs) by directly repressing the expression of the bag-of-marbles (bam) 
differentiation factor (Chen and McKearin, 2003; Song et al., 2004). GSCs are firmly 
anchored to the niche cap cells via adherent junctions, thereby ensuring exposure to 
high concentrations of the Dpp self-renewal signal secreted by these (reviewed in 
Kirilly and Xie, 2007). Cells further away from the niche have lower levels of Dpp 
activation and thus fail to repress bam transcription and differentiate (Chen and 
McKearin, 2003; Kirilly and Xie, 2007; Rhiner et al., 2009; Song et al., 2004). GSCs 
expressing different levels of dMyc have also been reported to experience 
competitive interactions. Differences in dMyc expression lead to differential metabolic 
activity, protein synthesis and endocytosis, and therefore to different efficiencies in 
the uptake and transduction of Dpp. Ultimately, these differences determine the 
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niche exclusion and differentiation of cells with lower activation of the Dpp pathway. 
In normal situations, dMyc is highly expressed in GSCs and considerably 
downregulated in their progeny (Maines et al., 2004). This has been suggested to 
create a naturally occurring cell competition border which facilitates the concentration 
of the niche self-renewal factor Dpp in metabolically active high dMyc GSCs (Rhiner 
et al., 2009). Differentiation-defective bam or bgcn mutant GSCs also out-compete 
normal cells displacing them from the niche independently of dMyc and Dpp/BMP 
signalling (Jin et al., 2008). Therefore, unlike cell competition in the wing epithelium, 
where cell-cell comparison of metabolic status determines apoptosis of weaker cells, 
competition for niche occupancy is adhesion-based and leads to differentiation of out-
competed cells (reviewed in Johnston, 2009). 
In mammals, cell competition has only been suggested to occur in chimeras of Belly 
spot and tail (Bst) mutant cells, that carry a mutation in the Rpl24 ribosomal protein 
(Oliver et al., 2004) and during liver regeneration in rats (Oertel et al., 2006). 
However, the mechanism of competition in these cases has not been appreciably 
explored. 
In this study, in order to investigate whether cell competition occurs between ES 
cells, and particularly to determine the role of BMP signalling in this process, a co-
culture system was developed using Bmpr1a-/- ES cells. Cells with lower levels of 
BMP signalling were found to be out-competed, particularly in conditions of limiting 
amounts of growth and survival factors.  
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5.2. Results 
5.2.1. Bmpr1a-/- cells are out-competed in co-cultures with WT 
cells 
Given the involvement of Dpp/BMP signalling in cell competition in the Drosophila 
wing and ovarian stem cell niche cells (Burke and Basler, 1996; Moreno and Basler, 
2004; Moreno et al., 2002; Rhiner et al., 2009), and their central role in mouse ES-
cell maintenance (Qi et al., 2004; Ying et al., 2003a), we have hypothesized that this 
pathway may also cause cell competition in ES cells.  
As a first approach to test if competitive interactions can be observed among ES 
cells, Fr124 (Bmpr1a-/--LacZ) cells were mixed in equal numbers with E14 (WT) cells 
and co-cultured in ES cell maintenance conditions, being passaged every three days. 
Mutant cells could be identified in the mixture since they contain the lacZ gene, thus 
expressing the beta-galactosidase reporter. When cultured together with E14-WT 
cells, Fr124-Bmpr1a-/- cells were progressively eliminated, being practically absent 
from the co-culture after 5 to 6 passages (Figure 5.1A).  
To better follow and analyse this process, GFP-expressing C1-Bmpr1a-/- cells were 
generated by electroporating an expression vector in which EGFP expression is 
driven by the ubiquitous CAG promoter (CMV Enhancer/chicken β-Actin Promoter). 
Similarly to what was observed for the Fr124- Bmpr1a-/--lacZ marked cells, C1-
Bmpr1a-/--GFP cells were progressively out-competed from co-cultures with 3.5-WT 
cells (Figure 5.1B).  
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Figure 5.1 Bmpr1a-/- ES cells are out-competed when co-cultured with WT cells. 
 (A) Equal numbers of E14-WT and Fr124-Bmpr1a-/--LacZ ES cells were mixed together and 
the two cell types were co-cultured in ES cell maintenance conditions containing LIF and FCS 
and passaged every 3 days. Represented are bright field images of β-galactosidase staining 
of the co-cultures 2 days after plating (P0) and after 2, 4 and 6 passages (P2, P4, P6) 
showing that Fr124-Bmpr1a-/--LacZ ES cells are gradually out-competed from co-cultures. (B) 
Co-culture of 3.5-WT and C1-Bmpr1a-/--GFP ES cells, in a similar way to the experiment 
described in A. Represented are overlapping fluorescence (GFP) and dark field images of the 
co-cultures. 
 
Expression of GFP by one of the cell types in the co-cultures allowed their analysis 
by Flow Cytometry (FC). FC analysis showed that cells lost GFP as they died, and so 
dead cells had to be excluded from subsequent studies based on propidium iodide 
(PI) staining. PI binds to double stranded DNA by intercalating between base pairs, 
but is excluded from cells with intact plasma membranes, therefore allowing the 
distinction between live and dead cells.  
To identify competitive interactions between the two cell types, the behaviour of the 
cells in co-cultures was always compared to that of the cells cultured separately. For 
this analysis, cells from separate cultures were dissociated and similar volumes of 
both cell suspensions were mixed before FC analysis.  
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As shown in Figures 5.2A and B, quantification of the percentage of GFP-positive 
and -negative cells in the co-cultures showed that approximately 10% of C1-Bmpr1a-
/--GFP cells were lost every three days, at the time of passaging. This was 
significantly different to the behaviour of the cells when they were cultured 
separately. To exclude the possibilities that GFP expression was causing a 
competitive disadvantage to the cells or that the cells were losing GFP expression 
during co-culture, the reverse experiment was also performed, in which 3.5-WT-GFP 
cells were mixed with non-marked C1-Bmpr1a-/- cells. When this was done, C1-
Bmpr1a-/- cells were equally eliminated from the culture (Figure 5.2C) confirming the 
results previously obtained. Finally, to determine whether Bmpr1a-/- cells were being 
lost due to adhesion defects that could impair their replating efficiency at the time of 
passaging, the percentages of each cell type in co-cultures were counted every day 
during 5 passages. This analysis showed that cells were progressively lost from co-
cultures and not specifically at the time they were split (Figure 5.2D).  
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Figure 5.2 Bmpr1a-/- ES cells are out-competed when co-cultured with WT cells. 
(A) Flow cytometry (FC) analysis of GFP expression in co-cultures of 3.5-WT and C1-
Bmpr1a-/--GFP ES cells allowed the quantification of the percentages of each cell type 
present at the time of each passage. The live-cell population was gated excluding propidium 
iodide (PI)-positive cells from the analysis. Represented are the histograms obtained by FC 
analysis of GFP fluorescence at the time of plating (P0), and at the second (P2) and fourth 
(P4) passages. (B) Graphical representation of FC analysis of the percentages of GFP-
positive (C1-Bmpr1a-/--GFP cells) and -negative (3.5-WT cells) cells present in co-cultures 
and separate cultures at the beginning of the experiment (P0) and at the time of each of the 
first four passages (P1-4). (C) Graphical representation of FC analysis of the percentages of 
GFP-positive (3.5-WT-GFP cells) and -negative (C1-Bmpr1a-/- cells) cells present in co-
cultures and separate cultures at the beginning of the experiment (P0) and at the time of each 
of the first four passages (P1-4). (D) Percentage of GFP-positive and -negative cells present 
in co-cultures of C1-Bmpr1a-/--GFP cells and 3.5-WT cells as assessed by FC analysis every 
day over the period of 6 passages. All data shown is from representative experiments. 
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5.2.2. Cell Competition is enhanced in conditions of limiting 
amounts of growth and survival factors 
Co-cultures of WT and Bmpr1a-null cells in ES-cell maintenance medium (containing 
FCS and LIF, in addition to other supplements commonly required for cell growth), 
showed that the latter cells were out-competed. However, this process was slow, 
requiring 5 to 6 passages (along more than two weeks) for the elimination of mutant 
cells. Therefore, to investigate which factors could enhance cell competition, different 
culture conditions were tested. 
With this aim, co-cultures were firstly performed at different confluencies. Figure 5.3A 
shows that when this was done, even though no major differences were observed, 
out-competition was slightly more efficient at high confluency (Figure 5.3A), 
suggesting that growth factors becoming limiting enhances this process.  
Cells were then cultured in serum-free conditions, with limiting amounts of growth 
and survival factors (Figure 5.3B). The ratio between the percentages of the two cell 
types represents the growth advantage of WT over Bmpr1a-/--GFP cells. Comparison 
of this parameter between cells grown separately and in co-cultures allows 
visualization of the extent of competitive interactions as opposed to the effect that 
each growth condition has on the cells on their own. 
Starting with equal number of WT and Bmpr1a-/--GFP cells, after 4 days in normal 
ESC maintenance conditions (FCS+LIF), the ratio between the two cell types was 
maintained when the cells were cultured separately, and only slightly changed in co-
cultures (Figure 5.3B), which is in accordance with previous results. In serum-free 
conditions, however, 3.5-WT cells showed a growth advantage over C1-Bmpr1a-/--
GFP cells in monotypic cultures. The decreased viability of Bmpr1a-/--GFP cells was 
observed both in Basal medium only, and when BMP4, LIF or both these factors 
were added to the cultures. Figure 5.3B shows that in Basal medium, the 
WT/Bmpr1a-/- ratio was significantly higher in co-cultures than in separate cultures, 
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indicating a high degree of competition. Interestingly, addition of LIF to the cultures 
caused inhibition of the competitive interactions. Cell competition was thus maximal 
in Basal medium and, therefore, this was the condition chosen for further studies. 
 
Figure 5.3 Out-competition of Bmpr1a-/- ES cells is enhanced in conditions of limiting 
survival and growth factors.  
(A) Graphical representation of flow cytometry (FC) analysis of the percentages of GFP-
positive (C1-Bmpr1a-/--GFP cells) and -negative (3.5-WT cells) populations of cells present in 
co-cultures at the beginning of the experiment (P0) and at the time of the first five passages 
(P1-5). Co-cultures were carried out at low (left; approximately 1x105 cells plated per well of a 
6-well plate) and high (right, approximately 8x105 cells plated per well of a 6-well plate) 
confluencies in medium containing FCS+LIF. (B) Co-cultures and separate cultures of 3.5-WT 
and C1-Bmpr1a-/--GFP ES cells were performed in medium containing FCS plus LIF or in 
basal medium in the absence (Basal) or presence of LIF, BMP4 or BMP4 plus LIF. The 
percentages of GFP-positive and -negative cells were assessed by FC at the beginning of the 
experiment (d0) and after 4 days in these culture conditions (d4). Represented are the ratios 
of the percentages of WT to Bmpr1a-/- cells (i.e. GFP-negative 3.5-WT to GFP-positive C1-
Bmpr1a-/- cells). This parameter indicates the growth advantage that WT cells have over 
Bmpr1a-/--GFP cells. Comparison of the ratios obtained for separate cultures and co-cultures 
allows determining if competitive interactions exist between the two cell types studied. 
Orange dashed line represents the WT/-/- ratio at the beginning of the experiment (ratio=1), 
which would be maintained if neither cell line had a growth advantage over the other one. 
Maximal competitive interactions were obtained in serum-free basal medium. Data shown as 
mean +/- s.d. (n=3) 
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As shown in Figure 5.4A, FC analysis of the percentages of GFP cells in co-cultures 
confirmed that out-competition of Bmpr1a-/- cells was considerably accelerated in 
Basal medium. After 4 days in co-culture only 10 to 20% of Bmpr1a-/--GFP cells were 
present, allowing the study of cell competition without the need for passaging the 
cells. Combining cell counting and GFP quantification by FC it was possible to follow 
the growth pattern of the 2 cell types in co-cultures (Figure 5.4B).  Even though a 
growth disadvantage of C1-Bmpr1a-/--GFP cells in Basal medium was evident in 
separate cultures, when in co-culture this disadvantage was greatly increased. 
Importantly, between the third and fourth day of co-culture, the number of C1-
Bmpr1a-/--GFP cells actually decreased whereas 3.5-WT cells continued proliferating. 
To determine whether this competitive behaviour was specific to the 3.5-WT and C1-
Bmpr1a-/- cells lines, the same experiment was performed using independently 
derived cells, and this time with GFP being expressed by the WT cells. The growth 
curves obtained when control E14-GFP cells were co-cultured with Fr124-Bmpr1a-/- 
cells again showed out-competition of the ones with a deficiency in BMP signalling, 
which was in fact even more pronounced than with the C1-Bmpr1a-/- cells (Figure 
5.4C). 
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Figure 5.4 Out-competition of Bmpr1a-/- ES cells in serum-free medium. 
 (A) The percentages of GFP-positive (C1-Bmpr1a-/--GFP cells) and -negative (3.5-WT cells) 
cell populations in separate cultures (left) and co-cultures (right) were analysed by flow 
cytometry (FC) at the beginning of the experiment (d0) and at each day during the following 4 
days of culture in Basal medium (d1-4).  One representative experiment is shown. (B) Growth 
curves of 3.5-WT and C1-Bmpr1a-/--GFP ES cells in separate cultures (left) and co-cultures 
(right) in basal medium were determined by combining data obtained by cell counting and FC 
analysis. Orange box highlights the period of co-culture when the cell behaviour significantly 
differs from the one of separate cultures, indicating competitive interactions. Data shown as 
mean +/- s.d. (n=3). (C) Growth curves of E14-WT-GFP and Fr124-Bmpr1a-/- ES cells in 
separate cultures (left) and co-cultures (right) in basal medium. Orange box highlights the 
period of co-culture when competitive interactions occur. Data shown as mean +/- s.d. (n=3) 
 
However, among the different ES-cell clones used in co-culture experiments, one of 
the controls in which BMP signalling was normal, but that showed a considerable 
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growth disadvantage, and abnormal colony morphology, was out-competed by 
Bmpr1a-/- cells (Figure 5.5). Given the growth defects of this cell line, this experiment 
does not contradict the previous data, but shows that other deficiencies besides 
faulty BMP transduction can cause cell competition. 
 
 
Figure 5.5 BMP transduction defects are not the only trigger of ES cell competition. 
Growth curves of separate cultures (left) and co-cultures (right) of 3.5-GFP-AG and C1-
Bmpr1a-/- ES cells in basal medium show that Bmpr1a-/- ES cells can out-compete cells with 
higher BMP transduction ability but which have impaired growth. Grey box highlights the 
period of co-culture when competitive interactions occur (n=1) 
 
5.2.3. Out-competition of Bmpr1a-/- cells is inhibited when BMP4 
signalling is restored. 
Analysis of co-cultures has shown that Bmpr1a-/- cells are out-competed by WT cells, 
particularly in conditions of limiting amounts of growth factors. To confirm that the 
cause for out-competition of Bmpr1a-/- cells in this system is the deficiency in BMP 
signal transduction, Bmpr1a expression was restored in mutant cells. This was 
achieved by creating an expression vector containing the coding sequences for 
Bmpr1a, EGFP and puromycin N-acetyl-transferase (Pac, which confers puromycin 
resistance) all driven by the ubiquitous CAG promoter (Figure 5.6A). In this vector, 
the sequence for the viral 2A peptide was used as a linker region between the 
Bmpr1a and EGFP cDNAs. Therefore, the two sequences should be co-translated 
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but, given the highly inefficient peptide bond formation between glycine and proline 
residues within the 2A peptide, are easily cleaved and generate 2 unfused, yet 
stoichiometric, proteins (Ryan and Drew, 1994; Trichas et al., 2008). This was 
followed by an internal ribosome entry site (IRES) and then the Pac coding 
sequence.  
After electroporation of the Bmpr1a-GFP expression vector into C1-Bmpr1a-/- cells, 
colonies were selected for puromycin resistance and screened for GFP expression. 
However, for some unknown reason, puromycin-resistant colonies did not show GFP 
expression. In order to determine whether Bmpr1a was being expressed and, more 
importantly, if it was functional, cells were stimulated with BMP4 and tested for 
SMAD 1/5/8 phosphorylation. Figure 5.6B shows that the parental C1-Bmpr1a-/- cells 
did not respond to BMP4 stimulation, as previously shown, but cells carrying the 
CAG-Bmpr1a-GFP transgene showed activation of SMAD1/5/8, indicating that they 
express a functional BMPR1A receptor. These cells were thus nam 
ed C1-Bmpr1ares (res, restored function).  
When co-culturing C1-Bmpr1ares cells with control 3.5-WT-GFP-expressing cells, no 
cell competition was observed (Figure 5.6C), unlike what happened with the parental 
C1-Bmpr1a-/- cells (compare with Figure 5.4B). Conversely, in co-cultures of C1-
Bmpr1ares cells and C1-Bmpr1a-/- GFP+ cells, C1-Bmpr1ares cells out-competed the 
parental ones, (Figure 5.6D). These results show that expression of BMPR1A 
rescued the competitive disadvantage of the C1-Bmpr1a-/- cell line, indicating that 
this disadvantage is due to a deficiency in transducing BMP signalling.  
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Figure 5.6 Out-competition of Bmpr1a-/- ES cells is rescued by restoring Bmpr1a 
expression in these cells 
 (A) Schematic representation of the vector constructed to express Bmpr1a in ES cells (CAG-
Bmpr1a-GFP transgene). The coding sequences for Bmpr1a and for EGFP (linked by the 
viral 2A sequence) were directionally cloned into the pPyCAGIP episomal expression vector, 
creating an expression cassette where Bmpr1a, EGFP and the puromycin resistance gene 
(pac) were all driven by the ubiquitous CAG promoter. The CAG-Bmpr1a-GFP transgene was 
electroporated into C1-Bmpr1a-/- ES cells and colonies were selected for puromycin 
resistence and screened for GFP expression. No GFP expression was detected. (B) Western 
blot analysis showed that BMP4 stimulation induces SMAD1/5/8 phosphorylation in C1-
Bmpr1a-/- ES cell clones carrying the CAG-Bmpr1a-GFP transgene (C1-Bmpr1ares1-6 cells), 
even though it does not activate this pathway in the parental cells, indicating that the 
transgene leads to expression of functional Bmpr1a. (C) Growth curves of 3.5-WT-GFP and 
C1-Bmpr1ares ES cells in separate cultures (left) and co-cultures (right) in basal medium. (D) 
Growth curves of C1-Bmpr1a-/--GFP and C1-Bmpr1ares ES cells in separate cultures (left) and 
co-cultures (right) in basal medium. Orange box highlights the period of co-culture when 
competitive interactions occur. Data shown as mean +/- s.d. (n=2) 
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These experiments demonstrated that co-culture of Bmpr1a-/- with control WT ES 
cells in Basal medium, a condition in which growth and survival factors are scarce, 
provide a good in vitro system to study the role of BMP signalling in cell competition 
in ES cells. 
 
5.3. Discussion 
The process of cell competition, initially described and mainly studied in Drosophila, 
represents an important mechanism for quality selection during development and 
maintenance of tissue homeostasis (Adachi-Yamada and O'Connor, 2004; Baker and 
Li, 2008; Johnston, 2009; Leevers and McNeill, 2005). Cell competition studies in the 
epithelium of the Drosophila wing have shown that the levels of protein synthesis and 
biometabolic function determine the competitive potential of cells in a heterogeneous 
environment (de la Cova et al., 2004; Johnston et al., 1999; Morata and Ripoll, 1975; 
Moreno and Basler, 2004; Simpson, 1979), probably due to differential abilities to 
internalize and transduce growth and survival signals (Moreno and Basler, 2004; 
Moreno et al., 2002). In the Drosophila ovary, competition for occupancy of the stem 
cell niche has an important role controlling the balance between differentiation and 
self-renewal of GSCs (Diaz and Moreno, 2005; Jin et al., 2008; Johnston, 2009; 
Rhiner et al., 2009). 
Both in the Drosophila wing and in the ovarian stem cell niche, cells that uptake and 
transduce Dpp/BMP signalling more efficiently have a competitive advantage over 
cells with lower activation of this pathway (Burke and Basler, 1996; Moreno and 
Basler, 2004; Moreno et al., 2002; Rhiner et al., 2009) 
In mouse ES cells, BMP signalling plays a crucial role sustaining self-renewal and 
pluripotency in combination with LIF (Qi et al., 2004; Ying et al., 2003a). Bmpr1a-null 
 128 
ES cells have reduced levels of activation of the BMP pathway but do not show self-
renewal or pluripotency defects (see previous chapters).  
In this study, Bmpr1a-null ES cells were cultured together with control WT cells in 
order to investigate whether competitive interactions occur between ES cells with 
differential activation of the BMP pathway. The generation of a GFP-labelled Bmpr1a-
/- ES cell line allowed the study of cell behaviour in co-cultures with other cell types 
without having to disturb the system. Furthermore, it facilitates multiparametric 
analysis by FC and sorting of the cells. 
Mixed cultures of Bmpr1a-/- and WT cells in medium containing FCS and LIF, 
conditions generally used for ES-cell maintenance, revealed that the cells with lower 
activation of the BMP signalling pathway are gradually out-competed, even though in 
these conditions this is a slow process. However, limiting the availability of growth 
and survival factors by culturing the cells in Basal serum-free medium increased the 
competitive disadvantage of Bmpr1a-/- cells, thereby greatly enhancing ES-cell 
competition. 
Definitive proof that BMP signalling, and not other factors intrinsic to the ES-cell lines 
used in the co-culture experiments, determines the competitive potential of ES cells 
was provided by restoring Bmpr1a expression in mutant Bmpr1a-/- ES cells. 
Expression of functional BMPR1A re-established the ability to respond to BMP 
activation and inhibited the out-competition of Bmpr1a-/- ES cells. 
However, differences in BMP signalling do not always determine the ES-cell 
competition outcome. Bmpr1a-/- ES were exhibited a “winner” behaviour when co-
cultured with a cell line with severely impaired growth. Given the growth defects of 
this cell line, this observation does not contradict the previous data. Nevertheless, it 
shows that other deficiencies besides faulty BMP transduction can be responsible for 
a competitive disadvantage of ES cells when in the presence of  “fitter” cells. 
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Taken together, these results demonstrate that the potential for proliferation and 
survival of an ES cell is determined by interactions with its neighbours. In particular, 
they show that, similarly to what occurs during the cell competition in the Drosophila 
wing epithelium and stem cell niche, defective BMP signalling confers a competitive 
disadvantage to ES cells when in the presence of WT cells. Moreover, the co-culture 
of Bmpr1a-/- ES cells with control WT cells in Basal serum-free conditions was 
established as a suitable in vitro system to study competitive interactions between 
ES cells with differing abilities to respond to BMP signalling. 
Cell competition has been suggested to ensure normal development, organ size and 
homeostasis in Drosophila (Adachi-Yamada and O'Connor, 2004; Diaz and Moreno, 
2005; Johnston, 2009). The results of the present study, together with the described 
out-competition of the ribosomal-defective Bst+/- cells during chimera colonisation 
(Oliver et al., 2004), suggest that cell competition may also represent an important 
mechanism that ensures tissue fitness and homeostasis during mammalian 
development. In addition, cell competition has been reported during organ 
regeneration (Oertel et al., 2006) and is likely to be involved in tumour formation 
(reviewed in Baker and Li, 2008; and Rhiner and Moreno, 2009). Therefore, 
understanding the mechanism and regulation of cell competition is an important 
issue in disease and developmental biology.  
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6. INVESTIGATING THE MECHANISM OF OUT-
COMPETITION OF BMPR1A-/- ES CELLS 
 
6.1. Introduction 
Given the likely involvement of cell competition in ensuring homeostatic balance and 
optimal function during development and tissue regeneration (Adachi-Yamada and 
O'Connor, 2004; Baker and Li, 2008; Diaz and Moreno, 2005; Oertel et al., 2006; 
Rhiner and Moreno, 2009), it is important to understand the processes by which cells 
compare their relative “fitness” and eliminate weaker ones during competitive 
interactions.  
In the epithelium of the Drosophila wing, cells with a lower protein synthesis and 
metabolic activity such as M/+ and lower dMyc-expressing cells are killed by 
surrounding more competitive cells. In turn, these over-proliferate thus maintaining 
normal tissue size and morphology (de la Cova et al., 2004; Johnston et al., 1999; 
Morata and Ripoll, 1975; Moreno and Basler, 2004; Moreno et al., 2002). During liver 
regeneration in the rat, increased apoptosis of diseased cells and overproliferation of 
WT transplanted fetal liver cells has also been observed (Oertel et al., 2006). 
Distinct mechanisms have been suggested to be responsible for triggering apoptosis 
of the out-competed cells in the Drosophila wing. Moreno and coworkers have 
suggested that the lower protein synthesis activity of these cells impairs their 
capacity to internalise and transduce survival factors, in particular Dpp, thus 
activating JNK-dependent apoptosis (Moreno and Basler, 2004; Moreno et al., 2002). 
They find that stimulation of endocytic uptake, constitutive activation of the Dpp 
pathway, inhibition of JNK activation, and blocking of apoptosis, all prevent cell 
competition (Moreno and Basler, 2004; Moreno et al., 2002). In this view, competition 
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is driven by the differential ability for internalization of limiting concentrations of the 
Dpp survival factor, leading to apoptosis of less competitive cells due to the 
transduction of insufficient amounts of survival signal (Diaz and Moreno, 2005).  
Studies by Johnston and coworkers indicate a different mechanism, independent of 
Dpp transduction, for the out-competition of lower dMyc expressing cells. These 
authors suggest that cell competition is executed via induction of the proapoptotic 
gene hid, and that cells do not compete for a limiting ligand but rather communicate 
via a short-range signal that allows them to sense and respond to local differences in 
dMyc levels (de la Cova et al., 2004). This communication does not require physical 
interaction between the two cell types, and the observation that it can be achieved in 
single cultures by medium conditioned by competing co-cultures indicates that it is 
mediated by soluble factors (Senoo-Matsuda and Johnston, 2007). The production of 
these active soluble factors requires the presence of both cell types during the 
process so that relative levels of dMyc expression can be compared and a 
“winner”/”loser” status established (Senoo-Matsuda and Johnston, 2007). 
A different type of cell competition takes place in the Drosophila ovary, where stem 
cells struggle for niche occupancy, resulting in the displacement and differentiation of 
weaker cells (Jin et al., 2008; Nystul and Spradling, 2007; Rhiner et al., 2009). 
Maintenance of GSCs (germline stem cells) requires the Dpp differentiation-
repressing signal from the supporting cap cells in the stem cell niche (Kirilly and Xie, 
2007). Both GSCs lacking the Dpp-repressed differentiation genes bam and bgcn 
and GSCs with relatively higher expression of dMyc have an advantage in competing 
for niche residency (Jin et al., 2008; Rhiner et al., 2009). The process by which 
GSCs compare their relative fitness for niche occupancy is also still unclear but the 
relative ability to adhere to cap cells (Jin et al., 2008) and competition for the Dpp 
signal (Rhiner et al., 2009) have both been suggested to be involved.  
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In summary, two essentially different types of competitive interactions have been 
described, in which determinants, effectors and sensing mechanisms specific to each 
type result in distinct outcomes. Cell competition in the wing epithelium leads to 
apoptotic death, whereas stem cell competition for niche occupancy determines the 
displacement and differentiation of less competitive cells. How cells sense the 
relative competitive potential is still unclear. 
 
In our system, Bmpr1a-/- mouse ES cells are out-competed when co-cultured with WT 
cells. This chapter aims to investigate how Bmpr1a-/- cells are being out-competed. 
With this purpose, several methods were used to detect variations in apoptosis, cell 
proliferation, and differentiation in WT and Bmpr1a-/- cells in co-cultures, both in 
medium containing FCS and LIF, and in basal medium. The potential involvement of 
c-Myc in this process, as well as the mechanism used to sense differences in BMP 
signalling between the two cell types, were also investigated.  
 
6.2. Results 
6.2.1. No significant differences in apoptosis or cell proliferation 
were observed in co-cultures of Bmpr1a-/- and WT cells in 
medium containing FCS and LIF. 
The mechanism responsible for the out-competition of C1-Bmpr1a-/- cells in co-
cultures with WT cells was first investigated in ES-cell maintenance conditions, 
containing LIF and FCS. In these conditions, C1-Bmpr1a-/- cells were eliminated from 
co-cultures after 5 to 6 passages, corresponding to 15 to 20 days (see previous 
chapter). To determine whether out-competed cells were undergoing apoptosis, 
immunostaining for activated (cleaved) caspase3 was initially performed in co-
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cultures at different passages (Figure 6.1A). Quantification of apoptotic cells based 
on immunostainings was difficult due to the compact structure of the ES cell colonies 
and diffuse GFP expression. Preliminary analysis of this experiment revealed that 
there was a higher proportion of GFP-negative cells expressing activated caspase-3. 
However, it was likely that C1-Bmpr1a-/-GFP cells lost GFP expression as they died 
and, therefore, apoptosis analysis using this assay could be misleading. Apoptosis 
analysis had thus to be limited to early apoptotic cells in live cultures, where dead 
cells (necrotic and late apoptotic cells) could be identified based on propidium iodide 
(PI) staining. Flow cytometry (FC) analysis of allophycocyanin (APC)-conjugated 
annexin V in combination with PI exclusion of dead cells was then used to assess 
apoptosis activation in GFP-positive (C1-Bmpr1a-/-) and -negative (3.5-WT) cells in 
co-cultures along 4 passages. As shown in Figure 6.1B no differences in annexin V 
staining were observed between cells grown separately and in co-culture, or between 
the two cell types within the co-cultures, for any of the time-points analysed. 
Apoptosis was further investigated using DiIC1(5), a cationic lipophilic dye which 
accumulates primarily in mitochondria with active membrane potential, a feature that 
is lost during apoptosis leading to a decrease in the fluorescence intensity of the dye 
(Galluzzi et al., 2007b). The efficiency of this method in mouse ES cells was first 
tested treating the cells with carbonyl cyanide m-chlorophenylhydrazone (CCCP), a 
compound that disrupts mitochondrial membrane potential. As expected, a decrease 
in DiIC1(5) fluorescence was observed after exposure to CCCP. However, no 
differences in the DiIC1(5) intensity were detected between the two cell types in co-
cultures (Figure 6.1C).  
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Figure 6.1 Apoptosis analysis of co-cultures of Bmpr1a-/- and WT ES cells in medium 
containing LIF and FCS. 
 (A) Confocal images showing projections of multiple optical z-sections after immunostaining 
for cleaved caspase 3 (red) in co-cultures of 3.5-WT and C1-Bmpr1a-/--GFP ES cells at 
passage 2 (P2) and 3 (P3). (B) Flow cytometry (FC) analysis of annexinV-APC and PI 
staining in co-cultures of 3.5-WT and C1-Bmpr1a-/--GFP ES cells. PI-positive (dead) cells 
were excluded from the analysis. The percentage of annexinV-positive/PI-negative cells 
within the GFP-positive and the GFP-negative populations was assessed in separate cultures 
and at passages 1 to 4 (P1-4) of co-cultures. Data shown as mean +/- s.d. (n=3) (C) Changes 
in mitochondrial membrane potential were assessed by FC analysis of fluorescence intensity 
of the lipophilic dye DiIC1(5) (far red emission). CCCP exposure was used as a positive 
control for induced apoptosis (left). No differences were observed in DiIC1(5) mean 
fluorescence intensities between the GFP-positive and -negative populations in co-cultures in 
medium containing FCS+LIF. 
 
Changes in cell proliferation during do-culture in ES cell medium were subsequently 
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investigated. Bromodeoxyuridine (BrdU), a synthetic thymidine analogue, gets 
incorporated into a cell's DNA when the cell is dividing (during the S-phase of the cell 
cycle) and can thus be used as a measure of cell proliferation. Co-cultures were 
incubated for 5 minutes in 20µM BrdU, immunostained and analysed by confocal 
microscopy. This analysis suggested that BrdU was incorporated mainly by GFP-
negative cells (Figure 6.2A) but quantification of this difference was difficult. To 
facilitate and make quantification more accurate, BrdU incorporation was 
subsequently analysed by FC. As shown in Figure 6.2B, FC analysis after different 
periods of exposure to BrdU demonstrated that a lower percentage of C1-Bmpr1a-/--
GFP cells in co-cultures incorporated BrdU, indicating a lower number of proliferating 
cells, both compared to 3.5-WT cells in the same co-cultures, and to C1-Bmpr1a-/--
GFP in separate cultures. However, this difference was small and not statistically 
significant (p>0.05, student’s t test).  
Cell proliferation in co-cultures was also assessed using the SNARF-1 dilution 
method (Magg and Albert, 2007). The carboxyl seminaphthorhodafluor (SNARF-1) 
dye is cell permeable in the acetomethyl ester form and diffuses passively into the 
cells where after deacetylation it is captured by cellular esterases. Once bound 
intracellularly this dye is symmetrically diluted in the daughter cells after each cell 
division and its dilution can therefore be used as a proliferation indicator. Unlike more 
commonly used proliferation dyes, such as CFSE, the far red emission of SNARF-1 
allows its use in combination with GFP. SNARF-1 was loaded into co-cultures at 
passage 3 and the fluorescence intensity was analysed by FC up to 72 hours after 
loading. After 72h the fluorescence intensity was almost at the background level and 
so no further analysis was possible. This analysis revealed that the two cell types in 
co-culture had very similar proliferation rates, and only a very small difference in 
fluorescence intensity indicated that 3.5-WT cells proliferate slightly faster than C1-
Bmpr1a-/--GFP cells in co-cultures (Figure 6.2C).  
 136 
 
 
Figure 6.2 Proliferation analysis of co-cultures of Bmpr1a-/- and WT ES cells in medium 
containing LIF and FCS. 
 (A) Confocal image showing the projection of multiple optical z-sections after immunostaining 
for BrdU incorporation (red) in co-cultures of 3.5-WT and C1-Bmpr1a-/--GFP ES cells at 
passage (P)4. (B) Flow cytometry (FC) analysis of immunostaining for BrdU incorporation 
after 5, 45 and 120 minutes of BrdU exposure. No significant differences were observed in 
BrdU incorporation between separate cultures and co-cultures (passage3) of 3.5-WT and C1-
Bmpr1a-/--GFP ES cells in medium containing FCS+LIF. Data shown as mean +/- s.d. (n=3)  
(C) Histograms of SNARF fluorescence analysis by FC (left) and graphical representation of 
mean fluorescence intensities (right), just after loading of the dye (0h), and at different time 
points after loading. Data shown as mean +/- s.d. (n=2) 
 
 
The cell cycle profiles of sorted cells after co-culture was also analysed but no 
differences were observed (Figure A.2, in appendixes section) 
Overall, these results show that the co-culture of C1-Bmpr1a-/--GFP cells with 3.5-WT 
cells in ES-cell maintenance conditions (containing LIF and FCS) does not induce 
changes in apoptosis but does seem to cause slightly reduced cell proliferation of 
C1-Bmpr1a-/- cells. 
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6.2.2. Reduced proliferation and increased differentiation of 
Bmpr1a-/- cells in serum-free medium lead to their out-
competition from co-cultures with WT cells. 
Since the co-culture of Bmpr1a-/- and WT cells in basal (serum-free) medium 
considerably enhanced cell competition, the role of apoptosis and cell proliferation in 
the out-competition of Bmpr1a-/- cells was subsequently analysed in these conditions.  
As can be seen in Figure 6.3A, after 4 days in co-culture, the levels of annexin V 
staining of C1-Bmpr1a-/--GFP cells were very similar to the ones of this cell type in 
separate cultures. Regarding 3.5-WT cells, a small decrease in apoptosis was 
observed in co-cultures, but this was not statistically significant (p>0.05, student’s t-
test).  
Apoptotic cell death was also investigated in competing co-cultures of E14-WT-GFP 
and Fr124-Bmpr1a-/- ES cells. In this case, the number of early apoptotic annexin V-
positive/PI-negative Fr124-Bmpr1a-/- cells was moderately increased in co-cultures in 
comparison to separate cultures (p>0.05, student’s t test) and did not change in E14-
WT-GFP cells (Figure 6.3B).  
These results suggest that apoptosis is not a major factor leading to the out-
competition of Bmpr1a-/- cells in basal medium.  
 
Figure 6.3 Apoptosis analysis of co-cultures of Bmpr1a-/- and WT ES cells in basal 
medium.  
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Figure 6.3 Apoptosis analysis of co-cultures of Bmpr1a-/- and WT ES cells in basal 
medium.  
Graphical representation of the percentage of annexinV-positive/PI-negative cells obtained by 
flow cytometry analysis for the GFP-positive and GFP-negative cell populations in separate 
cultures and co-cultures of (A) 3.5-WT and C1-Bmpr1a-/--GFP ES cells, and (B) E14-WT-GFP 
and Fr124-Bmpr1a-/- ES cells, in serum-free basal medium. Data shown as mean +/- s.d. 
(n=3) 
 
Changes in cell proliferation in serum-free co-cultures were next investigated. As 
shown in Figure 6.4A and 6.4B the number of BrdU-positive Bmpr1a-/- cells in co-
cultures was lower than in separate cultures and than in co-cultured WT cells. This 
was true both for co-cultures of C1-Bmpr1a-/--GFP with 3.5-WT cells and of Fr124-
Bmpr1a-/- with E14-WT-GFP cells. These differences were not statistically significant 
(p>0.05, student’s t test), which may be due to the variability in competition efficiency 
between assays, as well as the low number of biological replicates (n=3). However, 
the tendency for a lower number of Bmpr1a-/- cells in S-phase in co-cultures was 
constant and reproducible. 
These results indicate that the co-culture of Bmpr1a-/- with WT ES cells induces a 
decrease in proliferation of the cells with lower BMP signalling activation, hence 
contributing to their out-competition.  
 
Figure 6.4 Bmpr1a-/- ES cells show decreased proliferation when co-cultured with WT 
cells in basal medium. 
Percentage of cells positive for BrdU incoporation after a 2 hour BrdU exposure in separate 
cultures and co-cultures of (A) 3.5-WT and C1-Bmpr1a-/--GFP ES cells, and (B) E14-WT-GFP 
and Fr124-Bmpr1a-/- ES cells, in serum-free basal medium. Data shown as mean+/-s.d. (n=3) 
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Given the close association between cell-cycle regulation and the self-
renewal/differentiation choice in ES cells (Burdon et al., 2002; Orford and Scadden, 
2008; Singh and Dalton, 2009), and the role of BMP4 in ES-cell self-renewal (Qi et 
al., 2004; Ying et al., 2003a) we hypothesised that Bmpr1a-/- cells could be 
differentiating in result of the competitive interactions with WT cells. 
For the study of ES cell differentiation, cells in co-cultures were stained for the 
pluripotency marker SSEA-1 and analysed by FC. Figure 6.5A shows that a 
significantly higher percentage of SSEA-1 negative (differentiated) C1-Bmpr1a-/-cells 
cells were found in co-cultures compared to separate cultures (nearly 2-fold increase, 
p<0.05, student’s t-test). The role of differentiation in the out-competition of Bmpr1a-/- 
cells was further confirmed by performing co-cultures in conditions in which 
differentiation is inhibited. LIF promotes self-renewal by activating the STAT3 
transcription factor (Matsuda et al., 1999; Niwa et al., 1998; Smith et al., 1988; 
Williams et al., 1988), and is capable of maintaining relatively undifferentiated 
cultures, even though it only completely inhibits differentiation in combination with 
serum or BMPs (Ying et al., 2003a). Differentiation is also efficiently blocked, and 
self-renewal maintained, in the presence of chemical inhibitors of ERK (PD0325901) 
and GSK3 (CHIR99021) signalling (2i) (Ying et al., 2008). As shown in Figure 6.5B 
cell competition was completely inhibited both by LIF and 2i conditions. Surprisingly, 
even in the presence of each inhibitor separately (PD or CHIR) competition was 
blocked to a similar extent to the 2i. The role of differentiation in the out-competition 
of Bmpr1a-/- ES cells was also tested in co-cultures of the Bmpr1a-null Fr124 and 
E14-WT cells. Even though in this case a consistent increase in SSEA1-negative 
Bmpr1a-/- cells in co-cultures was not observed (Figure 6.5C), LIF and the ERK and 
GSK3 inhibitors were able to block cell competition, in a similar way to the co-
cultures of C1-Bmpr1a-/- and 3.5-WT cells (Figure 6.5D). 
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Figure 6.5 Inhibition of differentiation prevents the out-competition of Bmpr1a-/- ES 
cells from co-cultures with WT cells. 
(A) Expression of the mouse ES-cell marker SSEA1 was assessed by flow cytometry (FC) 
after immunostaining of live cells. The increased number of SSEA1-negative cells in co-
cultured C1-Bmpr1a-/--GFP ES cells is indicative of increased differentiation of these cells. 
Data shown as mean +/- s.d. (n=3) (B) Representation of the WT/Bmpr1a-/- ratios (3.5-
WTcells/C1-Bmpr1a-/--GFP cells) obtained when cells were grown in separate cultures and in 
co-cultures for 4 days (d4) in different growth conditions. The orange dashed line represents 
the WT/Bmpr1a-/- ratio at the beginning of the experiment (d0, ratio=1 would be maintained if 
neither of the cell lines had a growth advantage over the other one) and the purple dashed 
line represents the WT/Bmpr1a-/- ratio in serum-free basal medium, where significant 
competitive interactions are observed. Inhibition of differentiation by the addition of LIF, 2i 
(MEK inhibitor PD0325901 plus GSK3 inhibitor CHIR99021), or each inhibitor separately (PD 
or CHIR) to basal medium also prevented competitive interactions between 3.5-WT and C1-
Bmpr1a-/--GFP ES cells. (C) Percentage of SSEA1-negative cells in co-cultures of E14-WT-
GFP and Fr124-Bmpr1a-/- ES cells. (D) Representation of WT/Bmpr1a-/- ratios obtained for 
separate cultures and co-cultures of WT-GFP and Fr124-Bmpr1a-/- ES cells after 4 days (d4) 
in basal medium and in conditions where differentiation is inhibited (n=1). 
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To find out whether Bmpr1a-/- cells are differentiating into any particular fate, the 
expression of lineage specific markers was analysed. As shown in Figure 6.6, only 
Krt18 and Krt14 show some degree of up-regulation in C1-Bmpr1a-/- cells in co-
cultures, indicating differentiation into early epidermis (Turksen and Troy, 1998). 
Concomitantly, Bmpr1a-/- ES cells down-regulate the neural precursor marker Nestin 
in co-culture.  
 
Figure 6.6 Out-competed Bmpr1a-/- ES cells show upregulation of epidermal and 
downregulation of neural specific genes.  
qRT-PCR gene expression analysis of neural (Sox1, Pax6 and Nestin), epidermal (Krt18 and 
Krt14), endodermal (Gata4 and Gata6) and mesodermal (Flk1 and T)  lineage specific 
markers. Gene expression was analysed in 3.5-WT and C1-Bmpr1a-/--GFP ES cells cultured 
separately (sep) and in FACS sorted co-cultures (mix) at the fourth day of serum-free culture. 
Expression values were normalised to Hmbs and Hprt1 expression; data shown as mean +/- 
s.d. (n=2). 
 
6.2.3. “Winner” cells in competing co-cultures have increased 
levels of c-MYC. 
In Drosophila, dMyc expression levels determine cell competitive interactions 
between cells, both in the wing epithelium and in the stem cell ovary (de la Cova et 
al., 2004; Moreno and Basler, 2004; Rhiner et al., 2009). The MYC family of 
transcription factors is implicated in a variety of biological processes (reviewed in 
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Eilers and Eisenman, 2008; Meyer and Penn, 2008), among them cell cycle 
regulation (Obaya et al., 1999; Oster et al., 2002) and control of ES-cell self-renewal 
(Cartwright et al., 2005; Singh and Dalton, 2009). Therefore, we asked whether c-
MYC has a role in the out-competition of Bmpr1a-/- ES cells. 
We first analysed the c-Myc mRNA levels in 3.5-WT and C1-Bmpr1a-/--GFP cells in 
ES-cell maintenance conditions (with LIF and FCS), in FACS sorted co-cultures after 
3 and 4 days in basal medium, and in control separate cultures at the same stages. 
As shown in Figure 6.7A, C1-Bmpr1a-/- ES cells express higher levels c-Myc than 
matched WT cells in FSC+LIF. After LIF withdrawal, the levels of c-Myc expression 
drop in both cell types, but a relatively higher expression is maintained in C1-
Bmpr1a-/- cells in separate cultures. However, when the two cell types are mixed, c-
Myc expression is similar in the two cell types.  
The levels of c-MYC protein at these same stages were next analysed by western 
blot. To control for the potential protein degradation during the FACS sorting required 
to separate mutant and WT cells in the co-cultures, protein lysates from separate 
cultures were obtained both before and after submitting the cells to FACS.  
Regarding the samples that did not go through FACS sorting, it can be seen in 
Figure 6.7B that c-MYC expression was significantly lower in cells grown in serum 
free basal medium than in the maintenance conditions containing serum and LIF. 
After 3 days in basal medium, c-MYC levels were higher in C1-Bmpr1a-/- ES cells 
than in control WT cells, which is in agreement with the mRNA expression levels, but 
this difference was lost by the fourth day in culture. Comparing these with the 
expression levels of matched samples that were submitted to FACS sorting, it is 
clear that a substantial amount of protein degradation takes place during the duration 
of the sorting procedure (Figure 6.7B). We can thus infer that the co-culture samples 
underwent similar levels of degradation. This makes even more surprising the 
observation that, at the third day of co-culture in basal medium, c-MYC could be 
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detected at considerably higher levels in co-cultured 3.5-WT cells than in co-cultured 
C1-Bmpr1a-/- cells medium (Figure 6.7B and Figure A.3 in Appendixes section). No 
difference was observed when the cells were grown separately or at the fourth day of 
co-culture in basal medium (Figure 6.7B). 
 
Figure 6.7 WT ES cells have increased c-MYC levels when co-cultured with Bmpr1a-/- 
ES cells. 
 (A) qRT-PCR analysis of cMyc gene expression in separate cultures (sep) and FACS sorted 
co-cultures (mix) of 3.5-WT and C1-Bmpr1a-/--GFP ES cells grown in ES-cell maintenance 
conditions containing FCS+LIF, and at the third (d3) and fourth (d4) days of culture in serum 
free conditions (Basal medium). Expression values were normalised to Hmbs and Hprt1 
expression; data shown as mean +/- s.d. (n=2). (B) Protein lysates were obtained from 3.5-
WT and C1-Bmpr1a-/--GFP ES cells in the following conditions: separately cultured in 
FCS+LIF, separately cultured (sep) in serum free (basal) medium, before and after FACS 
sorting, at the third (d3) and fourth (d4) day of separate culture (sep), and after co-culture 
(mix) in serum free (basal) medium, after FACS sorting, at the third (d3) and fourth (d4) day of 
culture. The expression of c-MYC protein in these lysates was analysed by western blot. 
PCNA was used as loading control. 
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The higher levels of c-MYC observed in WT cells at the third day of co-culture could 
be due to a considerably increased expression of this protein. This is an unlikely 
hypothesis given the RNA expression, but it cannot be excluded as it could be 
regulated at the translational level or differences in transcription could have been 
present at earlier stages. Alternatively, the observed differences could be due to an 
increased stability of c-MYC in the WT cells when co-cultured with Bmpr1a-/- ES 
cells.  
 
6.2.4. Investigating how ES cells sense differences in BMP 
signalling during competition.  
Finally, the mechanism by which ES cells in competing co-cultures compare their 
relative levels of BMP signalling and determine the differentiation of Bmpr1a-/- cells 
was investigated.  
To determine whether Bmpr1a-/- and WT cells were competing for limiting amounts of 
BMPs in the culture medium, co-cultures were carried out in the presence of BMP 
ligands and of BMP antagonists.  
Adding BMP4 and BMP7 to the culture conditions has intrinsically different effects in 
terms of SMAD1//5/8 activation in WT and Bmpr1a-/- cells. BMP4 increases the 
disparity in BMP activation between the two cell types, whereas BMP7 induces 
activation of the pathway in both of them (see Figure 3.7B in chapter 3). Surprisingly, 
none of these ligands significantly altered the competition outcome in co-cultures 
(Figure 6.8A). 
To investigate the effect of further limiting BMP availability in culture, the competition 
assays were performed in the presence of the BMP antagonist Noggin and of the 
fusion protein BMPR1A-FC, a soluble dominant negative form of BMPR1A. The 
efficiency of different concentrations of Noggin and of BMPR1A-FC was initially 
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tested (Figure A.4, in appendixes section). Both 50 and 250 ng/ml of Noggin were 
able to block Smad1/5/8 activation in response to 10 ng/ml BMP4, whereas inhibition 
by BMPR1A-FC was only effective at the higher concentration. The addition of 
Noggin and BMPR1A-FC at concentrations that efficiently blocked Smad1/5/8 
phosphorylation led to a small and but not significant increase in competitive 
interactions (Figure 6.8B). 
 
 
Figure 6.8 Cell competition between WT and Bmpr1a-/- ES cells in the presence of BMP 
ligands and inhibitors. 
 (A) Representation of the WT/Bmpr1a-/- ratios  (3.5-WTcells/C1-Bmpr1a-/--GFP cells) in 
separate cultures and in co-cultures of the two cell types after 4 days (d4) in the absence 
(Basal) or presence of BMP4 or BMP7. (B) WT/Bmpr1a-/- ratios in separate cultures and in 
co-cultures, after 4 days growth in the presence or absence of Noggin and the BMPR1A-FC 
chimera. The orange dashed line represents the WT/Bmpr1a-/- ratio at the beginning of the 
experiment (d0, ratio=1) and the purple dashed line represents the WT/Bmpr1a-/- ratio in 
serum-free basal medium, where significant competitive interactions are observed. All data is 
represented as mean +/- s.d. (n=2). 
 
Together, these results indicate that WT and Bmpr1a-/- cells in mixed cultures do not 
compete for limiting amounts of BMPs. However competitive interactions may be 
enhanced when BMP availability is additionally restricted by inhibition of autocrine or 
paracrine signals. 
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If Bmpr1a-/- and WT ES cells do not compete for limited BMP availability, another 
mechanism must ensure that they communicate their relative degree of BMP signal 
transduction. In the epithelium of the Drosophila wing, this process has been 
reported to be mediated by soluble factors produced by both cell types, although 
these cells do not necessarily have to be in physical contact (Senoo-Matsuda and 
Johnston, 2007). 
We thus tested whether a similar mechanism may be allowing the cells to perceive 
and respond to differences in BMP transduction in neighbouring ES cells. With this 
aim, 3.5-WT and C1-Bmpr1a-/--GFP cells were grown in basal media conditioned by 
each cell type separately, or by 3.5-WT and C1-Bmpr1a-/--GFP co-cultures. The cell 
growth after 4 days culture in these conditions was assessed in terms of the number 
of viable cells present in the culture. Preliminary results (Figure 6.9) showed that 
cells grown in conditioned medium (CM) have a significantly reduced proliferation or 
viability, likely due to nutrient depletion of the medium while it was being conditioned. 
These experiments also indicated that medium conditioned by 3.5-WT cells as well 
as medium conditioned by competing co-cultures gives a small growth disadvantage 
to C1-Bmpr1a-/--GFP cells, which is not observed when these cells are grown in 
medium conditioned by C1-Bmpr1a-/--GFP cells. However, these differences could be 
explained by differential nutrient depletion in the medium. Nutrient depletion is highly 
dependent on the cell density, which may not be exactly the same in the different 
cultures along the duration of the experiment due to small differences in cell 
proliferation (see Figure 5.4B). For this reason, different assays must be designed to 
test the role of soluble factors in cell competition, such as the culture of the two cell 
types in chambers that prevent their physical contact but allow sharing the same 
culture medium, and hence the exchange of soluble factors. 
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Figure 6.9 Analysis of role of secreted factors in cell competition. 
3.5-WT and C1-Bmpr1a-/--GFP ES cells were cultured in fresh basal medium, or in medium 
previously conditioned (CM) for 24 hours by each cell type grown separately or by co-cultures 
of both cell types. The number of viable cells in each growth condition was counted at the 
fourth day of culture.  
 
 
6.3. Discussion 
In the previous chapter, Bmpr1a-/- and WT ES cells were shown to establish 
competitive interactions. When co-cultured, these two cell types exhibited a growth 
behaviour different to the one shown in separate cultures, leading to the out-
competition of the cells with lower BMP activation. This process was observed to be 
more prominent in basal medium, a condition in which survival and growth factors 
are very limiting. But how do cells perceive the differences in signalling activation and 
determine their response to those differences? 
Fundamentally, two processes can be responsible for the out-competition of Bmpr1a-
/- in this system: increased cell death, or changes in cell cycle and proliferation. Both 
of these possibilities were investigated in co-cultures of Bmpr1a-/- and WT ES cells. 
This study was initially carried out in cultures containing LIF and serum, where no 
significant differences in apoptosis or cell proliferation were identified by any of the 
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different methods used to study these cellular processes. This is probably due to the 
slowness of the process in these culture conditions as it takes 5 to 6 passages 
(around 15 to 20 days), for the Bmpr1a-/- cells to be completely eliminated from the 
co-cultures. In serum-free basal medium cell competition was more efficient but no 
increased apoptosis of Bmpr1a-/- cells was observed. However, this observation does 
not rule out the contribution of cell death to the competition process. A factor to take 
into consideration is that the study of cell death in these ES cell cultures is 
complicated by two technical problems: first, dead cells generally detach from the 
ES-cell colony and start floating and, second, GFP expression is lost as cells die. 
Although annexin V staining identifies one of the early features of the apoptotic 
process, the loss of phospholipid asymmetry in the plasma membrane, it cannot be 
excluded that ES cells die very soon after this. Also, apoptosis is the most common 
and best studied form of programmed cell death but not the only one (Degterev and 
Yuan, 2008; Edinger and Thompson, 2004; Galluzzi et al., 2007a) and so features of 
other types of cell death should also be analysed, such as the activation of specific 
pathways and effectors.  
Regarding the study of cell cycle changes during cell competition, a reduced number 
of proliferating (BrdU-positive) Bmpr1a-/- cells was observed in competing co-cultures 
when compared to cells in separate cultures. Staining for the pluripotency marker 
SSEA-1 revealed that the decrease in Bmpr1a-/- proliferating cells was accompanied 
by their increased differentiation. The upregulation of Krt18 observed in Bmpr1a-/- 
cells in mixed cultures suggests differentiation into simple epithelium (early 
epidermis), what was initially startling given the described role of BMPs in promoting 
epidermal differentiation (see chapter 4). However, a more careful analysis of the 
published data showed that the BMP4 epidermal-inducing activity has been reported 
to be restricted to a short window between the 4th and 8th day of differentiation 
(Coraux et al., 2003). Also, our previous results show that culture in BMP4 from the 
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onset of differentiation is permissive of the epidermal fate (see Figure 4.6, chapter 4) 
but we do not know whether this choice would be favoured in the absence of BMP 
signalling during initiation of the differentiation process.  
An alternative hypothesis is that cell competition mimics what has been suggested to 
occur in Xenopus and chick embryos at the border between cells with high and low 
BMP signalling, where a form of cell communication has been proposed to be 
required for the induction of different fates (Linker et al., 2009). In a similar way, 
Bmpr1a-/- ES cells would normally undergo neural differentiation as they have very 
low levels of BMP signalling. However, if they are adjacent to cells that are 
responding to higher concentrations of BMPs, they are instructed not to initiate 
neural differentiation but rather to initiate epidermal differentiation. This model would 
suggest that cell differentiation is not only regulated by the overall levels of signalling, 
but also by the relative levels of signalling perceived by neighbouring cells. 
The crucial role of differentiation in the out-competition of Bmpr1a-/- cells was 
confirmed by the observation that in the presence of LIF and in 2i, conditions that 
inhibit ES-cell differentiation, cell competition is prevented. Surprisingly, the single 
activity of each of the components of the 2i (the MEK inhibitor PD0325901 and the 
GSK3 inhibitor CHIR99021) also prevented the out-competition of Bmpr1a-/- cells. 
Inhibition of ERK signalling in serum free medium in the absence of LIF suppresses 
differentiation even though cell viability is compromised (Ying et al., 2008). Given the 
short duration of our assay (4 days), ERK inhibition did not significantly impair cell 
viability. However, its differentiation-suppressing effect did block cell competition. 
Regarding GSK3 inhibition, it has been suggested to be an important effector 
mechanism of two different self-renewal signals, possibly converging in a common 
target. GSK3 activity antagonises Wnt signalling, so its inhibition would increase Wnt 
signalling activation, which has been described to maintain pluripotency of mouse 
and human ES cells (Sato et al., 2004). Furthermore, GSK3 inhibition has also been 
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reported to act downstream of LIF/STAT3 as a mechanism to maintain MYC stability 
and thereby sustain ES-cell self-renewal (Cartwright et al., 2005). 
Several lines of evidence point to a likely involvement of MYC in the out-competition 
of Bmpr1a-/- cells: 1) dMyc is involved in cell competition both in the Drosophila wing 
epithelium (de la Cova et al., 2004; Johnston et al., 1999; Moreno and Basler, 2004) 
and in the ovarian stem cell niche (Rhiner et al., 2009); 2) the cell cycle changes in 
out-competed Bmpr1a-/- cells are likely to be regulated by MYC (Obaya et al., 1999; 
Oster et al., 2002; Singh and Dalton, 2009); 3) the increased differentiation of 
Bmpr1a-/- cells could be caused by low MYC levels (Cartwright et al., 2005; Leon et 
al., 2009; Singh and Dalton, 2009); and 4) the suppression of cell competition by 
GSK3 inhibition could be due to a stabilisation of MYC in Bmpr1a-/- ES cells 
(Cartwright et al., 2005). 
qRT-PCR analysis showed that c-Myc mRNA levels were not higher in WT cells than 
in Bmpr1a-/- ES cells in conditions where cell competition could be observed. Indeed, 
c-Myc was found to be more highly expressed in Bmpr1a-/- cells than in WT cells, 
both in ES-cell maintenance conditions containing FCS and LIF, and up to after 4 
days culture in serum-free basal medium.  
Besides transcriptional regulation and RNA turnover, post-translational mechanisms 
also play a very important role in regulating MYC expression, specifically at the level 
of protein degradation/stability (Meyer and Penn, 2008). In particular, 
phosphorylation of Thr58 by GSK3 directs MYC ubiquitination and proteasomal 
degradation. Analysis of c-MYC protein levels revealed that, indeed, increased levels 
are present in WT cells in competing co-cultures. This is probably due to increased 
protein stability, even though confirmation of this requires the analysis of GSK3 
activity and Thr58 phosphorylation in both cell types in mixed cultures. It is thus 
logical to reason that increased c-MYC stability is an important effector, downstream 
of BMP signalling, in determining the out-competition of Bmpr1a-/- ES cells. However, 
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the importance of c-MYC stabilisation during cell competition should be further 
confirmed, for example by analysing the competitive behaviour of cells expressing a 
stabilised form of c-MYC (with the T58A mutation (Cartwright et al., 2005)). 
An important question in the study of cell competition is how cells are able to 
perceive their competitive potential in relation to their neighbours. The approaches 
taken here to start investigating this matter have not been able to provide a clear 
answer. They have shown that cells in co-cultures do not compete for limiting 
amounts of BMPs, but also that competitive interactions are maximized when 
autocrine and paracrine BMP signals are also inhibited. This indicates that 
comparison of BMP signalling activity is important for cell competition, but other 
factors must also be mediating this process. The communication mechanism by 
which ES cells compare their competitive levels and instruct appropriate responses 
remain elusive. 
 
Overall, these findings establish a system in which competitive interactions between 
ES cells lead to the elimination of the cells with lower BMP signaling. Comparison of 
BMP transduction abilities, via a still unidentified mechanism, leads to a stabilisation 
of c-MYC in more competitive cells, and to reduced cell proliferation, increased 
differentiation and, therefore, out-competition, of cells with a lower ability to 
transduce BMP signaling. 
Stem cell interactions such as the ones described here may significantly contribute to 
the balance between self-renewal and differentiation, and ensure the elimination of 
abnormal or less adapted cells. Therefore, it may be an important mechanism 
regulating normal development and tissue homeostasis. 
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GENERAL DISCUSSION 
 
BMPR1A is the type I BMP receptor most highly expressed in the pluripotent ICM 
and early epiblast of the mouse embryo (Mishina et al., 1995; Roelen et al., 1997), 
and in undifferentiated ES cells (Qi et al., 2004; Ying et al., 2003a). Signalling via 
BMPR1A is required in the mouse embryo to maintain pluripotency and prevent 
precocious neural differentiation of the epiblast (Di-Gregorio et al., 2007) and for 
mesoderm and endoderm formation (Beppu et al., 2000; Mishina et al., 1995). In 
mouse ES cells, BMP4 signalling inhibits neural differentiation, maintaining self-
renewal and pluripotency in combination with LIF (Ying et al., 2003a), and previous 
efforts to derive Bmpr1a-null ES cells required inhibition of the p38 MAPK pathway 
(Qi et al., 2004).  
The first aim of this thesis was to analyse in more depth the role of BMPR1A in 
mouse ES-cell self-renewal and differentiation, as well as the downstream effectors 
involved in regulating these processes. In this study Bmpr1a-/- ES cells were derived 
in the absence of MAPK inhibitors. It is likely that this was possible due to the right 
balance between BMP/SMAD and LIF/STAT3 activation being achieved in the ES 
cell derivation conditions used. These cells could be maintained in culture for long 
periods in an undifferentiated state and although they did not activate any of the 
known intracellular responses to BMP4, they were able to self-renew and showed 
normal proliferation and gene expression patterns. The work presented indicates that 
Bmpr1a-/- ES-cell self-renewal is likely to be sustained by the presence of residual 
SMAD1/5/8 phosphorylation which is sufficient to maintain the expression of the 
target gene Id1. The low SMAD1/5/8 activation was maintained even in serum-free 
medium containing only LIF and BMP4. Evidence presented in this study indicates 
that this SMAD1/5/8 activation is probably due to autocrine stimulation of ACVR1 by 
BMPs of the OP-1 subgroup such as BMP7. Together, these results indicate that 
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SMAD1/5/8 is the main pathway involved in sustaining self-renewal downstream of 
BMPs. Additionally, they show that the ability to maintain ES-cell self-renewal and 
pluripotency is not restricted to BMP4/BMPR1A as signalling by members of the OP-
1 subgroup, like BMP7, elicits similar effects. 
Analysis of the differentiation of Bmpr1a-/- cells in different conditions showed that 
these cells are able to give rise to derivatives of the 3 gem layers, and therefore that 
they do not have pluripotency defects. However, they seem to have a predisposition 
for neural specification, which is in accordance with the described requirement for 
low BMP signalling during neural induction in the embryo (Arnold and Robertson, 
2009; Hemmati-Brivanlou and Melton, 1997; Kishigami and Mishina, 2005) and the in 
vitro function of BMPs in blocking ES-cell neural differentiation (Ying et al., 2003a; 
Ying et al., 2003b). The mechanism by which the lower BMP signalling levels in 
undifferentiated cells determine this tendency for increased neural differentiation is 
not clear in the present study. One possibility is that this could be a direct 
consequence of the differences in pSMAD1/5/8 and Id expression at the onset of 
differentiation, which could accelerate the differentiation process. However, the 
similar levels of expression of pluripotency and epiblast markers between mutant and 
control cells suggests that additional factors determine this increased neural 
differentiation. A possible alternative explanation is that, due to the lower BMP 
signalling, a permissive epigenetic state is established at the promoters of 
neurogenic genes, therefore allowing an accelerated neurogenesis once 
differentiation along the neural path is initiated. Clarification of this issue would 
contribute to the understanding of neural specification in the gastrulating mouse 
embryo where the BMP levels are kept low in certain epiblast populations due to the 
local expression of BMP antagonists (Arnold and Robertson, 2009; Kishigami and 
Mishina, 2005). 
A further observation made in this study was that in serum-free conditions at 
relatively high confluencies, differentiation of Bmpr1a-/- cells to an ectodermal fate 
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was favoured, with upregulation of markers of both neural and epidermal lineages. 
This observation raises the interesting possibility of the existence of a bipotent 
ectodermal precursor, previously postulated by Aberdam et al. (2007a). Further 
differentiation of this precursor to neural or epidermal lineages would be directed by 
external signals, in particular BMPs, or even possibly by mechanisms of cell-cell 
communication.  
 
In the second part of this study, the existence of competitive interactions between ES 
cells with differential levels of BMP signalling activation was investigated. Cell 
competition was first described to occur during the growth of the Drosophila wing 
epithelium where cells with higher ribosomal or biometabolic activity eliminate 
weaker cells in mosaic organisms (Diaz and Moreno, 2005; Johnston, 2009). Dpp is 
an important growth and survival factor during development of the Drosophila wing 
(Burke and Basler, 1996; Martin-Castellanos and Edgar, 2002) and the efficiency in 
Dpp uptake is one of the factors that determines the competitive potential of cells in 
this system (Moreno and Basler, 2004; Moreno et al., 2002). In the Drosophila ovary 
Dpp sustains self-renewal of GSCs by repressing the expression of differentiation 
factors (Chen and McKearin, 2003; Song et al., 2004) and it has also been involved 
in stem cell competition for niche residency of cells with different levels of dMyc 
expression (Rhiner et al., 2009).  
In this study, the co-culture of Bmpr1a-/- and WT ES cells led to changes in the 
behaviour of these cells, which resulted in the out-competition of those with lower 
levels of BMP activation. This process was inhibited when BMP signalling activity 
was re-established in Bmpr1a-/- cells, confirming that defective BMP transduction 
confers a competitive disadvantage to ES cells. However, it was also shown here 
that the ability for BMP signalling transduction is not the only factor that can induce 
competition in ES cells. 
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The competitive interactions between WT and Bmpr1a-/- cells were considerably 
increased in serum-free basal medium. In co-cultures in these conditions, a reduced 
cell proliferation and concomitant increased differentiation were observed in Bmpr1a-
/- cells. No evidence for the involvement of cell death in the out-competition of 
Bmpr1a-/- cells was found, although this matter requires further analysis.  
One important aspect to consider in these experiments is that the conditions that 
promote cell competition, besides being of very limiting amounts of survival and 
growth factors, are also conditions that induce ES-cell differentiation. When 
differentiation was prevented by the presence of LIF or in 2i medium, the out-
competition of Bmpr1a-/- cells was also prevented. Therefore, an intriguing 
hypothesis is that the undifferentiated ES-cell state is protective of cell competition, 
and only when the differentiation programme is initiated the cells become more 
vulnerable or responsive to competitive interactions. Differentiation is certainly 
involved in the out-competition of Bmpr1a-/- cells, but is it a trigger or a consequence 
of the competitive interactions? 
A striking way in which WT cells responded to the presence of Bmpr1a-/- cells was by 
increasing the levels of c-MYC protein, probably by increasing its stability. Increased 
Myc levels have been described to be involved in cell competition in both systems 
where this process has been studied in Drosophila (de la Cova et al., 2004; Johnston 
et al., 1999; Moreno and Basler, 2004; Rhiner et al., 2009). The observed c-MYC 
stabilisation could be achieved via the inhibition of GSK3 activity, which has been 
reported to direct MYC proteosomal degradation, but the mechanisms involved in the 
cell-cell comparison that leads to these changes are not known. The meaning of this 
increased stability is also unclear. High levels of c-MYC have been described to 
sustain self-renewal in the absence of LIF (Cartwright et al., 2005), and ectopic Myc 
expression promotes the stem cell state during reprogramming (Knoepfler, 2008; 
Takahashi and Yamanaka, 2006) and supports a “metastable” pluripotent state 
(Hanna et al., 2009). Therefore, one possibility would be that c-MYC stabilization 
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could be sustaining the undifferentiated state of WT cells, while Bmpr1a-/- cells 
differentiated, as expected in response to LIF withdrawal. However, SEEA-1 staining 
shows that the pluripotency of WT cells is only slightly increased in co-cultures. c-
MYC could also be regulating cell-cycle progression in WT cells (Singh and Dalton, 
2009) but again, changes in the number of proliferating cells were only observed in 
Bmpr1a-/- cells and not WT cells. Therefore, c-MYC stabilisation in WT cells seems to 
be part of a mechanism that will instruct changes in Bmpr1a-/- cells rather than 
directly changing the behaviour of WT cells. The specific role of c-MYC in this 
process, or the other players with which it interacts, should be subject of future 
studies. 
The specific changes in the behaviour of Bmpr1a-/- cells that lead to their out-
competition are also elusive. The most likely hypothesis is that WT cells are able to 
induce increased differentiation or instruct cell fate specification of Bmpr1a-/- cells in 
co-culture. As previously described, the culture of Bmpr1a-/- cells in basal medium at 
medium confluency, the same conditions in which the co-culture assays were 
performed, induces ectodermal differentiation. In these conditions, increased 
expression of both neural an epidermal markers was observed in Bmpr1a-/- cells, 
although it is not known yet whether this was in the same cell (a bipotent ectodermal 
precursor) or in different cells within the culture. In any case, our findings suggest 
that co-culture of Bmpr1a-/- ES cells with WT cells prevents them from undergoing 
neural differentiation and drives them towards an epidermal cell fate. The increased 
differentiation may then lead to these cells being diluted out from co-cultures, or their 
inability to respond to BMP4 may hinder progression of the epidermal differentiation 
programme causing cell-cycle arrest or cell death. In line with this, it would also be 
interesting perform the co-culture experiments in conditions that favour neural 
differentiation, using the monolayer differentiation protocol. 
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Figure 6.10 A model for cell competition between WT and Bmpr1a-/- ES cells. 
Competitive interactions between WT (left) and Bmpr1a-/- (right) ES cells lead to the 
elimination of the cells with lower BMP signaling. Comparison of BMP transduction abilities, 
via a still unidentified mechanism (?), leads to the stabilisation of c-MYC in more competitive 
cells. Stabilised c-MYC in WT cells, either by interacting with other effectors or via regulation 
of gene transcription, maintains proliferation in these cells and instructs differentiation and 
reduced cell proliferation in Bmpr1a-/-cells, eventually leading to their out-competition. The 
role of cell death in this process is still unclear (?). 
 
As summarised in Figure 7.1, in this study a system was established where 
competitive interactions between ES cells lead to the elimination of the cells with 
lower BMP signalling. An unidentified mechanism allows comparison of the relative 
BMP transduction abilities between the two cell types, leading to a stabilisation of c-
MYC in more competitive cells. c-MYC increased levels are probably part of a 
cascade of events that instruct reduced cell proliferation and increased differentiation 
or alternative cell fate choices in cells with a lower ability to transduce BMP 
signalling, eventually leading to their out-competition. Therefore, many intriguing 
questions remain. How do cells perceive the relative signalling abilities of 
neighbouring cells? Besides BMP transduction ability, which other factors determine 
competitive interactions between ES cells? Which effectors are involved, together 
with c-MYC, in responding to the relative competitive differences? How do cells 
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instruct the “winner” or “loser” behaviour to each other? These are just some of the 
many questions that this study raised for future investigations. 
The existence of cell competition in vivo is another important issue to resolve. As a 
first approach to an in vivo system, the behaviour of co-cultures of cells with 
differential BMP signalling during embryoid body differentiation should be 
investigated (as embryoid bodies recapitulate many of the events during early 
embryonic development). For further in vivo analysis, mutant clones should be 
specifically induced in wild-type mouse embryos (and vice-versa) by mitotic 
recombination (Liu et al., 2002) and the proliferative and apoptotic behaviour of this 
clones investigated. 
Overall, the system described here shows that the potential for proliferation and 
survival, and possibly the cell fate choices, of a differentiating cell are determined by 
interactions with its neighbours. These interactions may be fundamental in regulating 
the balance between self-renewal and differentiation, and selecting fitter cells during 
mammalian development and tissue homeostasis. For example, competitive 
interactions may be involved in many processes during development such as 
cavitation of the peri-implantation embryo, where cell death takes place in response 
to BMP signalling levels (Coucouvanis and Martin, 1995; Coucouvanis and Martin, 
1999) or in the maintenance of adult stem cell niches such as in the haematopoietic 
system where c-MYC controls the balance between stem cell self-renewal and 
differentiation (Wilson et al., 2004). Furthermore, expansion of one cell population at 
the expense of another is a characteristic of tumour progression (reviewed in Baker 
and Li, 2008; and Rhiner and Moreno, 2009). Therefore, understanding the 
determinants, mechanisms and regulation of cell competition is a fundamental 
biological question. 
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APPENDIXES 
Table 1 Primers for the amplification of transcripts by quantitative RT-PCR.  
 
Gene Forward sequence Reverse sequence 
Gapdh TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
Hprt1 TGACACTGGTAAAACAATGCA GGTCCTTTTCACCAGCAAGCT 
Hmbs ACTGGTGGAGTCTGGAGTCTAGATGGC GCCAGGCTGATGCCCAGGTT 
βActin CTAAGGCCAACCGTGAAAAG ACCAGAGGCATACAGGGACA 
Pgk1 GCTGTTCCAAGCATCAAATTCT CCCTTCCCTTCTTCCTCTACAT 
Oct4 CGTGGAGACTTTGCAGCCTG GCTTGGCAAACTGTTCTAGCTCCT 
Nanog CTTACAAGGGTCTGCTACTGAGATGC TGCTTCCTGGCAAGGACCTT 
Sox1 GCGAGATGATCAGCATGTACC TAGTGCTGTGGCAGCGAGT 
Msx1 GCCTCTCGGCCATTTCTCAG CGGTTGGTCTTGTGCTTGCG 
Pax6 ACTTCAGTACCAGGGCAACC TCATCCGAGTCTTCTCCGTTA 
Nestin CTGCAGGCCACTGAAAAGTT TCTGACTCTGTAGACCCTGCTTC 
Krt14 CCTCTGGCTCTCAGTCATCC GAGACCACCTTGCCATCG 
Krt18 GACGCTGAGACCACACTCAC CTCCATCTGTGCCTTGTATCG 
Flk-1 AGAACATTTGTCCGAGTTCACA CGGACTTGACTGCCCACT 
Nkx2.5 CCCCAAGTGCTCTCCTGCTTTCCC GCCATCCGTCTCGGCTTTGTCCA 
Bry(T) CGACCACAAAGATGTAATGGAG CCAGCACCAGGAACAAGC 
Gata4 GAGGCTCAGCCGCAGTTGCAG CGGCTAAAGAAGCCTAGTCCTTGCTT 
Gata6 GACTCCTACTTCCTCTTCTTCTAATTCAGA ACCTGAATACTTGAGGTCACTGTTCTC 
Cdx2 CACCATCAGGAGGAAAAGTGA CTGCGGTTCTGAAACCAAAT 
Eomes TTCACCTTCTCAGAGACACAGTTCAT GAGTTAACCTGTCATTTTCTGAAGCC 
Bmp4 GAGGAGTTTCCATCACGAAGA GCTCTGCCGAGGAGATCA 
Bmp2 CGGACTGCGGTCTCCTAA �� GGGGAAGCAGCAACACTAGA 
Bmp7 CGAGACCTTCCAGATCACAGT CAGCAAGAAGAGGTCCGACT 
Bmpr1a CTCATTTCCATGGCTGTCTG CGACCCCTGCTTGAGATACT 
Bmpr1b CCCGGCCATAAGTGAAGA GGGTGGGGGCTGTACTCT 
Acvr1 ATTGAAGGGCTCATCACCAC AAGACCGGAGCCACTTCC 
Acvrl1 ACACCCACCATCCCTAACC ACCAGCACTCTCTCATCATCTG 
Bmpr2 GAGCCCTCCCTTGACCTG GTATCGACCCCGTCCAATC 
Id1 GCGAGATCAGTGCCTTGG CTCCTGAAGGGCTGGAGTC 
Id2 GACAGAACCAGGCGTCCA AGCTCAGAAGGGAATTCAGATG 
Id3 CAAGAGGAGCTTTTGCCACT GAGAGAGGGTCCCAGAGTCC 
c-Myc CCTAGTGCTGCATGAGGAGAC CCTCATCTTCTTGCTCTTCTTCA 
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Figure A.1 Gene Expression in 3.5-WT and C1-Bmpr1a-/- co-cultures. 
Gene expression analysis by qRT-PCR of lineage specific markers in 3.5-WT and C1-
Bmpr1a-/- GFP cells sorted before (P0) and after co-culture for 2 (P2) or 4 (P4) passages 
 
 
Figure A.2 Cell cycle profiles  of cells in co-cultures.  
Cell cycle profiles of 3.5-WT and C1-Bmpr1a-/- GFP cells sorted before (top pannel) and after 
3 passages in co-culture (bottom panel)  
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Figure A.3 c-MYC protein expression in 3.5-WT and C1-Bmpr1a-/- co-cultures.  
Western Blot analysis of c-MYC expression in 3.5-WT and C1-Bmpr1a-/--GFP ES cells 
separately cultured in FCS+LIF, and after FACS sorting of cells separately cultured (sep) or 
co-cultured (mix) for 3 days in serum free (Basal) medium. PCNA was used as loading 
control. 
 
 
Figure A.4 Effect of Noggin and Bmpr1a-Fc in SMAD1/5/8 activation. 
Western Blot showing the effects of different concentrations of Noggin and Bmpr1a-Fc in the 
inhibition of BMP signalling in ES cells. 
 
 
 
 
 
 
 
 
